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Chapter 1
Introduction
Recent advances in genotyping technologies have offered new opportunities for unraveling the ge-
netic basis of common human diseases. This technology has generated an unprecedented wealth of
data that provide us information on millions of genetic variants on each individual, but this high-
dimensional data demands novel analysis strategies. Genome-wide association studies (GWASs),
which aim to detect association between genetic variants and diseases, have been published on vari-
ous complex diseases. Although, new variants or loci are found to be associated with these diseases,
still very little of the genetic risk or heritability of these diseases are explained by these variants.
Heritability is defined as the proportion of phenotypic variance attributed to genetic differences
among individuals in a population. This thesis aims at investigating several alternative hypothe-
ses to explain this ‘missing heritability’ (Manolio et al., 2009) and develop statistical techniques to
improve the power to detect genetic variants influencing such diseases.
Complex diseases are associated with effects of multiple genes along with lifestyle and environ-
mental effects. Genes are the functional units of heredity and are made up of DNA (deoxyribonucleic
acid). Humans have two copies of every gene (each inherited from each parent). Although most
genes are same for all humans, a small fraction of genes vary slightly from person to person. These
differences arise as a result of differences in the sequence of nucleotides in the DNA. Different forms
of the same gene are called alleles.
Complex diseases are difficult to study and treat due to a lack of clear-cut pattern of inheritance of
genes. Moreover, specific factors affecting such diseases have not all been identified. The elucidation
of genetic risk factors for such diseases will enable disease prediction (probabilistic prediction), which
is particularly important for diseases whose risk can be reduced by using preventive medications
and/or lifestyle changes. Identification of genetic variants influencing complex diseases is the key
ingredient for developing personalized medicines. Personalized medicine is a medical model that
1
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proposes to customize medical decisions, products and/or practices for individual patients based on
the individual’s genetic information, along with other characteristics.
A major tool in identifying genes contributing to susceptibility risk of diseases is association study.
Genetic association studies test for correlation between disease status and genetic markers to identify
regions of the human genome that contribute to the disease risk. The most widely tested markers in
association studies are SNPs (single nucleotide polymorphisms). A single nucleotide polymorphism
(SNP) is a single nucleotide variation in genetic sequence which has been found to contribute to
90% of genetic variation. There is an estimated 12 million SNPs in human genome, distributed
uniformly across the genome. A higher frequency of a SNP allele in a number of individuals in the
population affected with the disease under consideration may mean that the tested SNP affects the
disease risk. GWASs provide a powerful approach for detection of SNPs associated with complex
disorders. Advancement in genotypic technology in recent times have made it possible for GWAS
to uncover numerous genetic regions implicated with human diseases.
GWASs typically focus on associations between a SNP and a disease. In general, the single
SNP association analysis, which takes each SNP as basic unit of association analysis, has a few
well-recognized serious limitations. If we consider only the most significant SNPs identified through
single SNP association analysis, the genetic variants which jointly have significant risk effects but
individually make only a small contribution will be missed. It has been recognized in the literature
that the typical single SNP association analysis may not be optimal in the presence of interactions
among genes, which are expected to be commonly present (e.g., Moore (2003); Millstein et al. (2006);
Zhang and Liu (2007); Lou et al. (2008); Kooperberg and LeBlanc (2008), and references therein).
On the other hand, a gene-based association analysis may allow us to gain insight into the functional
basis of the association, and facilitate in unraveling the mechanisms of complex diseases (Peng et al.,
2010).
Multilocus association analysis, such as gene-based association, provides a powerful alternative
by jointly modeling the variants within a gene or a pathway. In modeling joint effects of multiple
SNPs, the number of parameters may exceed the number of observations (‘curse of dimensionality’)
and may not provide us ‘good’ estimates of the effects. Most approaches tend to have too many
parameters to estimate as compared to the sample size. This problem is often encountered in
GWASs. So one needs to do some kind of variable selection to reduce the dimension of the problem.
We aim to develop a novel Bayesian dimension reduction method to detect multi-locus association
when we have data on multiple SNPs and the complex disease status on unrelated individuals.
To achieve our first goal, we developed a parsimonious model to study the joint effect of a group
of SNPs on a binary trait (disease status) for unrelated individuals (Ray et al., 2015). Suppose p
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is the number of SNPs (usually hundreds of SNPs are considered). We hypothesized that SNPs
within a gene/pathway interact with each other in determining the susceptibility to complex traits
or diseases. We use a Bayesian dimension-reduction approach that enables efficient estimation of the
joint effect of a large number of SNPs. By pooling the multilocus genotypes into ‘low-risk’, ‘high-risk’
and ‘not-associated’ categories based on direction of effects, our method reduces the dimension of the
genotype predictors from p to 3. Our model does not distinguish between main effects or interaction
effects of a group of SNPs, but our flexible scoring scheme captures high order interaction effects
effectively, and our efficient MCMC algorithm screens out the SNPs that are not associated with
the disease status. Effects of other covariates can be easily incorporated in the model.
Just as modeling the joint effects of multiple SNPs to incorporate the possibilities of interaction
could significantly improve the power to detect associated SNPs, and hence provide some explanation
to the mystery of ‘missing heritability’, modeling multivariate correlated traits may also improve
detection of genetic variants associated with a disease. In the study of a complex disease, several
correlated traits are often measured as risk factors for the disease. There may be genetic variants
affecting several of these traits (‘pleiotropy’). There exists various types of pleiotropy (Solovieff
et al., 2013). The phenomenon where a genetic variant has a direct biological influence on multiple
traits is known as biological pleiotropy. If one trait is causally related to a second trait so that
a genetic variant associated with the first trait is indirectly associated with the second trait, the
phenomenon is known as mediated pleiotropy. It has been shown that modeling multivariate pheno-
types may increase the power over analyzing individual phenotypes separately in genetic association
studies (Klei et al., 2008; Basu et al., 2013; Stephens, 2013). Various methods have been developed
which consider multiple traits in mapping complex disease genes.
As our second goal, we have considered studying several univariate and multivariate approaches of
analyzing multiple traits measured on a random sample of unrelated individuals from a population.
For analyzing multiple related phenotypes at a GWAS level, we considered methods that can be
used to perform single-SNP association analysis. Multivariate analysis of variance (MANOVA) is a
popular approach for testing association of a single SNP with multiple correlated traits. However,
our extensive theoretical and empirical study revealed certain situations where MANOVA suffers
significant loss in power. Stephens (2013), too, emphasized that multivariate association analyses
(such as MANOVA) are usually not advantageous when the SNP is associated with all the traits
(‘pleiotropy’). In such a scenario, a testing approach based on univariate models has better power
to detect association. One such test is the Sum of Squared Score (SSU) test proposed by Pan (2009)
in the context of testing association of a binary trait with multiple SNPs. Based on the behavior of
these two tests, we proposed a novel unified test that adaptively uses the data to optimally combine
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the SSU test and MANOVA. Since this test is meant to be applied at a GWAS level (where we have
millions of SNPs to test), we have developed a fast approximate p-value calculation method that
uses one-dimensional numerical integration. Since both SSU and MANOVA are score-based tests,
we call our novel approach Unified Score-based Association Test (USAT, Ray et al. (2015)).
This study is especially motivated by the need for detecting genetic variants influencing mul-
tiple correlated substance use disorders (SUDs) in Minnesota twin family studies. Originating 20
years ago, the Minnesota Center for Twin and Family Research (MCTFR) consists of a series of
complementary investigations of families over time, where each family, at intake, consisted of a pair
of adolescent offspring and their parents. Several SUDs (nicotine, alcohol consumption, alcohol de-
pendence, illicit drug, and behavioral disinhibition) measured in MCTFR twin families exhibit high
levels of comorbidity (co-occurrence at greater than chance levels), but association analysis with
these multivariate phenotypes at a GWAS level can be computationally intensive. The papers Li
et al. (2011); Basu et al. (2013) propose computationally efficient approaches to perform univariate
and multivariate phenotype association analysis with family data.
In recent times, the analysis of multiple phenotypes has gained popularity fueled by the hope
of better insight of the biological mechanisms underlying common human diseases. Scientists are
using existing large GWASs to analyze and study multiple related phenotypes underlying a disease.
Leveraging existing datasets not only saves monetary resources but also saves considerable time.
However, many of these GWASs are based on a case-control design. The case-control status is the
primary outcome/trait while the multiple disease-related phenotypes, which were measured during
the study, are called secondary traits. These secondary traits may be associated with the primary
trait and may share common genetic variants. Often this primary outcome acts as a confounding
variable in the test for association of a particular genetic variant with these secondary phenotypes
(Greenland, 2003). This results in biased estimates of genetic effects and very high type I errors. In
an effort to alleviate this problem, one may analyze only the cases in the sample, or only the controls,
or analyze the whole sample while adjusting for the disease status. In some scenarios of dependency
of the primary phenotype, the secondary phenotypes and the genetic variant, these naive approaches
do not provide unbiased estimates of the genetic effects and may suffer from severely inflated type
I error. In the context of a single secondary phenotype, Monsees et al. (2009) showed simulation
scenarios where most of these methods fail to perform well. Thereafter, quite a few methods have
been developed which take into account the bias arising from case-control ascertainment. However,
all of these methods, except one, consider a single secondary phenotype (usually binary) that cannot
be readily extended to multiple continuous phenotypes.
Our third goal is, therefore, to study the existing methods for the analysis of multiple secondary
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phenotypes. We studied several alternative models for the association of the primary traits with the
secondary traits and the genetic variants. Our theoretical and empirical studies have shown that
the magnitude of bias and the extent of type I error depend on the cause-and-effect relationship
among these three kinds of variables. Under one scenario, we found that models with adjustment
for disease status may increase bias and type I error compared to the unadjusted models. In another
scenario, we found that adjustment of disease status alleviated the problem of bias and inflated type
I error. Based on our detailed simulation studies, we proposed two new approaches for testing the
null hypothesis of no association of the genetic variant with the secondary phenotypes. The first
proposed method is a maximum p-value approach, where our test statistic is the maximum of the
p-values obtained from MANOVA with and without adjustment for the disease status in the model.
Due to the unavailability of an asymptotic distribution of the test statistic, the p-value needs to
be calculated empirically from several permuted datasets, and is, thus, suitable for candidate gene
studies. Our second proposed method is based on a proportional odds model with adjustment for
an estimated propensity score. The propensity score is modeled as the conditional probability of
the disease status given the secondary traits. The likelihood ratio test statistic from this approach
has an asymptotic distribution and can be easily implemented at a GWAS level using existing R
packages.
This thesis has been organized as follows: Chapter 2 contains details of our novel Bayesian
dimension reduction approach called the ‘Bayesian Partitioning Model’ (BPM, Ray et al. (2015))
along with results from our extensive simulation studies as well as real data analysis. Chapter 3
contains details of the existing univariate and multivariate approaches for the association analysis
of multiple phenotypes with single SNPs from unrelated individuals. It also develops our novel
multivariate approach USAT (Ray et al., 2015) that reports an approximate p-value using a fast
one-dimensional integration. Detailed simulation studies and application to ARIC type 2 diabetes
data show the comparative performance of all the approaches discussed and the advantage of USAT
over them. Chapter 4 discusses and explores scenarios in which popular strategies for analyzing
multiple secondary traits may give biased estimates of genetic effects and do not provide valid tests
of no association due to high type I error. Two alternative hypothesis testing approaches have
been proposed, which can maintain proper type I error and can have reasonable power to detect
association. Supplementary materials for each chapter have been provided in appendices at the end
of this thesis. A discussion section at the end of each chapter summarizes each of the proposed
methods along with future research directions.
Chapter 2
A Bayesian Partitioning Model for
Detection of Multilocus Effects in
Case-Control Studies
Summary: Genome-wide association studies (GWASs) have identified hundreds of genetic variants as-
sociated with complex diseases, but these variants appear to explain very little of the disease heritability.
The typical single locus association analysis in a GWAS fails to detect variants with small effect sizes and
to capture higher order interaction among these variants. Multilocus association analysis provides a pow-
erful alternative by jointly modeling the variants within a gene or a pathway and by reducing the burden
of multiple hypothesis testing in a GWAS. We have proposed here a powerful and flexible dimension re-
duction approach to model multilocus association. We use a Bayesian partitioning model which clusters
SNPs according to their direction of association, models higher order interactions using a flexible scoring
scheme, and uses posterior marginal probabilities to detect association between the SNP-set and the disease.
Our model has been illustrated using extensive simulation studies and we applied it to detect multilocus
interaction in a GWAS study with type 2 diabetes in Atherosclerosis Risk in Communities (ARIC) dataset.
We demonstrate that our approach has better power to detect multilocus interactions than several existing
approaches. When applied to ARIC dataset with 9328 individuals to study gene based associations for type
2 diabetes, our method identified some novel variants not detected by conventional single locus association
analyses.
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2.1 Introduction
The rapid progress in genotyping technology has greatly facilitated our understanding of the genetic
predisposition to various diseases. Several genome-wide association studies (GWASs) have been
published on various complex diseases, where genotype data on a large number of single nucleotide
polymorphisms (SNPs) are collected to study the association between these SNPs and the disease.
A common strategy to assess the effects of the SNPs on the disease is to perform a univariate
regression with each SNP as a predictor and rank the SNPs based on their p-values from the
univariate regression analysis. The top significant SNPs, which satisfy the genome-wide threshold
of multiple testing are reported by the studies. Several such GWASs have successfully detected
susceptibility SNPs associated with complex diseases, such as type 2 diabetes (Voight et al., 2010),
and Crohn’s disease and rheumatoid arthritis (Wellcome Trust Case Control Consortium, 2007).
Due to huge computational requirements, most of these GWASs are often limited to single SNP
association analysis.
Multilocus association analysis such as gene-based association has gained great impetus in recent
days as the single locus association findings have explained very little heritability of these complex
traits. Moreover with the advent of high throughput sequencing technologies, there is a dire need
to generate computationally efficient statistical methodologies to perform multilocus association
analysis. Numerous recent studies (Tibshirani, 1996; Gaya´n et al., 2008; Province and Borecki,
2008; Bush et al., 2009; Chen et al., 2010; Mukhopadhyay et al., 2010; Pan, 2010) have developed
multilocus association analysis techniques and software packages that evaluate the simultaneous
association of multiple loci and traits. This large group of multilocus association analysis approaches
can be classified into two broad categories; one that focuses on the detection of a subset of significant
SNPs associated with a disease from a large group of loci (which include many null or not-associated
loci), and the other that tests for association between a large set of loci and a disease without
classifying each SNP to null or non-null category (Wu et al., 2010; Larson and Schaid, 2013; Ma
et al., 2013).
The set of approaches that focus on the detection of a subset of significant SNPs from a large
group of loci tend to focus on modeling only the main effects of the SNPs (Tibshirani, 1996; Servin
and Stephens, 2007; Park and Hastie, 2008; Guan and Stephens, 2011; Li et al., 2011). There is
evidence that diseases often arise as a result of complicated interactions among SNPs (Merryweather-
Clarke et al., 2003). Hence there could be significant gain in the power for detection of associated loci
by allowing higher order interaction among these multiple SNPs. The major obstacle in modeling
of multilocus interaction is that the number of parameters increases exponentially with the number
of loci. Thus the approaches that allow for higher order interaction need to incorporate variable
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selection or other dimension reduction techniques in their statistical model for association between
the SNP-set and the disease (Lunetta et al., 2004; Schwartz et al., 2008; McKinney et al., 2009).
Bayesian model selection or variable selection approaches offer an alternative technique for selecting
multiple SNPs, and interactions among them. Several Bayesian approaches (Conti and Gauderman,
2004; Lunn et al., 2006; Zhang and Liu, 2007; Wakefield et al., 2010) have been developed that
include efficient variable selection. Fridley (2009) recently gave an extensive overview on the Bayesian
variable and model selection methods applied to genetic association studies.
Recently several attempts have been made to incorporate higher order interaction in Bayesian
multilocus modeling. Marttinen and Corander (2010) used model searching algorithm starting from
the marginal model to a saturated model to identify the optimal model for a combination of SNPs.
Papathomas et al. (2012) proposed a Bayesian nonparametric clustering approach combined with
variable selection to search for gene-gene interaction. Another popular parametric approach to detect
interaction under the Bayesian framework is the Bayesian Epistasis Association Mapping (BEAM)
(Zhang and Liu, 2007; Zhang et al., 2011; Zhang, 2011), which can handle large number of markers.
This approach uses dimension reduction by classifying SNPs into ‘Null’, ‘main’ or ‘interaction’ group
given their disease status. It still has limitations in terms of the number of loci that could be placed
in the ‘interaction’ category since the model uses the saturated model for the ‘interaction’ category.
This chapter presents a new Bayesian methodology to detect multilocus effects incorporating
the possibility of interaction among them in a case-control study setup. It aims to implement the
data reduction strategy in Basu et al. (2010, 2011) within a Bayesian framework, by pooling the
multilocus genotypes into ‘low-risk’, ‘high-risk’ and ‘not-associated’ categories based on direction of
effects; and thus reducing the dimension of the genotype predictors from p to 3. An advantage over
BEAM is that this approach can easily be extended to handle quantitative trait. Moreover it does
not use a saturated model for interaction, rather uses different scoring algorithm to capture higher
order interaction. We have considered two such scores to demonstrate the usefulness of the proposed
model. Unlike Basu et al. (2010, 2011), this approach uses three parameters to classify the SNPs
into ‘low-risk’, ‘high-risk’ and ‘not-associated’ categories and hence is expected to have better power
to detect multilocus association. The not-associated SNPs are efficiently separated through MCMC
updating, which also provides the posterior probability of each SNP in the SNP-set being associated
with the disease. Unlike BEAM, our model does not distinguish between main effects or interaction
effects of a group of SNPs, but our flexible scoring scheme captures high order interaction effects
effectively. Although our method can potentially be applied to scan a larger number of markers
for association, it is more suitable to be used for a SNP-set, such as for a gene or pathways, where
associations are searched within each gene or pathway instead of the whole genome.
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This chapter is organized as follows. Section 2.2 describes our Bayesian Partitioning Model
(BPM) and the reversible jump Markov chain Monte Carlo (RJMCMC) scheme in detail. In section
2.3, simulation results are presented to investigate the performance of few existing methods and
our BPM approach, demonstrating the advantages of the proposed method over several approaches.
Section 2.4 illustrates the application of the method to detect SNPs from a gene-based association
study with type 2 diabetes data on Atherosclerosis Risk in Communities (ARIC) study. We conclude
with a short summary and discussion outlining a few future research topics.
2.2 Method
2.2.1 A Dimension Reduction Approach via Bayesian Partitioning Model
(BPM)
Here we propose a Bayesian approach to identify the SNPs associated with a disease from a group
of p (p ≥ 2) SNPs. The model employs the data reduction strategy proposed in Basu et al. (2010,
2011) and models the joint effects of a group of SNPs on the trait and computes, via MCMC, the
posterior probability of each SNP (or SNP-set) being associated with the disease. The dimension
reduction strategy is to assume that the minor allele of each SNP can be either of 3 types :
1. low risk (LR) : minor allele is associated with decrease in disease risk (‘protective effect’)
2. not associated (NA) : minor allele has no effect on disease
3. high risk (HR) : minor allele is associated with increase in disease risk (‘deleterious effect’)
Let Y = (y1, . . . , yn)
T be the case-control status of n individuals; X = (X1, . . . ,Xn)
T be the
n × p matrix of predictors. For the ease of explanation, we will assume that we only have data on
SNPs. Hence Xi is a vector of the number of minor alleles of p SNPs for i-th individual. Each SNP
can have 0, 1 or 2 minor alleles. Let Aj denote the risk-label allocation of SNP j; j = 1, 2, . . . , p,
where Aj = (0, 1, 0), (1, 0, 0) or (0, 0, 1) denotes that SNP j belongs to NA, LR or HR category
respectively. It is to be noted that the choice of which allele to code does not matter with respect
to our dimension reduction strategy. It does not affect our conclusion because BPM detects SNPs
associated with a disease. A priori we do not know if a SNP is NA, LR or HR. This is equivalent
to the problem of model selection. For a set of p SNPs, we consider the risk allocation matrix A,
where A = (A1, ...,Ap)′ is a p× 3 matrix. Hence there are potentially 3p choices of models, which
we need to search through in order to find the model that best explains the joint effect of the group
of p SNPs on the trait and compute the posterior probability of observing the best model (or risk
allocation) given the trait and the marker data on the n individuals.
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Given a specific risk allocation A, the effect of the group of p SNPs is assessed using logistic
regression :
log
(
P (yi = 1|Xi,A)
1− P (yi = 1|Xi,A)
∣∣∣∣α, β1, β2) = α+ β1Z1i + β2Z2i, (2.1)
where β1 < 0 and β2 > 0 respectively defines the fixed effects of the LR and the HR group of SNPs,
and the predictors Z1i, Z2i are respectively the values of scores for the LR and HR groups of an
individual i, (i = 1, 2, ..., n). It is to be noted that the values of the predictors Z1 and Z2 depend
on the allocation A. A particular choice of this score would be Z1i= total number of minor alleles
for the i-th individual in the low-risk group and Z2i = total number of minor alleles for the i-th
individual in the high-risk group; (i = 1, 2, ..., n). We call it the ‘M-score’. The flexibility of our
method lies in the fact that many other scores can be proposed in order to capture the joint effect
of the SNP-set on the disease. We discuss another such choice of score in section 2.2.3.
Next we obtain the joint posterior distribution of A and β as
P [A,β|y,X] ∝ P [y|X,β,A]P [β|A]P [A] (2.2)
Here we use MCMC to study the joint posterior density given by equation (2.2). To construct
the Markov Chain, we make 3 simplifying assumptions in the model. First, we assume equal prior
probabilities for a SNP to be in the 3 categories. If applied to a genome-wide data, a more informative
choice of prior would be to assign much higher probability for each SNP to be in the NA (null)
group (Servin and Stephens, 2007), but we applied this model to the top genes identified by a
gene-based association analysis. Hence we decided to assign high probability for each SNP to be
in the non-null group. Moreover, our choice of prior gave a simplified form (equation (2.4)) of the
acceptance probability in equation (2.3). Second, we assume independent prior distributions of all
the SNPs, i.e., P [A] = ∏pj=1 P [Aj ] = constant. Third, we assume P [β|A] = P [β], where P [β]
is the prior distribution of β = (α, β1, β2) following a truncated tri-variate normal distribution :
β ∼ N3(µ,V ) × I(β1 < 0) × I(β2 > 0). We let the prior parameters µ = (0, 0, 0)′ and set V
such that we expect 95% of the SNPs to have relative risks that lie within [e−1.5, e1.5], as suggested
by Wakefield et al. (2010). The diagonal of V is, therefore, set at {1, 0.2072, 0.2072} and the off-
diagonal elements are set to be zero for an uncorrelated prior setting. The joint posterior distribution
(equation (2.2)) of A and β lives on a high-dimensional product space. The SNP allocation label
A lies on a discrete space {(0, 1, 0), (1, 0, 0), (0, 0, 1)}p while β ∈ R× R− × R+.
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2.2.2 Construction of the Markov Chain
We construct a Markov Chain using reversible jump (RJMCMC) with “dimension” moves, and
“allocation” & “coefficient” moves within a fixed dimension. The “dimension” moves include ‘death’
and ‘birth’ steps to increase or decrease the dimension, K, by one. The dimension parameter K
can take 4 values : 0, 1, 2, and 3, which refers to the case that the model has parameter(s) α; α and
β1; α and β2; and all three parameters α, β1, β2 in equation (2.1), respectively. The first step in
our RJMCMC is to choose one of the ‘death’, ‘birth’ and ‘fixed dimension’ moves at random. In a
‘death’ step, we drop one parameter, randomly choosing between β1 and β2. In a ‘birth’ step, we
propose β1 or β2 and update A from its full conditionals (as described a little later). The acceptance
probability for these dimension moves (from step t− 1 to step t) is min (1, a(K(t−1),K(t))), with
a(K(t−1),K(t)) =
P [K(t)]P [β(t),A(t)|K(t)]P [y|A(t),β(t),K(t)]P [K(t−1)|K(t)]
P [K(t−1)]P [β(t−1),A(t−1)|K(t−1)]P [y|A(t−1),β(t−1),K(t−1)]P [K(t)|K(t−1)]
× Q[D
(t−1)|D(t)]
Q[D(t)|D(t−1)] × |1| (2.3)
where Q[D(t)|D(t−1)] is the proposal density of the move from model D(t−1) in step t− 1 to D(t)
in step t. Since we assumed equal prior probabilities of a SNP to be in any of the 3 categories,
P [K(t)] = P [K(t−1)]. The 4 possible moves are random, hence P [K(t−1)|K(t)] = P [K(t)|K(t−1)].
Also, P [β(t),A(t)|K(t)] = P [β(t)|A(t),K(t)]P [A(t)|K(t)]. The possible moves along with the corre-
sponding acceptance probabilities are listed in Appendix A1.
We now look into the general form of the proposal density Q[D(t)|D(t−1)]. Note that,
Q[D(t)|D(t−1)] = P [β(t),A(t),K(t)|β(t−1),A(t−1),K(t−1)]
= P [β(t)|A(t),K(t),β(t−1),A(t−1),K(t−1)]P [A(t)|K(t),β(t−1),A(t−1),K(t−1)]
× P [K(t)|β(t−1),A(t−1),K(t−1)]
= P [β(t)|A(t),K(t)]P [A(t)|K(t)]P [K(t)|K(t−1)]
So, equation (2.3) reduces to the simple form of a likelihood ratio :
a(K(t−1),K(t)) =
P [y|β(t),A(t),K(t)]
P [y|β(t−1),A(t−1),K(t−1)] (2.4)
We obtain P [y|β(t),A(t),K(t)] and P [y|β(t−1),A(t−1),K(t−1)] using the model in equation (2.1).
Within a fixed dimension, we update the Markov chain through “allocation” and “coefficients”
moves, that is, we first update A from its full conditionals and then update β using Metropolis
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Hastings algorithm.
Updating Aj from full conditionals : We assume a multinomial prior for the configuration of SNPAj
and equal prior probabilities of being in the “low-risk”, “NA”, and “high-risk” categories. So, Aj ∼
Multinomial(m = 1; pj1 = 1/3, pj2 = 1/3, pj3 = 1/3), where Aj ∈ {(1, 0, 0)′, (0, 1, 0)′, (0, 0, 1)′}. If
A(−j) denotes configuration of all SNPs except the jth SNP, then the full conditional of Aj at step t
also has a multinomial distribution :
[
A(t)j
∣∣∣∣β(t−1),A(t−1)(−j) ] ∼ Multinomial(m = 1; p(t)j1 , p(t)j2 , p(t)j3),
where p
(t)
j1 , p
(t)
j2 , p
(t)
j3 are the posterior probabilities of SNP j to be in the LR, NA and HR group
respectively. These posterior probabilities are given by
p
(t)
js =
P [y|β(t−1),A(t−1)(−j) ,A(t)j = as]P [A(t)j = as]∑3
k=1 P [y|β(t−1),A(t−1)(−j) ,A(t)j = ak]P [A(t)j = ak]
, (2.5)
where s = 1, 2, 3, as ∈ {(1, 0, 0)′, (0, 1, 0)′, (0, 0, 1)′}, and P [y|β(t−1),A(t−1)(−j) ,A(t)j = as] =
P [y|β(t−1),A(t−1)(−j) ,A(t)j = as,K(t)] is obtained using the model in equation (2.1).
Updating β using Metropolis-Hastings : After updating A from its full conditionals and getting
A(t), we sample β∗ from the proposal density N3
(
β(t−1),V
)
I(β1 < 0)I(β2 > 0). For each
draw of β∗ from the proposal, we accept β∗ as β(t) with probability min
(
1, a′(β(t−1),β∗)
)
, where
a′(β(t−1),β∗) =
P [y|β∗,A(t)].P [β∗|A(t)]
P [y|β(t−1),A(t)].P [β(t−1)|A(t)] ×
P [β(t−1)|β∗]
P [β∗|β(t−1)] . Note that P [y|β
∗,A(t)] =
P [y|β∗,A(t),K(t)] and P [y|β(t−1),A(t)] are obtained from model in equation (2.1).
Implementation of the RJMCMC : To implement our RJMCMC steps, we start with a starting
allocation A(0) at dimension K = 3 and a starting β(0). A random choice is made about whether
to stay in the same dimension (K = 3) or reduce the dimension by 1 (K = 1 or K = 2). If a move
is made from K(0) = 3 to K(1) = 2, β1 is dropped, else β2 is dropped. If β1 is dropped, there should
be only HR SNPs or HR and NA SNPs. So, all the LR SNPs of A(0) are assigned to the NA group
in the candidate allocation A∗. If the dimension move selects staying in the same dimension, a SNP
is then randomly selected. Using the probabilities
p
(t)
js =
P [y|β(t−1),A(t−1)(−j) ,A(t)j = as]P [A(t)j = as]∑3
k=1 P [y|β(t−1),A(t−1)(−j) ,A(t)j = ak]P [A(t)j = ak]
, (2.6)
where s = 1, 2, 3, as ∈ {(1, 0, 0)′, (0, 1, 0)′, (0, 0, 1)′}, a new allocation is chosen for the selected
SNP, which gives us a candidate A∗. Under this allocation A∗, β is updated using Metropolis-
Hastings (MH) Algorithm. Within a particular A∗, we iteratively updated β 10 times via the MH
algorithm. We thus obtain a candidate β∗ for a candidate allocation A∗. Using MH Algorithm, we
then decide whether the parameters should be updated (A(1) = A∗, β(1) = β∗) or remain the same
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(A(1) = A(0), β(1) = β(0)). In our simulation studies and the real data analysis, we repeated the
above process 10, 000 and 500, 000 times respectively to generate MCMC samples from the posterior
distribution P [A,β|y,X] and estimated the marginal posterior probabilities of LR, HR and NA
group for each SNP by averaging over the different β values for each risk allocation A. It is to be
noted that 10, 000 MCMC iterations really correspond to 100, 000 iterations in our case since within
each iteration, β is iterated 10 times.
2.2.3 M-score vs. P-score
The M-score corresponds to a model (equation (2.1)) where Z1(Z2) is the total number of minor
alleles in the LR (HR) group. The M-score technique is theoretically equivalent to considering only
main effects of the SNPs in a logistic regression model with equal effect sizes of the SNPs in the LR
group and equal effect sizes of the ones in the HR group. For example, let us consider the allocation
A where the first p1 SNPs are in LR group and the rest p2 SNPs are in HR group, p1+p2 = p. Thus,
for individual i, M-score for LR group is Z1i =
∑p1
k=1Xik and for HR group is Z2i =
∑p2
j=1Xij .
Equation (2.1) becomes
logit
(
P [yi = 1|Xi,β,A]
)
= α+ β1Xi1 + . . .+ β1Xip1 + β2Xi(p1+1) + . . .+ β2Xip
Now we propose a pair-wise score to capture higher order interaction among the SNPs. The P-score
is calculated as total number of pairs of minor alleles in LR and HR groups. To implement P-score in
equation (2.1), we define Z1i as the number of unordered samples of minor alleles of size 2 (without
replacement) from the total number of minor alleles in the LR group of individual i (i = 1, 2, ..., n).
Similarly Z2i is defined for the HR group. Z1i = 1 (Z2i = 1) when there are only 2 minor alleles in
the LR (HR) group of ith individual. A score of 0.5 is arbitrarily assigned if there is only 1 minor
allele in a group.
Each allocation A and the corresponding P-score is equivalent to a multiple logistic regression
model with predictors as some function of the main effects and the pairwise interaction among the
SNPs. For our hypothetical example with first p1 SNPs in LR group and the rest p2 SNPs in HR
group, we consider the multiple logistic regression model (2.1) :
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logit
(
P [yi = 1|Xi,β,A]
)
= α+ β1
 ∑p1k=1Xik
2
+ β2
 ∑p2j=1Xij
2

= α+ β1
( ∑
s,t:s<t
XisXit +
p1∑
k=1
Xik(Xik − 1)/2
)
+β2
 ∑
l,m:l<m
XilXim +
p2∑
j=1
Xij(Xij − 1)/2

Thus, through P-score we can theoretically capture main effects as well as pair-wise interaction
effects among the SNPs. In practice, our simulation studies showed that P-score can capture higher
order interaction effects as well (refer section 2.3.1). Our simulation study (refer to Appendix A2)
using 1000 cases and 1000 controls showed the advantage of the proposed pair-wise-score modeling
(P-score) over the main effect modeling (M-score) in presence of interaction. One can use other
scoring schemes, such as Gaussian kernels, to capture interaction among SNPs.
2.3 Simulation Experiments
We performed several simulation studies to demonstrate the importance of the choice of scores for
our model and to compare our approach with several existing ones.
2.3.1 Simulation 1
We first compared our BPM approach with BEAM (Zhang and Liu, 2007) using simulation studies
on uncorrelated SNPs. We also compared our approach with the logistic kernel machine (LKM)
regression method. The kernel machine regression (KMR) tests (Wu et al., 2010) are computationally
efficient tests which score similarity among individuals through different choices of kernels (such as
linear, identity-by-descent, quadratic) and use a score test to detect association between the SNP-set
and the disease status.
We simulated data on 20 uncorrelated SNPs with 200 cases and 200 controls. Only the first 4
SNPs were associated with the case-control status. We considered 5 epistatic models with different
main effect sizes (and directions) and interaction effect sizes. Two-way, three-way and four-way
interactions were considered. We considered both additive and dominant genetic model for this
power comparison. The following models were used in our simulations:
Model 1: logit(p) = −4 + 15X1 + 15X2 − X3 − X4, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2
minor alleles respectively.
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Table 2.1: Comparison of BPM & BEAM: Power of the three methods in detecting the four associated SNPs
for Bonferroni corrected error level 0.0025 (= 0.05/20) based on 200 datasets with 200 cases and 200
controls.
Simulated Model
Method 1 2 3 4 5
BPM M-score 0.48 0.29 0.15 0.23 0.22
BPM P-score 0.41 0.31 0.55 0.21 0.19
BEAM 0.26 0.30 0.25 0.05 0.15
Model 2: logit(p) = −4 − 2X4 + X1X2X3, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2 minor
alleles respectively.
Model 3: logit(p) = −4 + 2X1X2X3X4, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2 minor alleles
respectively.
Model 4: logit(p) = −4 + 12X1X2 + 12X1X3 +X3X4, where Xj = 0, 1 for SNP j with 0, ≥ 1 minor
alleles respectively.
Model 5: logit(p) = −4 + 15X1 + 25X2 + 35X3 −X4, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2
minor alleles respectively.
For each of these models, we simulated 200 datasets with each SNP at minor allele frequency
(maf) 0.2. We first compared, using ROCs, the power of our BPM M-score and P-score approaches
with that of BEAM to detect genetic variants associated with disease. Here, we are interested in
testing the null hypothesis that a chosen SNP is null. For every simulated model, we considered a
range of cutoffs between 0 and 1, and for each cutoff, we calculated the number of times the posterior
probabilities of each of the associated SNPs (such as SNP1, SNP2, SNP3, SNP4) in the non-null
category was higher than the cutoff value. We also calculated the number of times the posterior
probabilities of each of the truly null SNPs was higher than the cutoff out of 200 simulations. We
generated a ROC curve by calculating the average number of truly associated SNPs (true positive
rate) detected and the average number of false-positives (false positive rate) detected by BPM and
BEAM for a given cutoff. The average number of false positives detected by BPM gives an estimate
of BPM’s type I error in testing if a chosen SNP is null. For BPM, we ran single chain of size 10, 000.
The first 5, 000 were discarded as burn-in. For BEAM, we took the default chain size of 100, 000
with a burn-in of 50, 000. Thin parameter was set at 1. The default prior probabilities of 0.01 were
used for each SNP to belong to marginal or interaction groups.
According to Figure 2.1 and Table 2.1, our BPM approach outperformed BEAM for all 5 models
at Bonferroni corrected level of 0.0025 (= 0.05/20) except for Model 2 where the performances were
very similar. For Model 1, we only had main effects under an additive genetic model. BEAM had
lower true positive rate (tpr) than BPM for a false positive rate (fpr) < 0.1. Especially M-score
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Figure 2.1: The ROCs for BPM (M- and P-scores) and BEAM for the 5 epistatic models with 4 causal SNPs. True
positive rate (tpr) or sensitivity for each dataset was calculated as the proportion of causal SNPs detected
based on their posterior marginal probabilities in the non-null category and for a series of cutoffs for the
posterior probabilities. It was averaged across the 200 simulated datasets with 20 uncorrelated SNPs.
In a similar way, false positive rate (fpr) was calculated. As the cutoff for the posterior probability was
varied, the fpr also varied. Increasing order of fpr is plotted along x-axis, and tpr along y-axis. Here,
the heavy black curve represents BPM P-score, the heavy blue dashed curve is BPM M-score and the
light red dashed curve is BEAM.
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Table 2.2: Comparison of BPM, BEAM & LKM: Power of the six methods in detecting at least one of the
four associated SNPs for Bonferroni corrected error level 0.0025 (= 0.05/20) based on 200 datasets with
200 cases and 200 controls.
Simulated Model
Method 1 2 3 4
BPM M-score 1.00 1.00 0.41 0.50
BPM P-score 0.93 0.98 0.91 0.48
BEAM 0.81 1.00 0.34 0.12
LKM-linear 0.91 0.995 0.84 0.56
LKM-quadratic 0.89 1.00 0.96 0.64
LKM-ibs 0.93 0.99 0.80 0.69
performed well due to its ability to capture the main effects effectively. For a Bonferroni corrected
level of 0.0025, BPM had a power of 0.48, while BEAM had only 0.26.
For Model 2, as soon as we added an interaction term to a main effect model, BPM P-score had
uniformly better power than the M-score and the BEAM due to its ability to capture interaction
effects. Even in the presence of a strong main effect, M-score could not outperform P-score. Here,
BEAM performed marginally better than BPM M-score.
The same was true for Model 3 (an interaction-only model) where BEAM outperformed M-score
marginally, but P-score captured the four-way interaction efficiently and outperformed BEAM. Here,
while BEAM had very low tpr of 0.25 at a fpr of 0.0025, BPM P-score had a good tpr of 0.55 (refer
Table 2.1). To see if BPM really performs better than BEAM in capturing higher-order interactions,
we also considered another additive genetic model (figure not provided here) where the first 5 out of
20 independent SNPs were causal and were interacting with each other to increase the disease risk.
The BPM P-score had uniformly better power than BEAM again.
For Model 4, we considered a dominant genetic model with only pairwise interaction effects. The
true effect sizes being small, all the methods lost some power under the dominant model, but BPM
had better power than BEAM (except for error levels close to 1). BPM M- and P-scores performed
similar according to the ROC curve (Figure 2.1).
For Model 5, our method outperformed BEAM even when the basic model assumption of equal
effect size was violated for our BPM approach. BEAM had lower power than BPM for an error level
of < 0.2, especially for M-score due to M-score’s ability to capture the main effects effectively.
Next we compared the powers of BPM, BEAM and LKM methods to detect multilocus associa-
tion. Our null hypothesis of interest is that none of the SNPs is associated with the disease status.
Since LKM can only test if a group of SNPs is associated or not at a given type I error level, we
calculated the number of times each of these BEAM and BPM approaches detected at least one
causal SNP out of the 4 SNPs for varying error levels. Table 2.2 and Figure 3.3 show that at Bonfer-
roni adjusted error of 0.0025, BPM had better power over BEAM and LKM for the main-effect-only
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Figure 2.2: The power curves for methods BPM (M- and P-scores), BEAM and LKM (linear, quadratic and ibs
kernels) for detecting at least one causal SNP in a set of 20 independent SNPs, out of which first 4 were
causal and 16 were null. The power was calculated as the proportion of times (out of the 200 simulated
datasets) at least one associated/causal SNP was detected. The heavy black curve is for BPM M-score,
light black for P-score, red for BEAM, blue for LKM linear kernel, green for LKM quadratic kernel and
gray for LKM ibs kernel.
model (Model 1). All three methods had comparable power when there was a main effect and an
interaction effect in the model (Model 2). In presence of only a fourth-order interaction (Model 3)
or several pairwise interaction effects (Model 4), LKM had the best performance closely followed by
the BPM approach. One thing to keep in mind is that LKM can only test for association between a
SNP-set and a disease; its limitation is that it cannot specifically identify the null and the non-null
SNPs.
2.3.2 Simulation 2
Here we performed a simulation study with correlated SNPs to see the impact of linkage disequi-
librium (LD) on our BPM approach. We considered correlation coefficients of ρ = 0, 0.5 and 0.9.
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Figure 2.3: The barplot shows the power of BPM M-score approach for various type-1 error levels. We simulated
data on 20 SNPs. The 4 causal SNPs and the rest 16 null SNPs had AR1(ρ) correlation structures. The
causal SNP set was not correlated with the non-null SNP set. 3 different values of correlation parameter
were taken: ρ = 0, 0.5, 0.9. Moderate correlation among SNPs do not seem to affect the performance of
BPM much but for high SNP-SNP correlation, BPM may have low power for low error levels.
The SNPs were simulated from a latent multivariate gaussian variable with an AR1(ρ) structure.
As before, we simulated 200 datasets on 200 cases and 200 controls with 20 SNPs (first 4 are causal)
at maf 0.2. We performed this comparison with M-score and with Model 1. The power of BPM
for 3 different correlations (ρ = 0, 0.5, 0.9) at various error levels were plotted in Figure 2.3. At low
type-1 error levels, BPM lost power with the increase in LD values among the SNPs. For higher
error levels, the power of the BPM M-score approach to detect association were similar for ρ = 0
and ρ = 0.5. This observation was not consistent for all our simulations. We noticed sometimes
gain in power for ρ = 0.5 over ρ = 0 but fall in power for high correlation like ρ = 0.9, especially for
models with interaction effect. In summary, moderate correlation among SNPs did not affect the
performance of the BPM approach significantly but for high SNP-SNP correlation, BPM lost power
for stringent error levels.
2.3.3 Convergence diagnostics
Checking convergence of RJMCMC is not straightforward. The general consensus is to monitor
common parameters (in our case, α) using popular fixed-dimensional convergence diagnostics (Sisson,
2005). Gelman and Rubin’s diagnostic (Gelman and Rubin, 1992) gave point estimate for the median
potential scale reduction factor (psrf) for α as 1.00 (< 1.1 means the chain has converged to the
stationary distribution and we need not run the chain longer). We also plotted posterior distributions
of all 3 parameters α, β1 and β2 for 6 independent chains (using M-score) for a randomly chosen
dataset under Model 1 (main effect only model) with uncorrelated SNPs (refer Appendix A3). The
starting parameters β and A were different for each chain. Convergence was achieved for all these
chains. Mean values of β1 and β2 (averaged over all 6 chains) were respectively −0.96 (sd = 0.18)
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and 0.23 (sd = 0.15), which were close to the true effect sizes of −1 and 0.2 respectively.
In Figure A2 (Appendix A3), we presented summaries of β1 and β2 (using boxplots) for 15
randomly chosen datasets out of 200 datasets simulated under Model 1. In this model, the effect
size of SNPs with negative direction (protective or LR SNP) was −1 and that with positive direction
(deleterious or HR SNP) was 0.2. Since we are looking at M-score result, we expect the estimated
β1 and β2 to be close to −1 and 0.2 respectively. Figure 4 shows that the estimates align quite well
with the true values.
We also looked at convergence of the multivariate categorical parameter A. For this purpose,
we randomly selected 3 SNPs (out of 20), each of which was known to belong to 3 different groups
LR, NA and HR (refer Model 1). Figure A4 (Appendix A3) graphically compared the posterior
probabilities of each of the chosen SNPs to belong to each of the groups across 6 independent
chains. Stability of the posterior probabilities of the various categories over independent chains
indicate convergence.
2.4 Application to Real Data
2.4.1 ARIC Study dataset
The ARIC (Atherosclerosis Risk in Communities) study is an ongoing prospective study designed to
investigate the etiology and natural history of atherosclerosis and its clinical manifestations, and to
measure variation in cardiovascular risk factors, medical care and disease by race, gender, place and
time (The ARIC Investigators, 1989). It is a multicenter contract supported by the National Heart,
Lung, and Blood Institute. Participants were randomly chosen from four US communities (Forsyth
County, NC; Jackson, MS; suburban Minneapolis, MN; Washington County, MD), totaling 15, 792
persons (8710 women, 7082 men) aged 45-64 at baseline (1987-89). The Jackson cohort represents
100% black population while the other three cohorts represent ethnic mix of their communities. Re-
examinations of these participants were done in approximate intervals of 3 years. Yearly follow-up
interviews are conducted over telephone to assess health status of participants. ARIC has collected
fasting glucose measures from the entire cohort at 4 separate visits over a 9-year period and self-
reported physician diagnosis and medication use in up to 14 separate interviews over a 20-year
period. Diabetes was defined as fasting glucose ≥126 mg/dL, non-fasting glucose ≥ 200 mg/dL,
self-reported physician diagnosis of diabetes, or current use of diabetes medications.
The ARIC cohort has been genotyped using the Affymetrix Genome-Wide SNP Array 6.0. Geno-
typing was completed at the Broad Institute of MIT and Harvard in three batches; the Birdseed
algorithm was used for genotype calling. Imputation was performed using MACH 1.0 and HapMap
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release 21 (Build 35). SNPs with a call rate < 90%, maf < 1%, or deviation from Hardy-Weinberg
equilibrium (p < 10−6) were excluded for imputation. A total of 869, 224 SNPs were successfully
genotyped, and over 2.8 million SNPs were successfully genotyped or imputed. Subjects with call
rate < 95%, sex mismatches, inferred 1st degree relatives, extensive mismatches with a non-GWAS
reference panel, and genetic outliers based on IBS clustering or EIGENSTRAT (Patterson et al.,
2006) were excluded from GWAS analyses.
2.4.2 ARIC Type 2 Diabetes: Analysis using BPM
Extensive evidence, including that gathered from twin and family studies, supports the hypothesis
that genetic factors are a major contributor to the risk of type 2 diabetes (T2D). More recently, a
GWAS of T2D conducted in populations of European ancestry have identified more than 50 SNPs
reaching genome-wide levels of significance, most of which appear to act in the pancreatic beta-
cell development or function (Voight et al., 2010; Morris et al., 2012). Several GWASs of related
quantitative traits such as fasting glucose have offered additional signals. These loci are significant
contributors to risk of T2D, with population attributable risks > 5% per locus in many cases. These
results provide strong evidence for the existence and identification of common genetic risk factors
for T2D.
We intend to analyze the ARIC T2D dataset using our novel method BPM. For this purpose,
we first conducted single SNP association analyses on the Caucasians (sample size 9328 with 812
cases) using PLINK (Purcell et al., 2007) and a gene based association analysis in VEGAS (Liu
et al., 2010). As per VEGAS, the two strongest signals were located in genes TCF7L2 (gene pvalue
8 × 10−6) on chromosome 10 and MMRN1 (gene pvalue 5.7 × 10−5) on chromosome 4. PLINK
identified the SNPs rs7903146 (pvalue 1.7×10−11) and rs1318557 (pvalue 2.5×10−6) to be the most
significant SNPs of genes TCF7L2 and MMRN1 respectively. Since VEGAS gives only gene-based
pvalue, we wanted to explore if some additional SNPs in these two genes could be identified by our
BPM approach which were not detected in the single-SNP association analysis.
To implement our BPM approach, we again focused on the Caucasian participants. We imple-
mented the BPM approach on the SNP data separately for each of two genes mentioned above. We
followed the same definition used by VEGAS for the allocation of SNPs to the genes. Our goal was
to analyze each of the genes separately using our BPM approach (both M- and P-scores), find the
optimal allocation of the SNPs within each gene and compare the BPM performance with single-SNP
association findings.
For the gene-based association analysis, we excluded the SNPs with maf < 5% and the SNPs
with absolute pairwise correlation coefficient |ρ| > 0.8 with another SNP. For a given gene data,
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we computed posterior probabilities for the minor allele of each of the SNPs to be in each of the
three categories (LR, NA and HR) based on a long chain of 500, 000 MCMC iterations. Within each
iteration, β is iterated 10 times. The posterior probability of a SNP to be in a particular group was
calculated as the average number of times that SNP was allocated in that group in each MCMC
iteration. The starting allocation was randomly generated for each chain. Using Heidelberger-Welch
(HW) tests (Heidelberger and Welch, 1983), the burn-ins were decided for each gene and each score
to ensure stationarity of the common parameter α of each chain at 5% significance level.
Given the posterior probabilities of a SNP in the LR, NA and HR group, we used a cutoff of 0.4
for the non-NA (LR+HR) posterior probability to assign a SNP into a non-NA group. Any SNP
with a non-NA (LR+HR) posterior probability exceeding the threshold was assigned to be non-NA.
The allocation of a non-NA SNP to LR or HR group was based on the group having higher posterior
probability among the two. For each score and each gene, we thus obtained the final allocation A
of the SNPs and calculated the approximate Bayes Factor (ABF) (Wakefield, 2008) as a measure of
evidence in favor of null or the alternative hypothesis of association.
For the calculation of ABF01 (the posterior odds of null model to the alternative model A
selected using ≥ 0.4 posterior probability for a SNP to belong to non-NA group), we evaluated
the joint likelihood of Y and β under the null as well as under the alternative. Since there is no
closed form of the joint likelihood, we used Laplace approximation around the maximum a posteriori
(MAP) estimate of β to obtain the null likelihood. On the other hand, we computed the alternative
joint likelihood by using the Laplace approximation around the posterior mode of β obtained from
the posterior samples (Zheng et al., 2012). In our calculations, we found the posterior mode to be
almost same as the MAP estimate of β under the alternative.
We first analyzed gene MMRN1 from Chromosome 4 with 57 SNPs after screening. For BPM, the
M-score chain for α passed HW stationarity test and half-width mean test at 5% level without any
burn-in while a burn-in of 100, 000 was needed for P-score. Figure A5 (Appendix A4) also showed
convergence of these two chains. From Table 2.3 we saw that, at cutoff 0.4, only 4 SNPs were
detected as LR for M-score, which included the most significant SNP rs1318557 (pvalue 2.5× 10−6)
from the single-SNP association analysis. The posterior probabilities of this SNP to belong to LR
category was 0.47. The other 3 SNPs chosen by BPM were not at all significant in the single-SNP
association analysis (refer Table 2.3). M-score had −2 log10(ABF01) = 10.5 > 10, which indicated
very strong evidence of association (Zheng et al., 2012).
On the other hand, P-score could not detect any SNP as LR/HR at the chosen cutoff, although
at a lower cutoff of 0.2, it detected these above mentioned SNPs. This may indicate the fact that
these SNPs in MMRN1 are not contributing through interactions and hence the P-score could not
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Table 2.3: The final allocation of the non-null SNPs selected by using a 0.4 cutoff on the posterior probability of
each SNP to be in non-NA(LR+HR) group from BPM M-score analysis. The single-SNP results of these
non-null SNPs in MMRN1 gene are also listed for comparison. The direction of single-SNP coefficient
and the group allocation by BPM match.
SNP rsID rs11727074 rs6812192 rs12646270 rs1318557
Final allocation A LR LR LR LR
Posterior probability 0.38 0.48 0.43 0.47
Single-SNP coefficients −0.2 −0.2 −0.3 −0.3
Single-SNP pvalues 6.2× 10−2 1.4× 10−3 4.0× 10−2 2.5× 10−6
Table 2.4: The final allocation of the non-null SNPs selected by using a 0.4 cutoff on the posterior probability of
each SNP to be in non-NA(LR+HR) group from BPM M-score analysis in TCF7L2 gene. The single-SNP
results of these non-null SNPs are also listed for comparison. The direction of single-SNP coefficient and
the group allocation by BPM match.
SNP rsID rs17747324 rs7903146
Posterior A HR LR
Posterior probability 0.46 0.48
Single-SNP coefficients 0.42 −0.38
Single-SNP pvalues 3.6× 10−11 1.7× 10−11
Table 2.5: The final allocation of the non-null SNPs selected by using a 0.4 cutoff on the posterior probability of
each SNP to be in non-NA(LR+HR) group from BPM P-score analysis in TCF7L2 gene. The single-SNP
results of these non-null SNPs are also listed for comparison. The direction of single-SNP coefficient and
the group allocation by BPM match.
SNP rsID rs7079711 rs11196181 rs17747324 rs7903146 rs7079673
Posterior A LR LR HR LR LR
Posterior probability 0.49 0.46 0.61 0.41 0.37
Single-SNP coefficients −0.33 −0.24 0.42 −0.39 −0.12
Single SNP pvalues 5.2× 4.2× 3.6× 1.7× 2.8×
10−4 10−2 10−11 10−11 10−1
rs11196228 rs7084875 rs290483 rs7922641 rs4918801 rs10885424
LR LR HR HR HR LR
0.27 0.40 0.36 0.26 0.52 0.23
−0.33 −0.01 −0.02 0.001 0.11 0.01
3.1× 8.8× 7.3× 9.9× 3.7× 9.2×
10−2 10−1 10−1 10−1 10−1 10−1
perform as well as the M-score.
We next analyzed gene TCF7L2 from chromosome 10 with 109 SNPs after screening. Using
HW tests at 5% level, burn-ins of 200, 000 and 150, 000 for M- and P-scores respectively ensured
stationarity for common parameter α. At cutoff 0.4, with −2 log10(ABF01) = 15.7 > 10, M-score
found only 2 SNPs rs17747324 and rs7903146, which were allocated in HR and LR group respectively
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(refer Table 2.4). Meanwhile P-score detected 11 SNPs (including the 2 non-NA SNPs from M-score)
with −2 log10(ABF01) = 11.5 > 10 (refer Tables 2.5). Both scores detected the two most significant
SNPs from single-SNP analysis. It is to be noted that ABF values across scores are not comparable
since the two scores can give different ABF values even if the same allocation is used. As per ABF,
both the allocations from BPM indicated very strong association of the selected non-NA SNPs with
the disease. The high ABFs from both scores seemed to be driven by the very strong association
through rs17747324 and rs7903146. Also, P-score detecting more SNPs than M-score suggested
possible interaction among the selected SNPs. As seen from Tables 2.4 & 2.5, BPM captured some
novel SNPs, which again emphasizes the power gain by joint modeling of SNPs within a gene over
single SNP association analysis.
2.5 Discussion
Our BPM approach makes use of the fact that we are interested in detection of the associated SNPs
and not in the estimation of individual SNP effects. The main advantage of classifying the SNPs
into these three groups is that for each specific choice of allocation of risk-labels to the SNPs, we can
model the joint effect of the SNP-set on the disease with only three parameters. This approach could
be especially advantageous when we are considering joint modeling of a large group of SNPs with
a relatively small sample size. In addition to this, our proposed approach provides the flexibility
of assigning scores to each of these low-risk or high-risk group of SNPs in order to capture the
high-order interaction among the SNPs. Our model provides the flexibility of adjusting for other
covariate effects (refer Appendix A6) and allows for modeling of epistatic and nonlinear SNP effects.
Here we considered a pair-wise scoring scheme that captures such higher order interaction among
the SNPs. Other scores such as Gaussian kernels can be used to capture these epistatic effects. Our
simulation studies and real data analysis demonstrated the usefulness of this proposed method to
detect SNPs with higher order interaction. It is to be noted that we only considered multiplicative
interaction in our simulation experiments. In general, the concept of interaction is much broader
than multiplicative interaction. We intend to study the performance of BPM for broader class of
interactions in future.
One advantage of the BPM approach is that it models the latent state of association (risk-
allocation) of the SNPs given the phenotype and genotype data and thus does not get strongly
influenced by the LD among the SNPs. We conducted simulations to study the impact of the LD on
power of detection of our BPM approach. In general, we found that the approach loses some power
when there is strong correlation (0.9) among the SNPs, but the performance was very similar between
SNPs with no LD and SNPs with moderate LD (0.5). One must note that for large number of SNPs
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in very high LD, the autocorrelation plots will show high autocorrelation even for large values of
lag and hence more RJMCMC iterations will be needed for convergence. In such a scenario, the
BPM chain (due to its single-site updating scheme) is likely to get stuck, which will be indicated
clearly in the running mean plot of α parameter. On the same note, our assumption of independent
prior distributions for risk-allocations of all SNPs is reasonable since we model the latent state of
association for each SNP. For our future work, we intend to implement some Markovian structure
on the prior distribution to model the dependency among the SNPs and investigate if there is any
improvement on the power for detection of association.
One big assumption for this BPM approach is that it assumes all the SNPs within each risk
group have same effect-sizes. We investigated the performance of our proposed approach through
simulation studies when this assumption is violated (Model 5). In our simulation studies, the
proposed approach performed quite well as compared to BEAM and LKM even when the SNPs had
very different effect sizes.
One limitation of the current version of the BPM approach is that the update of Aj is realized
conditionally on A(−j) for a locus j = 1, 2, . . . , p. Given that the space being explored is huge,
the sampler is not very computationally efficient in exploring the entire model space. BPM was
also found to be somewhat sensitive to starting parameter β for the real data analysis. We intend
to implement Block-Gibbs sampler and simulated annealing strategies for better exploration of
the model space. We have developed a C++ program for implementation of our BPM approach.
Although potentially this approach could be applied to a large set of SNPs, the current algorithm
is more suitable for gene-based association analysis.
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Chapter 3
USAT: A Unified Score-based
Association Test for Multiple
Phenotype-Genotype Analysis
Summary: Genome-wide Association Studies (GWASs) for complex diseases often collect data on multiple
correlated endo-phenotypes. Multivariate analysis of these correlated phenotypes can improve the power
to detect genetic variants. Multivariate analysis of variance (MANOVA) can perform such association
analysis at a GWAS level, but the behavior of MANOVA under different trait models has not been carefully
investigated. In this chapter, we show that MANOVA is generally very powerful for detecting association
but there are situations, such as when a genetic variant is associated with all the traits, where MANOVA
may not have any detection power. In these situations, marginal model based methods, however, perform
much better than multivariate methods. We investigate the behavior of MANOVA, both theoretically and
using simulations, and derive the conditions where MANOVA loses power. Based on our findings, we propose
a unified score-based test statistic USAT that can perform better than MANOVA in such situations and
nearly as well as MANOVA elsewhere. Our proposed test reports an approximate asymptotic p-value for
association and is computationally very efficient to implement at a GWAS level. We have studied through
extensive simulations the performance of USAT, MANOVA and other existing approaches and demonstrated
the advantage of using the USAT approach to detect association between a genetic variant and multivariate
phenotypes. We applied USAT to data from three correlated traits collected on 5, 816 Caucasian individuals
from the Atherosclerosis Risk in Communities (ARIC, The ARIC Investigators (1989)) Study and detected
some interesting associations.
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3.1 Introduction
In the study of a complex disease, data on several correlated endo-phenotypes are often collected to
get a better understanding of the disease. For example, in the study of thrombosis, the intermediate
correlated phenotypes such as Factor VII, VIII, IX, XI, XII, and von Willebrand factor influence
greatly the risk of developing thrombosis (Souto et al., 2000; Germain et al., 2011). An epidemiologic
study on type 2 diabetes (T2D) typically collects data on a number of risk factors and diabetes-
related quantitative traits. The standard approach to analyze these phenotypes is to perform single-
trait analyses separately and report the findings for individual trait.
van der Sluis et al. (2013) demonstrated several alternative models which would benefit from
a joint analysis. Blair et al. (2013) illustrated the comorbidity between Mendelian disorders and
different complex disorders, which indicates that there may be common genetic variants affecting
several of these complex traits. Recently, many articles advocating joint analysis over univariate
analysis of multiple correlated traits (Ferreira and Purcell, 2009; Zhang et al., 2009; Korte et al.,
2012; O’Reilly et al., 2012; Stephens, 2013; Aschard et al., 2014; Galesloot et al., 2014; Zhou and
Stephens, 2014; Ried et al., 2014, and references therein) have been published that illustrate the
benefits of jointly analyzing these correlated traits to improve the power of detection of genetic
variants. Moreover this joint analysis could reveal some pleiotropic genes involved in the biological
development of the disease.
Few approaches have been developed to perform association analysis with multivariate traits at a
GWAS level. O’Reilly et al. (2012) proposed MultiPhen to detect association between multivariate
traits and a single nucleotide polymorphism (SNP) with unrelated individuals. MultiPhen uses
ordinal regression to regress a SNP on a collection of phenotypes and tests whether all regression
parameters corresponding to the phenotypes in the model are significantly different from zero. It
can accommodate both binary and continuous traits but may suffer from lack of power when a SNP
is associated with all the highly correlated traits. van der Sluis et al. (2013) proposed Trait-based
Association Test (TATES) for testing association between multiple traits and multiple SNPs using
extended Simes procedure on the p-values derived from univariate trait and single SNP association
analysis. Even when the phenotypes are strongly correlated, TATES gives appropriate type I error
for varying minor allele frequency (m.a.f.). It may have low power when a SNP affects only a
few of the strongly correlated traits. Maity et al. (2012) proposed a kernel machine method for
unrelated individuals for joint analysis of multimarker effects on multiple traits. Kernel machine
is a powerful dimension-reduction tool that can accommodate linear/non-linear effects of multiple
SNPs. Their test for association between multiple SNPs and the phenotypes is equivalent to testing
the variance components in a multivariate linear mixed model (mvLMM). Implementation of this
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approach requires parametric bootstrapping to estimate the distribution of the test statistic and
could be computationally intensive at a GWAS level. Korte et al. (2012); Zhou and Stephens
(2012) implemented mvLMM for GWAS. Zhou and Stephens (2014) explored efficient algorithms
for mvLMM in a GWAS setting.
Recently, data reduction methods such as principal component analysis (PCA) and canonical
correlation analysis (CCA) are being explored to perform multivariate association analysis (Tang
and Ferreira, 2012; Basu et al., 2013; Aschard et al., 2014). The advantage of using CCA to perform
gene-based tests on multivariate phenotypes has been elaborately discussed in Tang and Ferreira
(2012); Basu et al. (2013). Previously, Ferreira and Purcell (2009) proposed a multivariate test of
association based on CCA to simultaneously test the association between a single SNP and multiple
phenotypes. Their CCA approach is equivalent to multivariate analysis of variance (MANOVA) or
more generally the Wilk’s lambda test in multivariate multiple linear regression (MMLR) approach
(Muller and Peterson, 1984). Basu et al. (2013) extended the MANOVA to family data. Both
O’Reilly et al. (2012) and van der Sluis et al. (2013) found significantly high power for MANOVA
when a subset of traits was associated with the causal variant or gene. One major advantage of
MANOVA is that it can easily be extended to incorporate multiple phenotypes as well as multiple
SNPs (such as a gene). Moreover other covariates can easily be incorporated in the model.
In this chapter, we explore the performance of MANOVA to detect multi-trait association under
various alternative trait models. Our simulation studies consider a single marker to investigate the
properties of MANOVA. Further, we theoretically justify the behavior of MANOVA and provide
a geometrical explanation as well. We demonstrate that MANOVA may lose significant power
when the genetic marker is associated with all the traits and any test that does not consider the
within trait correlation can have more power in such a situation. In such a scenario, methods
based on marginal models have better power than MANOVA. Stephens (2013), too, emphasizes
that “multivariate association analyses are often most advantageous when not all phenotypes are
associated with the genetic variant being tested!” Utilizing these findings, we propose a novel
unified score-based association test (USAT), which considers an optimal weighted combination of the
multivariate score test (MANOVA) and a score-based test from marginal models. USAT maintains
good power under various alternative trait models and performs significantly better than MANOVA
when all the traits are associated.
This chapter evolves as follows. Section 3.2 describes some popular existing methods for doing
association analysis using multiple phenotypes. More specifically, section 3.2.1 describes the univari-
ate methods that completely ignore trait correlations, section 3.2.2 describes a method that accounts
for the within trait correlation only through the distribution of the test statistic while section 3.2.3
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describes a multivariate method that directly incorporates the trait correlation structure. Section
3.2.4 theoretically and geometrically justifies some aspects of the behavior of MANOVA, for K traits
and a single SNP, in situations that commonly arise in such genetic studies. Section 3.2.5 intro-
duces our unified approach USAT for association analysis using multiple traits and a single marker
for unrelated individuals. Section 3.3 illustrates a comparison of different existing approaches and
USAT using simulated data. We analyzed type 2 diabetes phenotypes from ARIC dataset in section
3.4, which establishes USAT as a sensible choice for testing association of multiple phenotypes with
genotypes in population based GWAS. Section 3.5 concludes this article with a short summary and
discussion.
3.2 Methods
Consider K correlated traits Y1, Y2, . . . , YK in n unrelated individuals. Let Y k be the n× 1 vector
of k-th trait and Y be the n×K matrix of traits for all individuals. Consider a GWAS setting with
data on a large number p ( n) of genetic variants. We are interested in testing the association
of a single SNP with the K correlated traits. For a given SNP, let Xi be the number of copies of
minor alleles (0, 1 or 2) for i-th individual and X be the n × 1 vector of genotypes for all samples.
Without loss of generality, it is assumed that the phenotype matrix Y and the genotype vector X
are centered but not standardized.
Due to the correlatedness of the traits, a standard approach would be to consider an MMLR
model for the association test of K traits and the SNP:
Y n×K = Xn×1β′1×K + En×K (3.1)
where β′ = (β1, ..., βK) is the vector of fixed unknown genetic effects corresponding to the K
correlated traits, and E is the matrix of random errors. For testing that the SNP is not associated
with any of the K traits, the null hypothesis of interest is H0 : β = 0.
In the MMLR model (3.1), each row of E is i.i.d. with mean 0K×1 and variance ΣK×K . In
particular, E may be assumed to be an n × K normal data matrix from NK(0,Σ), where Σ is a
positive definite (p.d.) matrix representing residual covariance among the traits. The likelihood ratio
test (LRT) of H0 based on the MMLR model with matrix normal errors is equivalent to MANOVA
(Muller and Peterson, 1984; Yang and Wang, 2012). One may consider a further partition of E to
arrive at mvLMM:
Y n×K = Xn×1β′1×K +W n×K + n×K
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where W is a matrix of random effects representing heritable component of the phenotypes (for
related individuals), and  is the matrix of errors characterizing random variation arising from
unmeasured sources. In recent times, mvLMMs have been recognized as powerful tools for testing
H0. mvLMM can not only control population structure, sample relatedness and other confounding
factors, but can also account for dependence among multiple traits. Association tests based on
mvLMM can be computationally challenging and many efficient algorithms have been developed to
this end (Yang et al., 2011; Korte et al., 2012; Zhou and Stephens, 2014).
Apart from multivariate models, one may use marginal/univariate models for such an association
test. Although marginal modeling effectively assumes the traits to be uncorrelated, approaches based
on marginal models are often computationally faster and easier to implement. The marginal model
for testing association of a SNP with k-th trait is given by
Y k = βM,kX + ek, ek ∼ N(0, σ2In), k = 1, 2, ...,K (3.2)
For each k = 1, ...,K, we explicitly distinguish k-th genetic effect βM,k in marginal models (3.2)
from the k-th genetic effect βk in the MMLR model (3.1). For the k-th marginal model, our null
hypothesis is H0,k : βM,k = 0. In order to carry out the simultaneous test H0, one still needs to
devise an approach to combine the results from the marginal tests H0,k, k = 1, 2, ...,K.
Broadly, the different statistical approaches for testing our global null hypothesis of no association
can be classified into three categories: (1) tests that completely ignore the within trait correlation; (2)
tests that incorporate within trait correlation only in deriving the distribution of the test statistic;
and (3) tests that incorporate the within trait correlation directly in deriving the test statistic.
We compare through extensive simulation studies these three broad approaches and discuss their
advantages and shortcomings under various alternative trait models.
3.2.1 Combination Tests that completely ignore within trait correlation
This category of tests considers separate regression models for the K traits (i.e., K univariate
analyses), thereby treating the traits as uncorrelated. Let pk be the p-value for testing H0,k based
on the k-th marginal model in (3.2). This class of tests proposes several approaches of combining
the p-values p1, ..., pK for testing our global null hypothesis H0 = ∩Kk=1H0,k.
3.2.1.1 Fisher’s Test
Fisher’s method (Fisher, 1925) involves combining the logarithmic transformation of the p-values
p1, ..., pK . The test statistic is −2loge
∑K
k=1 pk, which under H0 and the assumption of independent
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tests, has a χ22K distribution. In the presence of strong correlation among traits, inflated type-I error
is observed (‘anti-conservative’).
3.2.1.2 minP Test
The minP test statistic is based on the minimum of adjusted p-values, where adjustment is usu-
ally done by Bonferroni’s method to take care of multiple-testing issue. It is given by pmin =
minKk=1{Kpk}. Under H0 and the assumption of independence among the phenotypes, pmin is dis-
tributed as the minimum of independent U(0, 1) variables. In the presence of correlation structure,
this test can be conservative.
To take care of this conservativeness, van der Sluis et al. (2013) proposed TATES which combines
p-values from univariate analyses while correcting for the relatedness among the phenotypes. It is
a hypothesis-free and model-free approach. If p(1), ..., p(K) are the univariate analyses p-values (of
the K phenotypes on a single marker) arranged in ascending order, then the TATES statistic is
given by PT = min
K
k=1
(
mep(k)
mek
)
, where me is the effective number of independent p-values among
{p(1), ..., p(K)}, and mek is the effective number of p-values among the top k p-values {p(1), ..., p(k)}.
Note that me = meK . Thus, PT is the smallest weighted p-value associated with H0.
3.2.2 Test that incorporates trait correlation only through distribution
This category of tests does not explicitly consider the trait correlation in the test statistics. The
correlation is taken into account in finding the true null distribution of the test statistic due to which
the statistic maintains proper type I error. A notable test in this category is the Sum of Squared
Score (SSU) test as outlined by Yang and Wang (2012), an extension of the SSU test for association
of multiple SNPs with a single trait proposed by Pan (2009).
3.2.2.1 SSU Test
SSU is a score-based test where the score vector is derived from the marginal normal models in
equation (3.2). Under the global null H0, the K × 1 vector of marginal scores is given by
UM =
1
σˆ20
Y ′X
where σˆ20 =
1
K(n−1)
∑n
i=1
∑K
k=1 Y
2
ik is the maximum likelihood estimate (MLE) of σ
2 in equation
(3.2) under the null. The SSU test statistic is TS = U
′
MUM , which has an approximate asymptotic
scaled and shifted chi-squared distribution aχ2d + b (Zhang, 2005) under H0. The distributional
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parameters are determined as
a =
∑
c3k∑
c2k
, b =
∑
ck − (
∑
c2k)
2∑
c3k
, d =
(
∑
c2k)
3
(
∑
c3k)
2
(3.3)
where {ck}Kk=1 are the ordered eigenvalues of Cov(UM ) = X ′XY ′Y /(nσˆ40).
An important aspect of the SSU test is that the test statistic does not incorporate the trait
covariance structure. Notice that, according to equation (3.3), Cov(UM ) contains information on
within trait correlations and is used in deriving the distribution of the statistic. If U be the score
vector from MMLR model (3.1) under H0, a test statistic of the form U
′U will not be an SSU type
test since the within trait covariance matrix is incorporated in U .
3.2.3 Multivariate Test that incorporates within trait correlation directly
in the test statistic
This class of tests explicitly incorporates the within trait correlation structure in the test statistics
as well as in finding their distributions.
3.2.3.1 MANOVA
Consider the MMLR model in equation (3.1). Assume each row of E to be i.i.d. NK(0,Σ). The
log-likelihood for the data matrix Y is given by
l(β,Σ) = −1
2
n log |2piΣ| − 1
2
tr
{
Σ−1(Y −Xβ′)′(Y −Xβ′)} (3.4)
For testing H0, the LRT is equivalent to the MANOVA test statistic (Wilk’s Lambda), which is
the ratio of generalized variances |E|/|H +E|. Here H is the hypothesis sum of squares and
cross product (SSCP) matrix and E is the error SSCP matrix. The explicit forms of these SSCP
matrices in terms of phenotype and genotype data are H = βˆ(X ′X)βˆ
′
and E = Y ′Y − βˆ(X ′X)βˆ′,
where βˆ = Y ′X(X ′X)−1 is the MLE of β. Thus, H is calculated as the covariance matrix of the
fitted values, and E is calculated as the covariance matrix of the residuals of the model. Under
H0, −2 log Λ = −n log (|E|/|H +E|) has an approximate asymptotic χ2K distribution. It can be
shown that the MANOVA Wilk’s Lambda test is asymptotically equivalent to the multivariate score
test U ′I(0)−1U , where U = (Y ′Y /n)−1Y ′X is the score vector based on the MMLR model and
I(0) = (X ′X)(Y ′Y /n)−1 is the expected Fisher information matrix under the null.
Another such multivariate approach is MultiPhen where the genotype is modeled as ordinal using
a proportional odds regression model. O’Reilly et al. (2012) empirically showed that for a single
SNP, MultiPhen’s performance is similar to MANOVA. For testing the global null of no association,
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whether one treats Y as a multivariate response and X as a predictor (as done in MANOVA)
or treats X as a univariate response and Y as multiple predictors (as done in MultiPhen), both
approaches lead to same p-values (Anderson, 1984; Stephens, 2013).
3.2.4 MANOVA and its behavior
A major challenge in multivariate disease-related trait analysis is the lack of a test that is uniformly
most powerful under different patterns/levels of association and different within trait correlation
structures. The association tests which do not consider within trait correlation at all are either
‘conservative’ or ‘anti-conservative’. Our simulation studies with compound symmetry (CS) corre-
lation structure show that MANOVA generally has better performance but loses significant power
when within trait correlation is high and is in the same direction as all the genetic effects. For a
moderate number of traits, MANOVA may fail to detect pleiotropy (phenomenon where a single
genetic variant affects all the traits) even at low within trait correlations (refer sections 4.3.1, 4.3.2).
The following theorems provide conditions under which MANOVA loses power when a SNP is
associated with all K correlated traits. We assume a CS residual correlation structure. Theorem
proofs are provided in Appendix B1.
Theorem 3.1. Consider the MMLR model Y n×K = Xn×1β′1×K+En×K with vec(E) ∼ NnK(0, In⊗
Σ), Σ = σ2 ((1− ρ)IK + ρ11′), σ2 > 0, ρ (> 0) is the within trait correlation such that Σ is
a p.d. matrix, and β′ = (β1, ..., βK) is the vector of genetic effects. Assume that the genetic
effects of the associated traits are equal in size and in positive direction. Consider two scenarios of
association: ‘partial association’ (when the SNP is associated with u (< K) traits), and ‘complete
association’ (when all K traits are associated). For testing H0 : β = 0, the power of MANOVA
under partial association will be asymptotically more than that under complete association if uK >
1−ρ
1+(K−u−1)ρ =
2nd eigenvalue of ΣK−u
1st eigenvalue of ΣK−u
. Here ΣK−u is the CS residual covariance matrix of the K − u
truly unassociated traits.
For K = 2 traits, Theorem 3.1 can be generalized further to encompass genetic effects in opposite
direction, and negative within trait correlation.
Theorem 3.2. Consider the MMLR model in Theorem 3.1 with K = 2 traits. The genetic effects of
the associated traits may or may not be equal in size or in same direction. The within trait correlation
ρ may or may not be positive. For testing H0 : β1 = β2 = 0, the power of MANOVA when only one
trait is associated is asymptotically more than when both traits are associated if 0 < β2 < 2ρβ1 or
0 > β2 > 2ρβ1.
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Corollary 3.2.1. In particular, let us assume that the genetics effects of the associated traits are
equal in size. That is, |β1| = |β2| when the SNP is associated with both the correlated traits. Asymp-
totically, the power of MANOVA under Ha1 : β1 > 0, β2 = 0 will exceed the power of MANOVA
under
i) Ha2,1 : β1 = β2 > 0 when ρ > 1/2;
ii) Ha2,2 : β1 = −β2 > 0 when ρ < −1/2.
The theoretical 95% acceptance regions of SSU and MANOVA for K = 2 correlated traits in
Figure 3.1 provide a geometrical explanation of the above theorems. The acceptance region of SSU is
drawn using the marginal scores UM,1 and UM,2. MANOVA’s acceptance region is drawn using the 2
components Z1 and Z2 of vector Z since MANOVA is asymptotically equivalent to the test Z
′I(0)Z.
Here Z is an N(0, I(0)−1) variable and I(0) is Fisher Information matrix under H0 : β = 0. Details
of this equivalence and the acceptance region plots are provided in Appendix B2. For SSU, a high
true value of β1(β2) will be reflected by a high value of UM,1(UM,2). In Figure 3.1, observe that the
SSU acceptance regions are almost circular in shape irrespective of correlation ρ. With increase in ρ,
the shape of the acceptance region remains same. Only the size increases a little which causes slight
loss in power to reject H0. For MANOVA, a high true value of β1(β2) will be reflected by a high
value of Z1(Z2). When ρ → 1, notice that the acceptance region for MANOVA becomes elongated
along the direction of 1 vector in Figure 3.1. Recall that for a CS correlation matrix, the eigen
vector corresponding to the largest eigenvalue (for ρ > 0) is along the direction of 1 vector. When
the true genetic effect sizes are equal and in the same direction, the corresponding components of Z
are equal as well and they will lie on vector 1. This suggests that the Z’s (and hence the non-zero
genetic effects) need to be really large to cross the MANOVA acceptance region boundary for high
ρ. The black box in Figure 3.1 represents such a situation, and it arises when the SNP is associated
with both the correlated traits. This fail-to-reject situation will prevail even when the genetic effects
are unequal but similar in magnitude. In genetic association studies, we may not expect equal effect
sizes but we can expect them to be very close since each effect size is very small. On the other hand,
if the effect sizes are very different, the Z vector will lie in some direction significantly away from
the major axis 1 of the acceptance region. The closer it gets towards the minor axis, the greater
is the chance for MANOVA statistic to fall outside the boundary and reject the null. The dark
green triangle in Figure 3.1 represents a situation where MANOVA’s power to reject H0 is higher
when ρ is higher. This is the situation when only one of the two traits is associated. Furthermore,
Figure 3.1 shows that MANOVA’s loss in power will not be observed (irrespective of the strength
and direction of within trait correlation) in studies where the effect sizes are reasonably large. This
was observed in our simulation study with large genetic effects (simulation results not provided). It
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Figure 3.1: Comparison of theoretical 95% acceptance regions of SSU test and of MANOVA for K = 2 traits and
ρ = 0.2, 0.8 (Compound Symmetry correlation). The area within the pink (blue) ellipse is the acceptance
region when ρ = 0.2 (0.8). Details of these plots are provided in Appendix B2. SSU’s acceptance region
is drawn using the marginal scores UM,1 and UM,2. MANOVA’s acceptance region is drawn based on
the test Z′I(0)Z, where I(0) is Fisher Information matrix under H0 : β = 0. The blue dotted line is
the 1 vector and coincides with the major axes of the ellipses. When β1 = β2, we expect Z1 = Z2. The
solid black square represents a situation where β1 = β2  0. When β1 & β2 are significantly apart, we
expect the same for Z1 & Z2, and such a situation in represented by the dark green triangle.
is also to be noted that if all the traits are associated but not all are correlated, MANOVA is not
expected to lose power (refer section 3.3.4).
3.2.5 An alternative test: A unified score-based association test (USAT)
Our proposed test is motivated by the geometrical findings in section 3.2.4. As mentioned earlier,
SSU test statistic does not explicitly incorporate within trait correlation and hence its acceptance
region is not much affected when we increase the degree of dependency among the traits. On the
other hand, MANOVA suffers from lack of power when the correlation is high and the genetic effect
sizes are similar in magnitude and in same direction as the correlation. One, of course, does not know
the true size and direction of the genetic effects and hence one would not know which association
test to use. In such a scenario, one can see the clear advantage of combining MANOVA and SSU.
We decided to choose the weight optimally from the data. We call our test unified score-based
association test (USAT). The USAT test statistic is not exactly the best weighted combination of
MANOVA and SSU. It is the minimum of the p-values of the different weighted combinations. Lee
et al. (2012) proposed a similar test statistic based on minimum p-value in the context of rare
variants in sequencing association studies.
Let TM be the MANOVA test statistic based on Wilk’s lambda. From Bartlett’s approximation,
TM
a∼ χ2K . On the other hand, the SSU test statistic, denoted as TS , has an approximate aχ2d + b
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distribution, where the parameters a and b and the degrees of freedom d are estimated from the
data using equation (3.3). Consider the weighted statistic Tω = ωTM + (1− ω)TS , where ω ∈ [0, 1]
is the weight. Both MANOVA and SSU are special cases of the class of statistics Tω. Under the null
hypothesis of no association, for a given ω, Tω is approximately a linear combination of chi-squared
distributions. For a given ω, the p-value pω of the test statistic Tω can be calculated using Liu et al.
(2009) algorithm for chi-square approximation of non-negative quadratic forms. It is worth noting
that the calculation of pω does not require independence assumption of the two test statistics (refer
Appendix B3).
Apriori the optimal weight ω is not known. We propose our optimal unified test USAT as
TUSAT = min
0≤ω≤1
pω
For practical purposes, a grid of 11 ω values were considered: {ω1 = 0, ω2 = 0.1, ..., ω10 = 0.9, ω11 =
1}. A finer grid of more ω values did not change the USAT power curve much.
To find the p-value of our USAT test statistic, we need the null distribution of USAT. One
option is to calculate the empirical p-value by considering several permuted datasets or by generating
several datasets under the null (as done for Figure 3.5). Finding empirical p-values is computationally
intensive and is not suitable when USAT is applied on a GWAS scale with large number of traits. We
propose an approximate p-value calculation using a one-dimensional numerical integration. Observe
that the p-value of statistic TUSAT is
pUSAT = P (TUSAT ≤ tUSAT ) = 1− P (TUSAT ≥ tUSAT )
= 1− P (Tω1 < qmin(ω1), ..., Tω11 < qmin(ω11)) ≈ 1−
∫
FTS
(
δω(x)|x
)
fTM (x)dx
where tUSAT is the observed value of USAT test statistic for a given dataset, qmin(ωb) is the (1 −
tUSAT )-th percentile of the distribution of Tωb for a given ω = ωb, FTS (.) is the cdf of SSU test
statistic TS , δω(x) = minω∈{ω1,...,ω11}
qmin(ω)−ωx
1−ω and fTM (.) is the pdf of MANOVA test statistic
TM . Mathematical details are provided in Appendix B3.
3.3 Simulation Experiments
We compared the performances of different methods mentioned in sections 3.2.1, 3.2.2, 3.2.3. We
investigated their type I errors and powers by simulating data on unrelated subjects under a variety
of trait models. In Simulation 1 (section 4.3.1), we considered K = 2 correlated traits with genetic
effects in different directions and correlation ρ varying between −1 and 1. For Simulation 2 (section
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4.3.2), we considered K = 5, 10, 20 traits with genetic effects in the same direction as the positive
correlation. CS correlation structure was considered. As part of Simulation 2, we also compared the
performance of USAT against MANOVA and SSU. In Simulation 3 (section 4.3.3), we used data from
Simulation 2 and investigated the type I error of USAT using the p-value approximation method
described in section 3.2.5. In Simulation 4 (section 3.3.4), we used the same set-up as Simulation 2
to investigate the behaviors of existing methods under correlation structures other than CS.
For our simulation studies, we first simulated X taking values 0, 1, 2 with probabilities (1 −
f)2, 2f(1 − f), f2 respectively. f = 0.2 was the m.a.f. of the the single SNP. The two alleles at
the SNP were sampled independently to ensure Hardy-Weinberg equilibrium. Conditional on X, we
simulated Y for a fixed K using the simulation model Y = β01 + βX + , where the vectors Y ,
1, β,  are K-dimensional. We took β0 = 1 and simulated  from NK(0, σ
2R(ρ)), where R(ρ) is a
CS correlation matrix. The genetic effect size for a given associated trait was chosen such that h%
(0 < h < 1) of the total phenotypic variance was explained by the SNP. For a given trait, the choice
of h and the minor allele frequency of the SNP determine the effect size for the SNP. One may refer
Section 2.4 of Basu et al. (2013) to find details on how the SNP effect sizes were found. The specific
choices of h, β, σ2 and ρ for each simulation are given in their respective sections (4.3.1 and 4.3.2).
Before applying any method on the simulated datasets, we centered both Y and X for each dataset.
We are interested in testing H0 : β = 0. All the association tests except MultiPhen were coded by
us in R 3.0.1 (R Development Core Team, 2014). For MultiPhen, we used ‘Joint Model’ output
(p-value) from the R package MultiPhen 2.0.0.
3.3.1 Simulation 1: K = 2 traits
We first studied the performances of different association tests by considering only 2 correlated traits
so that the genetic effects and the pairwise correlation can have different directions. We considered
genetic effects β such that 0.2% of the total variance of an associated trait was explained by the
SNP. The total variance of an associated trait was taken to be 10. This ensured that the variance
due to SNP was 0.02 while the residual variance was σ2 = 9.98. For an unassociated trait, the
variance explained by SNP was 0 and hence its residual variance was same as the total variance.
We considered 3 possible levels of association: no trait was associated (β1 = 0 = β2), only the first
trait was associated (β1 = 0.25, β2 = 0) and both the traits were associated (β1 = 0.25 = β2). We
also considered genetic effects in opposite directions (β1 = 0.25, β2 = −0.25).
First, type I error comparison was done for the 6 existing methods. Estimation of type I error
generally requires a large number of replicates (N) and a large sample size (n) in order to generate a
reliable estimate at a stringent level of significance α. The type I error is estimated as the proportion
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Table 3.1: Estimated type I errors of the afore mentioned existing association tests for K = 2 correlated traits. 4
values of pairwise correlation ρ were considered. The p-values were calculated for 10, 000 null datasets
with 4, 000 unrelated individuals. Type I error rate was calculated as the proportion of null datasets with
p-value ≤ α. The 95% confidence intervals for the estimates are provided in square braces.
α ρ Fisher minP TATES SSU MANOVA MultiPhen
0.01 −0.8 0.029 0.009 0.012 0.010 0.009 0.010
[0.024, [0.006, [0.009, [0.008, [0.007, [0.008,
0.033] 0.011] 0.014] 0.013] 0.012] 0.013]
−0.2 0.012 0.011 0.011 0.011 0.011 0.011
[0.009, [0.008, [0.009, [0.008, [0.008, [0.008,
0.015] 0.014] 0.014] 0.013] 0.014] 0.013]
0.2 0.011 0.010 0.010 0.010 0.011 0.010
[0.008, [0.008, [0.008, [0.007, [0.008, [0.008,
0.014] 0.013] 0.013] 0.012] 0.013] 0.013]
0.8 0.026 0.008 0.012 0.009 0.009 0.009
[0.022, [0.006, [0.009, [0.007, [0.007, [0.007,
0.030] 0.011] 0.015] 0.012] 0.012] 0.012]
0.05 −0.8 0.079 0.039 0.053 0.049 0.049 0.048
[0.074, [0.036, [0.049, [0.045, [0.045, [0.044,
0.084] 0.044] 0.057] 0.054] 0.054] 0.053]
−0.2 0.053 0.051 0.052 0.049 0.051 0.051
[0.049, [0.046, [0.048, [0.045, [0.046, [0.047,
0.057] 0.055] 0.056] 0.054] 0.055] 0.055]
0.2 0.051 0.049 0.051 0.05 0.052 0.05
[0.047, [0.045, [0.047, [0.046, [0.048, [0.046,
0.056] 0.054] 0.056] 0.054] 0.056] 0.054]
0.8 0.079 0.039 0.055 0.047 0.052 0.051
[0.074, [0.035, [0.05, [0.043, [0.047, [0.047,
0.084] 0.043] 0.059] 0.051] 0.056] 0.055]
of null datasets in which the p-value ≤ α. We considered significance levels of α = 0.01 and 0.05. At
α = 0.01, one expects to find one ‘non-null’ dataset out of every 100 null datasets. Hence, for this
purpose, we simulated N = 10, 000 null datasets with n = 4, 000 independent individuals. Table
3.1 shows the type I errors (along with 95% confidence intervals of the estimates) for each of the
methods for 4 values of ρ: −0.8,−0.2, 0.2, 0.8. For high magnitude of correlation ρ, notice that
Fisher’s method has inflated type I error while minP is conservative. Unlike minP, TATES is not
conservative since it corrects for the relatedness among the traits. SSU maintains proper type I
error since the distribution of the test statistic incorporates the within trait correlation structure.
As expected, MANOVA and MultiPhen maintain correct type I error.
Next, we compared the powers of the methods. Compared to type I error analysis, we re-
duced the number of datasets to reduce computation time while ensuring reasonably good esti-
mates of the power for different methods. N = 500 datasets with n = 4, 000 unrelated individuals
were simulated for different levels of association. 8 different values of correlation ρ were used:
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Figure 3.2: Empirical power curves of the different existing association tests for K = 2 traits and different within
trait correlation values ρ = −0.8,−0.6,−0.4,−0.2, 0.2, ..., 0.8 based on N = 500 datasets with n = 4, 000
unrelated subjects. Same direction and same size genetic effect used when both traits are associated (i.e.,
datasets are generated from an alternative model Ha2,1 : β1 = β2 > 0). Effect size of 0.25 (proportion
of variance explained is 0.2%) is used for the associated traits. The power is plotted along y-axis while
the fraction of traits associated with the genetic variant is plotted along x-axis.
−0.8,−0.6,−0.4,−0.2, 0.2, 0.4, 0.6, 0.8. Since the methods do not have comparable type I errors (as
seen in Table 3.1), we plotted empirical power curves for comparison. The empirical power at 5%
error level was calculated in the following way. For each of Fisher’s method, MANOVA and SSU,
the 95-th quantile of the empirical distribution of the test statistic was determined based on the
N = 500 test statistics obtained from N null datasets. Empirical power for these methods was
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Figure 3.3: Empirical power curves of the different existing association tests for K = 2 traits and different within
trait correlation values ρ = −0.8,−0.6,−0.4,−0.2, 0.2, ..., 0.8 based on N = 500 datasets with n = 4, 000
unrelated subjects. Opposite direction but same size genetic effect used when both traits are associated
(i.e., datasets are generated from an alternative model Ha2,2 : β1 = −β2 > 0). Effect size of 0.25
(proportion of variance explained is 0.2%) is used for the associated traits. The power is plotted along
y-axis while the fraction of traits associated with the genetic variant is plotted along x-axis.
calculated as the proportion of test statistics that exceeded the 95-th quantile. For each of minP
and TATES, the 5-th quantile of the empirical distribution of the test statistic was determined using
the N = 500 test statistics under null. Empirical power was, then, calculated as the proportion
of test statistics that could not exceed the 5-th quantile. The empirical power of MultiPhen was
determined using p-values in a way similar to empirical power calculation of minP and TATES.
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From Figure 3.2, we observe that, irrespective of the value of ρ, the tests that do not consider within
trait correlation have increase in power with increase in the number of associated traits. They seem
to have similar performance when both traits are associated. On the other hand, MANOVA and
MultiPhen have similar performance and are usually the most powerful approaches for detecting
association. But, both experience power loss when ρ > 0.5 and both traits have same direction of
association. For traits with genetic effects in opposite directions, similar behavior of MANOVA was
observed. Figure 3.3 shows that the power of MANOVA drops when ρ < −0.5 and the 2 traits have
opposite directions of association. These empirical observations on MANOVA are consistent with
Corollary 3.2.1 of Theorem 3.2. No such power loss is observed for multiple univariate model based
approaches. In particular, SSU maintains correct type I error and does not experience power loss
like MANOVA. This observation on SSU is consistent with our geometrical insight from Figure 3.1.
3.3.2 Simulation 2: K = 5, 10, 20 traits
To further study the performance of different tests with increase in the number of correlated traits,
we simulated three sets of data where the first set had K = 5, second had K = 10 and the third
had K = 20 correlated traits. Since this experiment involves a large number of comparisons for
varying K and ρ, we reduced the sample size further to save computation time. We considered
N = 500 simulated datasets for each scenario with n = 400 unrelated individuals. When we plotted
estimated power as a function of N for five different simulation runs (results not provided), no
appreciable between-simulation variability was observed at N = 500. This ensures that reasonably
good estimates of power can be obtained for our choice of N and n. For this simulation study, we
considered only non-negative genetic effects, and positive correlation ρ = 0.2, 0.4, 0.6 between each
pair of traits. We did not consider ρ = 0.8 since it is unlikely for a large number of traits to have
such high pairwise correlation. The total variance of a trait was fixed at 10. Following Ferreira
and Purcell (2009), β was chosen such that 0.5% of the total variance of an associated trait was
explained by the single SNP. We considered 6 possible levels of association: 0%, 20%, 40%, 60%,
80% or 100% of the traits were associated with the SNP. Empirical power curves are presented for
comparison.
From Figure 3.4, we again observe how MANOVA suffers from power loss at ‘complete association’
when the within trait correlation is high. This power loss increases with increase in total number
of correlated traits. At ‘complete association’ (where MANOVA loses power), the power difference
between MANOVA and other methods (such as SSU) increases with increase in number of correlated
traits and decrease in correlation ρ. At a given ‘partial association’, MANOVA is seen to dominate
over other methods. Here, the difference in powers of MANOVA and any other method increases with
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increase in number of traits as well as the correlation. MANOVA’s performance in this experiment
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Figure 3.4: Empirical power curves of the different existing association tests for K = 5, 10, 20 traits and different
within trait correlation values ρ = 0.2, ..., 0.6 based onN = 500 datasets with n = 400 unrelated subjects.
Same effect size of 0.395 (proportion of variance explained is 0.5%) is used for all the associated traits.
The power is plotted along y-axis while the fraction of traits associated with the genetic variant is plotted
along x-axis.
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Figure 3.5: Empirical power curves of the SSU and MANOVA tests along with our novel approach USAT for CS(ρ)
within-trait correlation structure. K = 5, 10, 20 traits have been simulated at different within trait
correlation values ρ = 0.2, 0.4, 0.6. For each value of K and ρ, there were N = 500 datasets of n = 400
unrelated individuals. Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for
the traits that are associated. The power is plotted along y-axis while the fraction of traits associated
with the genetic variant is plotted along x-axis.
is consistent with the asymptotic result in Theorem 3.1.
Next we studied the performance of our approach USAT compared to MANOVA and SSU. Since
the sample size as well as the true genetic effects are small, the type I errors of the three approaches
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differed from α = 0.05. So, we plotted empirical power curves in Figure 3.5 for comparison. Empirical
powers for MANOVA and SSU were calculated as in section 4.3.1. Empirical power calculation of
USAT was implemented in a way similar to minP and TATES (as described in section 4.3.1). In
Figure 3.5, observe that USAT has better power than MANOVA whenever it suffers from power loss
due to same direction of residual correlation and equal-sized genetic effects. In such situations, SSU
performs significantly better than MANOVA, and USAT follows the SSU power curve closely. In
other situations where MANOVA is seen to be most powerful among existing methods, USAT tends
to have power close to MANOVA. USAT maximizes power by adaptively using the data to combine
the MANOVA and the SSU approach.
3.3.3 Simulation 3: p-value approximation for USAT
In this section, we applied our approximate p-value approach for finding USAT p-values to study
its impact on type I error. We generated N = 100, 000 independent datasets (as in section 4.3.2)
with n = 10, 000 unrelated individuals under H0. Since we aim to consider stringent error levels,
a large sample size as well as a large number of datasets have been chosen. The type I error was
estimated by the proportion of datasets in which the asymptotic approximate p-value of USAT test
statistic was ≤ 10−4, ≤ 10−3, ≤ 10−2, and ≤ 0.05. Table 3.2 gives the estimated type I error rates
(along with 95% confidence intervals of the estimates) for USAT using p-value approximation. The
estimated values of type I error for different values of K and ρ were very close to the true error
level α in most scenarios. USAT is somewhat conservative at level α = 0.05 for moderate number
of traits with low correlations but maintains proper type I error for other scenarios even at very low
levels of significance.
3.3.4 Simulation 4: Other correlation structures
We first considered an independent structure. Apart from the residual correlation matrix R(ρ),
the data simulation was exactly same as in Simulation 2 (section 4.3.2). The figures and detailed
explanations can be found in Appendix B4. When all the traits are independent (i.e., R(ρ) = IK),
MANOVA does not suffer from power loss at any level of association. Empirical power curves (Figure
B5) showed that the performances of all the methods described in sections 3.2.1, 3.2.2, 3.2.3, except
minP and TATES, were similar. As expected, the powers steadily increased with increase in number
of associated traits. Next we considered a correlation structure where the first 80% of the traits had
pairwise correlation ρ while the rest were independent. Empirical power curves (Figure B6) showed
that MANOVA suffered power loss when only the correlated traits were associated. Performance
of MANOVA improved when the SNP was associated with some of the uncorrelated traits. This
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Table 3.2: Estimated type I errors of the approximate p-value calculation approach for our USAT test. The p-values were calculated for 100, 000 null datasets with
10, 000 unrelated individuals. Type I error rate was calculated as the proportion of datasets that had approximate p-value ≤ α. The 95% confidence
intervals for the estimates are provided in square braces.
K 5 10 20
ρ 0.2 0.4 0.6 0.2 0.4 0.6 0.2 0.4 0.6
0.00008 10−4 0.00008 0.00015 10−4 0.00008 0.00015 0.00011 10−4
α = 10−4 [−0.00003, [−0.00002, [−0.00003, [−0.00000 [-0.00002, [−0.00003, [−0.00000, [−0.00002, [−0.00002,
0.00019] 0.00022] 0.00019] 0.00030] 0.00022] 0.00019] 0.00030] 0.00024] 0.00022]
0.00081 0.00092 0.00086 0.00108 0.00099 0.00089 0.00149 0.00117 0.00109
α = 10−3 [0.00051, [0.00060, [0.00055, [0.00074, [0.00066, [0.00058, [0.00109, [0.00081, [0.00075,
0.00111] 0.00123] 0.00116] 0.00142] 0.00132] 0.00120] 0.00189] 0.00153] 0.00143]
0.0082 0.0091 0.0093 0.0094 0.0098 0.0097 0.0103 0.0104 0.0103
α = 10−2 [0.0075, [0.0083, [0.0085, [0.0086, [0.0089, [0.0089, [0.0095, [0.0096, [0.0095,
0.0089] 0.0099] 0.0101] 0.0102] 0.0106] 0.0105] 0.0111] 0.0112] 0.0112]
0.0362 0.0413 0.0438 0.0397 0.0441 0.0461 0.0431 0.0463 0.0471
α = 0.05 [0.0350, [0.0401, [0.0425, [0.0385, [0.0428, [0.0448, [0.0419, [0.0450, [0.0458,
0.0374] 0.0425] 0.0450] 0.0409] 0.0454] 0.0473] 0.0444] 0.0476] 0.0484]
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simulation study showed us that MANOVA may not experience power loss even when all the traits
are associated if some of them are uncorrelated. Appendix B5 provides a theoretical support for this
observation. The third type of non-CS correlation structure that we considered was AR1(ρ) (Figure
B7). MANOVA’s power loss was mainly observed for small K and strong ρ. With increase in K and
decrease in ρ, MANOVA did not experience power loss even at ‘complete association’. The strength
of AR1(ρ) correlation becomes negligible at or near ‘complete association’ when ρ is small and K
is moderately large. For all these trait models, the power curves of multiple univariate model based
approaches rose with increase in number of associated traits (irrespective of strength or direction
of residual correlation). All these observations on MANOVA for various correlation structures were
expected based on our geometrical insight from Figure 3.1 (section 3.2.4).
3.4 Application to ARIC Type 2 Diabetes data
As introduced in chapter 2, ARIC has collected measures on many type 2 diabetes (T2D) related
traits at 4 separate visits over a 9-year period. A diagnosis of T2D is considered positive if fasting
plasma glucose concentration is ≥ 126 mg/dL, or casual plasma glucose level is ≥ 200 mg/dL, or
2-hour plasma glucose value after a standard glucose challenge is ≥ 200 mg/dL (WHO, 2003)1.
Sedentary lifestyle and obesity are major risk factors for T2D. In addition to general obesity, the
distribution of body fat (or abdominal obesity, as estimated by waist-to-hip circumference ratio)
contributes to T2D risk.
For our analysis, we focused on the Caucasian participants and the following 3 T2D related
quantitative traits measured at visit 4 (1996−98): fasting glucose; 2-hour glucose from an oral glucose
tolerance test; fasting insulin. The pairwise correlations among these 3 traits were within (0.2, 0.35).
These traits are substantially affected by treatment with diabetes medications, and so statistical
analysis results are not generally interpretable in the same way they can be interpreted in non-
diabetic individuals. Other available traits were Body Mass Index (BMI) and waist circumference
(WC). WC was measured at the umbilical level. BMI was calculated as weight/height2 (kg/m2), and
obesity was defined as a BMI ≥ 30 kg/m2. BMI, being a major risk factor for T2D, is traditionally
adjusted as a covariate in association analysis of glycemic traits (Manning et al., 2012; Scott et al.,
2012; Dupuis et al., 2010, for example). Manning et al. (2012) notes that “adiposity may also hinder
the identification of genetic variants influencing insulin resistance by introducing variance in the
outcome that is not attributable to genetic variation, suggesting that adjustment for adiposity per
se may be necessary”. Due to a high pairwise correlation of 0.9 between WC and BMI, we chose
1All analytes were determined at central laboratories according to standard protocols: plasma glucose by a
hexokinase assay, and insulin by radioimmunoassay (125Insulin Kit; Cambridge Medical Diagnosis, Billerica, MA).
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to adjust BMI only. When BMI is adjusted, inclusion of WC or any other adiposity trait in the
multivariate response makes it difficult to interpret analysis results. We chose not to include the
adiposity traits (BMI, WC, waist-hip ratio, hip circumference) along with the glycemic traits (fasting
glucose, 2-hour glucose, fasting insulin) in the response vector because not many SNPs have been
reported to jointly influence both adiposity traits and glycemic traits. As in most studies of T2D,
BMI was used as a covariate along with age and sex. Individuals with diagnosed or treated diabetes
at visit 4 were removed. Since USAT requires complete phenotype data, individuals with missing
traits were excluded too, leaving 5, 816 in our analytic sample.
The ARIC cohort has been genotyped using the Affymetrix Genome-Wide SNP Array 6.0. Geno-
typing was completed at the Broad Institute of MIT and Harvard in three batches; the Birdseed
algorithm was used for genotype calling. Imputation was performed using Mach 1.0 86 and HapMap
release 21 (Build 35). SNPs with a call rate < 90%, m.a.f. < 1%, or deviation from Hardy-Weinberg
equilibrium (p < 10−6) were excluded for imputation. There was a total of 2.5 million genotyped or
imputed SNPs. Apart from USAT and MANOVA, we also performed separate univariate analyses to
emphasize the importance of joint analysis over univariate ones. Before implementing any of these
approaches, we centered both phenotype and genotype data. SNPs with m.a.f. < 5% were excluded.
All statistical models were adjusted for Age, Sex and BMI.
Figure 3.6 shows the manhattan plots of negative log-transformed p-values for the single trait
single SNP analyses for chromosomes 1− 22. The red horizontal line (at 7.3) in each plot indicates
the log-transformed GWAS significance p-value 5×10−8. There were 53 significant SNPs for fasting
glucose, and none for the other two traits. On the other hand, there were 96 and 77 signals for
MANOVA and USAT respectively that reached this stringent threshold (refer Figure 3.7, and Table
B1 in Appendix B7). Most of these signals mapped near the genes GCKR, ABCB11, C2orf16,
CCDC121, ZNF512, FAM148A, C2CD4A, which are already known to be associated with diabetes
related traits (Yamauchi et al., 2010; Kraja et al., 2011, for example). It is worth noting that these
detected SNPs are in high linkage disequilibrium (LD). Among the SNPs reported in Table B1,
MANOVA and USAT respectively detected 44 and 27 SNPs that none of the univariate analyses
could detect. Most notable genes that the univariate analyses completely missed are GCKR (on chr
2) and FAM148A (on chr 15).
Since most of the detected SNPs in Figure 3.7 are in high LD, Table 3.3 reports only the important
SNPs after removing the ones in high LD. In a group of highly correlated SNPs (i.e., SNPs with
estimated absolute pairwise correlation coefficient > 0.8 with another SNP), we kept one SNP as
a representative. The choice of representative SNP was based on previous reports of association.
The correlation coefficients (as measures of LD) were obtained from PLINK (Purcell et al., 2007)
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Figure 3.6: ARIC Study: Manhattan plots of negative log-transformed p-values of the univariate analyses are plotted
against base pair positions for chromosomes 1 − 22. Only SNPs with m.a.f. > 5% are reported. Age,
Sex and BMI were adjusted in the statistical models. The red horizontal line in each plot corresponds to
the genome-wide significance level 5× 10−8. 53 SNPs (all from chr 2) detected as significant for fasting
glucose; and none for the other traits. Note that many of these significant SNPs are in high linkage
disequilibrium.
using the command plink --file mydata --r. All of the signals in Table 3.3 have been previously
reported. The minor allele T of rs1260326 (gene GCKR of chr 2) is known to be associated with
T2D and hypertriglyceridemia. Risk allele A of rs13022873 (gene ZNF512 of chr 2) was found to be
significantly associated with waist circumference (a T2D related trait highly correlated with BMI)
and triglycerides (Kraja et al., 2011). rs13431652 (gene G6PC2 of chr 2) was reported to be a
potentially causative SNP linking G6PC2 to increased fasting plasma glucose levels and elevated
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Figure 3.7: ARIC Study: Manhattan plots of negative log-transformed p-values of multivariate analyses (USAT
and MANOVA) are plotted against base pair positions for chromosomes 1− 22. Only SNPs with m.a.f.
> 5% are reported. Age, Sex and BMI were adjusted in the statistical models. The red horizontal line
in each plot corresponds to genome-wide significance level 5× 10−8. Note that many of these SNPs are
in high linkage disequilibrium.
promoter activity (Bouatia-Naji et al., 2010). The rs1402837 T allele (gene G6PC2 of chr 2) is
known to be associated with blood sugar levels (glycated hemoglobin levels). McCaffery et al. (2013)
reported that SNPs in ABCB11 (like rs484066) of chr 2 are associated with weight loss and regain.
Meta-analysis of several GWAS found rs17271305 (gene VPS13C of chr 15) to be associated with
glucose levels 2 hours after an oral glucose challenge (Saxena et al., 2010). The diabetogenic A allele
of rs7172432 (gene VPS13C/C2CD4A/C2CD4B of chr 15) significantly impairs glucose-stimulated
insulin response in non-diabetics (Grarup et al., 2011).
In Table 3.3, we notice one SNP (rs7172432) that USAT missed at the stringent significance level
of 5× 10−8. One also notices that difference in the p-values of USAT and MANOVA for this SNP is
negligible. If one takes a closer look at the manhattan plots of Figure 3.7, one will find that certain
Chapter 3. Association Analysis of Multiple Traits 50
Table 3.3: List of SNPs that exceed the genome-wide significance level 5 × 10−8 for USAT and MANOVA. SNPs
with m.a.f. < 5% have been screened out. The SNPs listed here are the ones left after LD screening.
In a group of highly correlated SNPs (i.e., SNPs with estimated absolute pairwise correlation coefficient
> 0.8 with another SNP), one SNP was kept as a representative. p values for the univariate analysis of
the individual traits are also provided for these significant SNPs. SNP rs ID in bold is the one detected
solely by MANOVA but not by USAT at this stringent genome-wide significance level. ω denotes the
weight assigned to MANOVA statistic in the USAT approach. The abbreviations used are FG (Fasting
Glucose), 2-hr GL (2-hour glucose from an oral glucose tolerance test), FI (Fasting Insulin).
MANOVA USAT Univariate Analysis p
chr SNP m.a.f. p p ω FG 2-hr GL FI
2 rs1260326 0.41 3.77× 10−15 4.44× 10−15 1.00 1.24× 10−4 6.26× 10−6 1.24× 10−5
2 rs13022873 0.27 9.94× 10−10 2.34× 10−9 1.00 1.49× 10−2 6.01× 10−6 1.07× 10−2
2 rs13431652 0.29 1.85× 10−13 5.48× 10−13 1.00 2.24× 10−12 9.57× 10−1 2.85× 10−1
2 rs1402837 0.23 4.91× 10−9 1.15× 10−8 1.00 2.78× 10−10 5.18× 10−2 8.07× 10−1
2 rs484066 0.36 2.01× 10−12 2.32× 10−12 1.00 6.10× 10−12 8.54× 10−1 4.87× 10−1
15 rs17271305 0.39 6.87× 10−9 1.35× 10−8 1.00 6.29× 10−3 1.17× 10−5 2.86× 10−1
15 rs7172432 0.41 1.68× 10−8 5.98× 10−8 1.00 7.98× 10−4 3.52× 10−4 4.88× 10−2
SNPs are prominently visible for USAT but not for MANOVA (even though none could reach genome
wide significance). The most noticeable regions (details in Appendix B8) are in chromosomes 1, 5,
12 and 18. Regions in chr 18, for example, have only been identified by USAT, and some recent
studies have reported findings on chr 18 for T2D (Morris et al., 2012; Yuan et al., 2014). For most of
these interesting findings, USAT gave more significant p-value than MANOVA by borrowing almost
the entire information from SSU.
3.5 Discussion
In the study of a complex disease, several correlated traits are often measured as risk factors for the
disease. There may be genetic variants affecting several of these traits. Analyzing multiple disease-
related traits could potentially increase power to detect association of genetic variants with such a
disease. The elucidation of genetic risk factors of such diseases will help us in better understanding
and developing therapeutics against them. In this chapter, we have studied some of the common
univariate and multivariate approaches for analyzing association between multiple phenotypes and
a genetic variant. Our simulation results showed that no single method perform uniformly better
than the others under the simulation scenarios we considered. Multivariate methods like MANOVA
and MultiPhen usually had higher power than the univariate tests only in situations where a few
of the correlated traits were associated. Univariate model based methods in sections 3.2.1 & 3.2.2
outperformed multivariate methods when all the correlated traits were associated and the genetic
effects as well as the residual correlations were in the same direction. Under the assumption of a CS
residual correlation structure, we not only established theoretical conditions for MANOVA’s loss of
power but also provided geometrical explanation for the observed dominance of marginal methods
over MANOVA (refer section 3.2.4). Although we have not established similar theoretical conditions
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for other correlation structures, we have seen similar behavior of MANOVA in our simulation studies.
We also proposed a novel weighted approach USAT, which maximizes power by adaptively using
the data to optimally combine MANOVA and the SSU test. Approximate USAT p-values can be
computed using a very fast one-dimensional numerical integration, which makes implementation on
GWAS data easy. It also allows for adjustment of other covariates (details in Appendix B6). As
shown by our simulation studies, USAT maintains correct type I error in most scenarios (refer Table
3.2). It may be noted that the approximation involved in the p-value calculation can be conservative
at heavier tails of the USAT distribution under null (refer Appendix B3). Unlike MANOVA, USAT
is powerful in detecting pleiotropy under the simulation models we considered. For a large number of
traits with weak correlations or for a few traits with strong correlations, USAT has clear advantage
over MANOVA (refer Figure 3.5). For traits with AR1 covariance structure, USAT is more powerful
in most situations (refer Appendix B9.1). Although the reported simulation studies considered
multivariate normal traits, USAT performed well for multivariate t distributed traits (non-normal
continuous traits) and common genetic variants (refer Appendix B9.2). The conclusions from the
ARIC data analysis are twofold. First, it emphasizes the importance of joint analysis of correlated
phenotypes over multiple univariate analyses. Secondly, USAT can give significant findings by giving
more weight to MANOVA for certain SNPs while giving more weight to SSU for the rest. For any
real data, the underlying association scenario (which may vary from one SNP to another) is not
known apriori and a specific approach of association test (univariate vs multivariate modeling) may
not be powerful enough. USAT overcomes this challenge and has proven to be a sensible choice.
Finally, the simulation scenarios we considered are not exhaustive. Under the scenarios we
considered, the relative behavior of these two tests did not vary much with change in m.a.f. (refer
Appendix B9.3), or with increase in the number of correlated traits. It may be noted that for SNPs
with low m.a.f., USAT may show slightly inflated error when considering genome-wide significance
threshold. Our simulation studies also assumed no missing data and no trait outliers. USAT
requires complete phenotype data. In presence of missing traits, one may consider imputation before
performing association analysis. van der Sluis et al. (2013) showed that 10% missing-completely-at-
random data caused quite a drop in power for MANOVA when only 1 trait was associated. O’Reilly
et al. (2012) showed that in the presence of outliers in the phenotype distribution, MANOVA and
the standard univariate approach were substantially inflated for low m.a.f. We simulated data for
an additive model only and did not consider any non-additive genetic model and/or interactions. In
future, we intend to study how power of our USAT test would be affected in such situations.
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Chapter 4
Population-based Multiple
Secondary Phenotype-Genotype
Analysis
Summary: In the past decade, many genome wide association studies (GWASs) have been conducted
to explore association of genetic variants with complex diseases using a case-control design. These GWASs
not only collect information on the complex-disease status (primary phenotype, D) and the genetic variants
(genotypes, X), but also collect extensive data on several risk factors and other quantitative traits. These
additional traits (secondary phenotypes, Y ) may be associated with the primary disease outcome. One may
analyze these secondary traits with the hope that the primary and the secondary traits share common genetic
factors. An association study using these multiple traits can have improved power to identify the genetic
variants associated with the complex disease than a study using the binary disease status alone. Secondary
trait analysis is also conducted with the view that such traits measure one common underlying trait in which
one may be interested in studying. This underlying trait of interest is different from the primary outcome
and might be associated with it. Multivariate genetic association analysis with the secondary traits from a
case-control sample is not straightforward since one may need to take care of the ascertainment bias arising
from over-representation of cases in the sample. In this chapter, we explore the behavior of several methods
for multivariate association test between a genetic variant and multiple secondary phenotypes under various
scenarios of dependency among Y , X, and D. One popular strategy is to adjust for the case-control status
in the analysis model. We have shown that the bias of estimated genetic effect from an approach with
adjustment for disease status can be very different from that without adjustment. This bias, and hence
type I error, is substantial when X as well as Y are associated with D, even though there is no association
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between X and Y in the underlying population. Based on our findings from the extensive simulation
experiments, we have proposed two alternative tests of association in such a framework. The first approach
is a maximum p-value approach that guards against such high error levels. The second approach involves
adjustment of propensity score as a covariate. The propensity score is defined as the conditional probability
of being diseased given the secondary traits. Through simulated data, the validity and advantage of these
novel approaches has been demonstrated.
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4.1 Introduction
In an effort to better understand the genetic factors associated with complex diseases, several GWASs
have been conducted, where extensive data on genetic variants and several quantitative phenotypes
are often collected. These phenotypes may be correlated, and some or all of them may be associated
with common genetic variants. As discussed in chapter 3, joint analysis of multiple correlated
phenotypes can give substantially better power, over individual trait (univariate) analyses, to identify
genetic variants associated with the complex disease (Basu et al., 2013; Stephens, 2013; Ray et al.,
2015, and references therein). In chapter 3, we were interested in testing such genetic associations
using a random sample of unrelated individuals from a population. In this chapter, we are interested
in testing association of multiple traits with a genetic variant within the framework of a case-control
design.
In a case-control GWAS, the primary goal is to analyze association of the complex disease-status
(primary phenotype, D) with a genetic variant (genotype X). Further, one may be interested in
analyzing the association of X with the additional traits collected during the study. This interest is
fueled by the belief that the additional traits may share common genetic factors with the primary
outcome and, hence, such analyses may provide additional insight about the complex disease being
studied. These phenotypes may be associated with the primary trait and are called secondary
phenotypes (Y ). One may also conduct such association tests using secondary phenotypes when it
is believed that these traits measure one common underlying trait, which one may be interested in
studying. For example, Schifano et al. (2013) analyzed a lung cancer case-control GWAS to identify
SNPs that are associated with smoking behavior. The smoking behavior was represented by four
smoking-related continuous traits, which may be associated with the primary trait (lung cancer
status) and may share common genetic variants.
For any inference using secondary phenotypes (irrespective of the biological interest), one may
need to take care of the ascertainment bias that may arise from the over-representation of diseased
individuals in the case-control sample. Two popular strategies are to conduct case-only or control-
only analyses. Restricting analyses to only a particular subset of the data is tantamount to discarding
valuable information and losing statistical power. The multivariate tests of association between a
genetic variant X and multiple secondary quantitative traits Y from a case-control sample can be
categorized into two groups. The first group of tests consists of the popular multivariate tests like
MANOVA, SSU, MultiPhen (discussed in chapter 3). A popular and convenient approach is to adjust
the primary disease status D as a covariate in these models to reduce the effect of any ascertainment
bias. The second group consists of tests specifically proposed for secondary trait analysis (Lin and
Zeng, 2009; He et al., 2012; Schifano et al., 2013, for example).
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Most of the methodological research towards the second group of tests have considered a single
secondary phenotype, especially a binary trait. In the context of a single secondary trait Y , there
exists evidence that the bias in estimating genetic effects can be substantial (even though there is
no association between X and Y in the general population) when both X and Y are associated with
D (Greenland, 2003; Lin and Zeng, 2009; Monsees et al., 2009). Richardson et al. (2007) proposed
a stratum-weighted logistic regression for estimating the association between X and a binary Y .
For a given stratum (or disease status), the weight chosen is the inverse of the selection probability
(inverse probability weights, IPW). This IPW regression assumes that the sampling fractions are
known, which may not be available unless the case-control study is nested within a well-defined
cohort study. Monsees et al. (2009) studied the IPW regression in detail and investigated (using
varied scenarios of dependency among X, Y and D) the consequences of univariate approaches
that adjusted D in the model or completely ignored the non-random sampling scheme (unadjusted
models). Lin and Zeng (2009) developed valid and efficient methods (based on likelihood functions
that properly reflect the case-control sampling) for accurately estimating the genetic effect size.
Lutz et al. (2014) argued that Lin and Zeng’s approach can encounter numerical issues in practice,
and hence proposed a computationally faster hypothesis testing approach using proportional odds
likelihood. However, contrary to the limited simulation results shown therein, the proportional odds
likelihood may not provide a valid test for association of X and Y in many scenarios. Wang and Shete
(2011a) developed a bias corrected odds ratio estimation approach based on method of moments and
involving the prevalences of both Y and D. Wang and Shete (2011b) established its better power
over unadjusted and adjusted logistic regression models but did not provide any comparison against
a test specifically designed for secondary trait analysis (Lin and Zeng’s approach, for example). He
et al. (2012) proposed a Gaussian copula approach to jointly model Y and D.
Most of the above-mentioned methods focus on the proper estimation of odds ratio, and these
methods cannot be readily extended to a continuous Y (let alone multiple continuous secondary
traits Y ). The reverse regression method of Lutz et al. (2014) can accommodate multiple secondary
phenotypes (continuous or binary or both), which is similar to the MultiPhen approach (O’Reilly
et al., 2012). He et al. (2012) claimed that their Gaussian copula method can easily accommodate
multiple secondary traits. The joint modeling of multiple secondary traits in the context of case-
control studies was explored for the first time by Schifano et al. (2013). They proposed SMAT (Scaled
Multiple-phenotype Association Test), which uses a scaled marginal model and IPW-estimating
equations to estimate and test common effect of the genetic variant on the traits. Their simulation
results established SMAT to be powerful in detecting association of positively correlated secondary
traits. But, their assumptions are often violated and SMAT may have inflated type I error and
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reduced power in practical situations.
In this chapter, following Monsees et al. (2009), we consider six possible dependency scenarios
among the secondary phenotypes Y , the disease status D and the genotype X. We are interested in
testing the null hypothesis H0 that the genetic variant is not associated with any of the secondary
phenotypes. In each of these scenarios, we explore the bias in estimated genetic effects and the impact
on the type I error for testing H0 using methods from the first as well as the second group. The
magnitude of this bias and the extent of type I error of these methods depend on the cause-and-effect
relationship among X, Y and D. We provide mathematical proofs to support the observed behavior
of the methods in these scenarios. Moreover, we quantify the biases for two popular approaches,
MANOVA and SSU, under one important scenario.
Based on our findings, we propose two alternative hypothesis testing approaches that do not
suffer from such inflated type I errors and may provide reasonably powerful tests for association.
Our first approach is based on a maximum p-value approach, where our test statistic is the maximum
of the p-values obtained from MANOVA with and without adjustment for D in the model. There is
no straightforward way of calculating the p-value of this statistic. One needs to calculate empirical
p-value by considering several permuted datasets. Our second approach uses a proportional odds
regression model where we consider covariate adjustment using estimated propensity score. The
propensity score is defined as the conditional probability of being a case given the observed covariates.
The asymptotic p-value for the likelihood ratio test of the null can be easily computed. This approach
maintains proper type I error in all the scenarios we considered.
The outline of the remaining chapter is as follows. Section 4.2 provides details on some existing
methods as well as our proposed methods. In particular, sections 4.2.1 and 4.2.2 describe meth-
ods that are popularly used for analysis of multiple continuous (secondary) phenotypes. In section
4.2.3, we have extended the retrospective proportional odds regression model for a single secondary
phenotype in Lutz et al. (2014) to multiple secondary phenotypes, and proposed an SSU test in the
proportional odds framework. Section 4.2.4 describes, using directed acyclic graphs (DAGs), the
different scenarios of dependency among Y , X and D. Furthermore, we have mathematically justi-
fied which DAGs will render the existing analysis approaches invalid for inference on the association
of Y and X under H0. We have proposed two alternative hypothesis testing approaches in section
4.2.5. Section 4.3 shows extensive simulation studies of the existing methods as well as our proposed
hypothesis testing approaches. Finally, the chapter ends with a summary of the results we observed
mathematically and empirically, and some future direction for this research topic.
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4.2 Methods
Consider a GWAS based on a case-control design. Let us assume that n unrelated individuals were
sampled for the study based on a disease status D (primary outcome/trait). Individuals with D = 1
are cases (n1 of them) while the rest (n0 = n−n1) are controls. Let S denote the sampling indicator.
For a specific individual in the underlying population, S = 1 if that individual is included in the
sample. Evidently, all the individuals in the GWAS sample have S = 1. For simplicity, we assume
that the sampling strategy (S) depends only on the disease outcome (D). Consider K correlated
traits Y1, Y2, . . . , YK (secondary traits) which were measured on these n subjects. Let Y k be the
n × 1 vector of k-th trait and Y be the n × K matrix of traits for all individuals in the sample.
Consider a GWAS setting with data on a large number p ( n) of genetic variants. For analyzing
multiple related phenotypes at a GWAS level, the methods described herein are used to perform
single-SNP association analysis. We are interested in testing the null hypothesis that a chosen SNP
is not associated with any of the K correlated traits. For a given SNP, let Xi be the number of
copies of minor alleles (0, 1 or 2) for i-th individual and X be the n× 1 vector of genotypes for all
subjects. Denote the vector of primary phenotypes by D.
4.2.1 Existing tests for multiple phenotype analysis
This section describes two multivariate tests that are often used in the analysis of multiple phenotypes
from cross-sectional studies.
4.2.1.1 MANOVA
Due to the correlatedness of the K traits, one may consider the multiple multivariate linear regression
(MMLR) model for the association test of K traits and the SNP:
Y n×K = Xn×1β′1×K +Zn×qΦq×K + En×K (4.1)
where β′ = (β1, ..., βK) is the vector of fixed unknown genetic effects corresponding to the K
correlated traits, Z is the matrix of q covariates (including intercept), Φ is the matrix of nuisance
parameters corresponding to the q covariates and K traits, and E is a normal data matrix from
NK(0,Σ). The covariate matrix Z may contain the vector of primary outcomes D along with other
covariates like age and sex. The log-likelihood for the data matrix Y is given by
l(β,Φ,Σ) = −1
2
n log |2piΣ| − 1
2
tr
{
Σ−1(Y −Xβ′ −ZΦ)′(Y −Xβ′ −ZΦ)}
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For testing that the SNP is not associated with any of the K traits, the null hypothesis of interest
is H0 : β = 0. The MLE of β is given by βˆ = Y
′PZX(X ′PZX)−1, where PZ = I−Z(Z ′Z)−1Z ′
is the projection matrix onto the space orthogonal to the space spanned by Z. For testing H0, the
LRT is equivalent to the MANOVA test statistic (Wilk’s Lambda), which is the ratio of generalized
variances |E|/|H +E|. Here H is the hypothesis sum of squares and cross product (SSCP) matrix
and E is the error SSCP matrix. The explicit forms of these SSCP matrices in terms of phenotype
and genotype data are H = βˆ(X ′PZX)βˆ
′
and E = Y ′PZY − βˆ(X ′PZX)βˆ′. Under H0,
−2 log Λ = −n log (|E|/|H +E|) a∼ χ2K
4.2.1.2 SSU
Apart from multivariate models, one may use marginal models for an association test of a genetic
variant with multiple secondary phenotypes. The marginal normal model for testing association of
a SNP with k-th trait is given by
Y k = βM,kX +ZΦk + k, k ∼ Nn(0, σ2In) (4.2)
where βM,k is the parameter associated with the SNP effect on the k-th trait, Z is the matrix
of q covariates (including intercept), Φk is the q × 1 vector of parameters associated with the q
covariates and the k-th trait. For each k = 1, ...,K, we explicitly distinguish k-th genetic effect
βM,k in marginal models (4.2) from the k-th genetic effect βk in the MMLR model (4.1). The null
hypothesis associated with k-th marginal model is H0,M,k : βM,k = 0. The log-likelihood for the
k-th genetic effect from the k-th marginal model is given by
l(βM,k) ∝ − 1
2σ2
(Y k − βM,kX −ZΦk)′(Y k − βM,kX −ZΦk)
Under the null (H0,M : ∩Kk=1H0,M,k), the marginal score vector is
UM = Y
′PZX/σˆ20
with covariance Cov(UM ) =
1
σˆ40
(X ′X)Σˆ0, where σˆ20 =
1
nK
∑K
k=1(Y k − ZΦˆk)′(Y k − ZΦˆk), Φˆk =
(Z ′Z)−1Z ′Y k and Σˆ0 = Y ′PZY /n. The SSU test is a score test based on UM :
TS = U
′
MUM
approx∼ aχ2d + b
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where parameters a, b, d are estimated as a =
∑
δ3i∑
δ2i
, b =
∑
δi − (
∑
δ2i )
2∑
δ3i
, d =
(
∑
δ2i )
3
(
∑
δ3i )
2 , {δi}Ki=1 are the
ordered eigenvalues of Cov(UM ).
The important aspect that differentiates the SSU test from MANOVA is that SSU does not
incorporate the trait covariance structure in its statistic. However, the trait covariance structure is
taken into account in finding the true null distribution due to which it can maintain proper type I
error.
4.2.2 Existing test for multiple secondary phenotype analysis
This section describes the only test that has been proposed specifically for the analysis of multiple
secondary phenotypes.
4.2.2.1 SMAT
SMAT (Schifano et al., 2013) is a scaled marginal model for genome-wide association analysis of
multiple continuous secondary phenotypes in case-control studies. Specifically, when multiple phe-
notypes are positively correlated and measure the same underlying trait in the same direction, the
authors proposed the use of IPW-estimating equations in order to estimate and test the shared
common effect of SNPs. The IPW weights are said to account for the case-control ascertainment in
the analysis of secondary phenotypes. SMAT tests for the common effect of SNP using a 1-DF test
while allowing for phenotype-specific covariate effects. As an estimating-equation-based approach,
it accounts for arbitrary correlation among multiple phenotypes and is robust to departure from
normality and misspecification of correlation among multiple continuous phenotypes. Furthermore,
the assumption of common effect can be tested with an estimating-equation-based score test by
comparing scaled marginal models with heterogeneous SNP effect models.
4.2.3 Extension of existing tests for single secondary phenotype analysis
This section extends the proportional odds model (POM) approach for a single secondary phenotype
suggested by Lutz et al. (2014). The hypothesis test of H0 employs a likelihood ratio test (LRT),
similar to MultiPhen (O’Reilly et al., 2012). In chapter 3, we have seen that the performance of
MultiPhen and MANOVA are similar for multiple phenotypes and single genetic variant. Since SSU
is an alternative to MANOVA/MultiPhen, one can consider a marginal score-based test (similar to
SSU) derived from the POM. An advantage of the methods based on POM is that both continuous
and binary traits can be easily incorporated.
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4.2.3.1 LRT based on POM
Lutz et al. (2014) proposed modeling of P[X|Y,D] and P[X|D] (under H0) when hypothesis testing
is the primary goal of secondary phenotype analysis. They suggested use of the LRT statistic
−2 log
( ∏n
i=1 P [Xi|Di]∏n
i=1 P [Xi|Yi,Di]
)
∼ χ21. This model can easily accommodate multiple phenotypes and other
covariates. The joint POM with X as response, Y1, ..., YK as predictors, and adjusted for covariates
Z (including disease status D) is given by:
logit (P(Xi ≤ 0)) = η00 + η′Y i + Ψ′Z(1)i ,
logit (P(Xi ≤ 1)) = η01 + η′Y i + Ψ′Z(1)i ∀ i = 1, 2, ...n (4.3)
where η = (η1, ..., ηK)
′ is the vector of coefficients corresponding to the K traits in the reverse
regression model, Z
(1)
i is the (q−1)×1 vector of covariates (excluding intercept) for the i-th subject
in the sample, and Ψ is the corresponding vector of coefficients. All the parameter estimates and
their SE (standard error) estimates can be easily obtained using the R function polr() from MASS
package. We are interested in testing the null hypothesis H∗0 : η = 0. Under H
∗
0 , the estimates
of nuisance parameters ηˆ00, ηˆ01 and Ψˆ are obtained using the model (4.3) with η = 0. Once the
estimates are obtained, one can calculate the LRT statistic (∼ χ2K) for testing association of K
secondary phenotypes. Alternatively, one may directly use the mPhen() function from R package
MultiPhen 2.0.0.
4.2.3.2 SSU based on POM
Instead of modeling all the K traits together, one may use the marginal POM for k-th trait:
logit (P(Xi ≤ 0)) = ηM,0k + ηM,kYik + Ψ′kZ(1)i ,
logit (P(Xi ≤ 1)) = ηM,1k + ηM,kYik + Ψ′kZ(1)i ∀ i = 1, 2, ..., n (4.4)
where Z
(1)
i is the (q − 1) × 1 vector of covariates (intercept not included) for the i-th subject in
the sample, and Ψk is the corresponding vector of coefficients for the k-th model. The k-th null
hypothesis associated with the k-th marginal model is H∗0,M,k : ηM,k = 0. Define the variable X0i = 1
if Xi = 0, and 0 otherwise. Similarly X1i and X2i are defined. The log-likelihood for the parameters
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corresponding to k-th trait is given by
l(ηM,0k, ηM,1k, Ψk, ηM,k)
=
n∑
i=1
{
x0i(ηM,0k + ηM,kYik + Ψ
′
kZ
(1)
i )− x0i log
(
1 + eηM,0k+ηM,kYik+Ψ
′
kZ
(1)
i
)}
+
n∑
i=1
x1i log
 eηM,0k+ηM,kYik+Ψ′kZ(1)i − eηM,1k+ηM,kYik+Ψ′kZ(1)i(
1 + eηM,0k+ηM,kYik+Ψ
′
kZ
(1)
i
)(
1 + eηM,1k+ηM,kYik+Ψ
′
kZ
(1)
i
)

−
n∑
i=1
x2i log
(
1 + eηM,1k+ηM,kYik+Ψ
′
kZ
(1)
i
)
Under H∗0,M : ∩Kk=1H∗0,M,k, the estimates of nuisance parameters ηˆM,0k, ηˆM,1k and Ψˆk are obtained
by minimizing the log-likelihood l(ηM,0k, ηM,1k, Ψk, ηM,k = 0). All the parameter estimates and
their SE estimates can be obtained using the R function polr() from MASS package. The k-th
component of the marginal score vector U∗M is given by
U∗M,k =
∂l
∂ηM,k
∣∣∣∣
H∗0,M
=
n∑
i=1
x0iYik
(
1− e
ηˆM,0k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,0k+Ψˆ
′
kZ
(1)
i
)
−
n∑
i=1
x2iYik
eηˆM,1k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,1k+Ψˆ
′
kZ
(1)
i
+
n∑
i=1
x1iYik
(
1− e
ηˆM,0k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,0k+Ψˆ
′
kZ
(1)
i
− e
ηˆM,1k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,1k+Ψˆ
′
kZ
(1)
i
)
(4.5)
The marginal-score test (SSU) based on POM is given by
T ∗S = (U
∗
M )
′U∗M
approx∼ a∗χ2d∗ + b∗
where U∗M = (U
∗
M,1, ..., U
∗
M,K)
′ is the marginal score vector obtained from equation (4.5), and the
parameters a∗, b∗, d∗ are estimated as a∗ =
∑
(δ∗i )
3∑
(δ∗i )2
, b∗ =
∑
δ∗i − (
∑
(δ∗i )
2)2∑
(δ∗i )3
, d∗ = (
∑
(δ∗i )
2)3
(
∑
(δ∗i )3)2
, {δ∗i }Ki=1
are the ordered eigenvalues of Cov(U∗M ). Observe that Cov(U
∗
M ) can be estimated by using the
score statistic U∗M,i from each unrelated individual i, i = 1, 2, ..., n. We have a sample of i.i.d. K×1
marginal score vectors U∗M,1, ...,U
∗
M,n, where
U∗M,i =
{
x0i
(
1− e
ηˆM,0k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,0k+Ψˆ
′
kZ
(1)
i
)
+x1i
(
1− e
ηˆM,0k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,0k+Ψˆ
′
kZ
(1)
i
− e
ηˆM,1k+Ψˆ
′
kZ
(1)
i
1 + eηˆM,1k+Ψˆ
′
kZ
(1)
i
)
− x2i e
ηˆM,1k+Ψˆ
′
kZ
(1)
i
1 + eβˆM,1k+Ψˆ
′
kZ
(1)
i
}
Y i
One can calculate the mean and covariance based on this i.i.d. sample. Note that U∗M =
∑n
i=1U
∗
M,i
so that Cˆov(U∗M ) = Cov
(∑
U∗M,i
)
.
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Figure 4.1: The directed acyclic graphs (DAGs) showing 6 possible scenarios of association of X (genotype), Y
(multiple secondary phenotypes), D (primary trait or disease status) and S (sampling indicator) in the
general population. These scenarios have been considered following Monsees et al. (2009). For simplicity,
it is assumed that the sampling mechanism depends only on the case-control variable D. The direction of
the arrows indicate cause-effect relationships. Without an arrow between X and Y , the DAGs represent
null simulation scenarios. The alternative scenario is represented by an arrow from X to Y . For DAGs
A-C, E, the order simulation is [X], [Y |X], [D|Y , X]. For DAGs D and F, the order of simulation is
[X], [D|X], [Y |X,D].
4.2.4 Bias and type I error: Mathematical results
In order to investigate the performances of all the above-mentioned methods (either adjusted for
disease status or not adjusted), we consider six possible scenarios, following Monsees et al. (2009),
for the joint distribution of the secondary phenotypes, the primary outcome (disease status) and
the genetic variant. This joint distribution in the underlying population is presented using directed
acyclic graphs (DAGs) (refer Figure 4.1). The direction of the arrows in the DAGs represent the
cause-effect relationships among the variables. No arrow connecting X and Y represents the scenario
under the null. The alternative is indicated by an arrow from X to Y .
The following theorems theoretically justify conditions and scenarios when unadjusted and primary-
outcome-adjusted methods for multiple phenotype analysis will or will not provide valid tests of
association. Proofs of all the theorems are provided in Appendix C1. For ease of notation, the
distribution of any random variable/vector (discrete or continuous or mixed) will, henceforth, be
denoted using square braces [.]. For example, [X] denotes the distribution (probability mass func-
tion) of X, [Y ] denotes the joint distribution (probability density function) of Y , [Y |X] denotes the
conditional distribution of Y given X and so on.
Theorem 4.1. For DAGs ‘A’,‘B’,‘C’,‘D’, the secondary phenotypes and the genotype remain inde-
pendently distributed (under the null hypothesis of no association) when conditioned only on ascer-
tainment S, as well as when conditioned on both S and the case-control status (or, primary disease
outcome) D.
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Theorem 4.2. For DAG ‘F’, the secondary phenotypes and the genotype remain independently dis-
tributed (under the null hypothesis of no association) when conditioned on both ascertainment S and
the case-control status (or, primary disease outcome) D. When conditioned only on ascertainment
S, they no longer remain independent under the null.
Theorem 4.3. Under DAG ‘E’, consider the following model for X, Y and D in the general
population:
[X] : P(Xi = x) =

(1− f)2, if x = 0
2f(1− f), if x = 1
f2, if x = 2[
Y |X] : Y i = β∗01 +Xiβ∗ + i, i i.i.d.∼ NK (0,Σ)[
D|Y , X] : logit(P(Di = 1)) = α0 +α′Y i + αxXi, ∀ i = 1, 2, ..., n (4.6)
where f is the minor allele frequency (m.a.f.) of the SNP under consideration. In this scenario,
conditioned on the ascertainment S, the distribution of secondary phenotypes given genotype is same
as that in the underlying population if α = 0 in the population model for the primary outcome D.
Further, the secondary phenotypes and the genotype do not remain independently distributed (under
the null hypothesis of no association) when conditioned on both ascertainment S and case-control
status (primary disease outcome) D.
According to Theorem 4.1, the ordinary multiple phenotype analysis methods (with or without
adjustment of case-control status), provide valid tests for association in the situations represented
by DAGs ‘A’-‘D’. Our simulation studies (refer section 4.3) confirmed that in these situations, the
over-representation of cases do not affect the estimates of the genetic effects in the general population
and hence naive analysis approaches can maintain proper type I error. Theorem 4.2 points out that
the naive analyses that ignore case-control ascertainment and treat the sample as if it were cross-
sectional do not provide valid test of the null in the scenario DAG ‘F’. Due to this dependence of Y
and X in the ascertained population under the null, analyzing the case-control sample without any
adjustment for ascertainment yields biased estimates of the genetic effects. However, when case-
control status is adjusted as a covariate in such analyses, one has a valid test of the null hypothesis,
and no bias in the genetic effect estimates is observed.
4.2.4.1 Behavior of MANOVA and SSU under DAG ‘F’
In this section, we have particularly focused on the behavior (in terms of bias) of popular multiple
phenotype analysis approaches MANOVA and SSU. Under the null, these approaches give biased
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estimates in scenarios following DAGs ‘E’ and ‘F’. Although DAG ‘E’ seems to be a more likely
situation in practice, it is quite difficult to quantify the bias in this case. So we have specifically
quantified MANOVA’s and SSU’s biases under DAG ‘F’ only. Let us consider the following model
for X, Y and D in the general population under DAG ‘F’:
[X] : P(Xi = x) =

(1− f)2, if x = 0
2f(1− f), if x = 1
f2, if x = 2[
D|X] : logit(P(Di = 1)) = α0 + αxXi[
Y |D,X] : Y i = β∗01 +Xiβ∗ +DiΦ∗ + i, i i.i.d.∼ NK (0,Σ) (4.7)
where Φ∗ = (φ∗1, ..., φ
∗
K)
′ is the vector of K coefficients for the covariate D. For simplicity, let us
assume β∗0 = 0.
4.2.4.1.1 No adjustment for D: Without loss of generality, it is assumed that the phenotypes
and genotype are centered (so intercept is excluded) and there is no covariate other than D. The
SSU model when no adjustment is considered:
Y k = βM,kX + k, k ∼ Nn(0, σ2In)
The estimated k-th trait effect is βˆM,k =
(
X ′X
)−1
X ′Y k. Define p1d = P (S = 1|D = d) for
d = 0, 1. For a given trait k, one can show that
E(Yk|X,S = 1) =
∫
R
Yk P (Yk|X,S = 1) = β∗kX + ω1(x)φ∗k
where ωd(x) =
p1dP (D=d|X=x)∑
d′ p1d′P (D=d′|X=x) for d = 0, 1.
∴ E[Y |X,S]
(
βˆM,k
)
=
(
X ′X
)−1
X ′ E (Y k|X, S = 1) = β∗k +
(
X ′X
)−1
X ′

ω1(x1)
...
ω1(xn)
φ∗k (4.8)
Evidently, the MANOVA model without adjustment for D will give the same bias as in equation
(4.8). In our null simulation study with K = 2 traits, we found this expected bias to concide with the
empirical bias (refer Appendix C2). Observe that these methods will not provide biased estimates
if φ∗k = 0 for all k = 1, 2, ...,K. When Φ
∗ = 0, the model (4.7) for DAG ‘F’ reduces to a model for
DAG ‘B’.
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4.2.4.1.2 Adjustment for D: Without loss of generality, it is assumed that the phenotypes and
genotype are centered (so intercept is excluded). The SSU model when adjusted for D is given by
Y k = βM,kX + φkD + k, k ∼ Nn(0, σ2In)
The estimated k-th trait effect is βˆM,k =
(
X ′cXc
)−1
X ′cY c,k, where Xc = (In − DD′/n1)X is
the adjusted genotype vector, Y c,k = (In −DD′/n1)Y k is the vector of adjusted k-th trait for n
unrelated individuals, and n1 is the number of cases in the sample. Assume that the first n0 among
n individuals are controls, and the rest n1 = n−n0 are cases. For a given trait k, one can show that
E(Yk|X,D = d, S = 1) = E(Yk|X,D = d) = β∗kX + dφ∗k
∴ E[Y |X,D,S]
(
βˆM,k
)
=
(
X ′cXc
)−1
X ′c E (Y c,k|X,D, S = 1)
=
(
X ′
(
In −DD′/n1
)
X
)−1
X ′
(
In −DD′/n1
) {β∗kX + φ∗kD}
= β∗k (4.9)
Clearly, both SSU and MANOVA, when adjusted for the primary outcome D, will provide unbiased
estimates of the genetic effects under DAG ‘F’. One can similarly show the unbiasedness of estimated
genetic effects from MANOVA and SSU for DAGs ‘A’-‘D’.
4.2.5 Two alternative association tests
4.2.5.1 pmax: A maximum p-value approach
This test is motivated by our findings in sections 4.2.4 and 4.3. For DAG ‘F’, the theoretical results
in section 4.2.4 indicate that MANOVA adjusted for D and SSU adjusted forD maintain proper type
I error. Though we could not establish a similar theoretical result for DAG ‘E’, our simulation results
from section 4.3 indicate that only unadjusted MANOVA and SSU will maintain type I error. Our
simulation experiments also show that MANOVA is usually the most powerful approach in detecting
association, and the empirical power for adjusted and unadjusted MANOVA did not differ much
from one another in the varied scenarios we considered. While analyzing any real dataset, one
might not know the scenario (DAGs ‘A’-‘D’ or ‘E’ or ‘F’) apriori. Since MANOVA (adjusted or
unadjusted) has similar behavior for DAGs ‘A’-‘D’ and has complementary behavior (in terms of
bias and type I error) under DAGs ‘E’ and ‘F’, a naive approach would be to consider the maximum
of the unadjusted and the adjusted MANOVA p-values for any given scenario. Taking the maximum
guards against inflated type I error but we will lose some power in the process. If pM and pM,adj are
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the p-values of unadjusted MANOVA and D-adjusted MANOVA respectively, then our proposed
test statistic is
Tpmax = max{pM , pM,adj}
Observe that the unadjusted statistic TM and the D-adjusted statistic TM,adj from MANOVA are
correlated quadratic forms, and their joint distribution is not known. As a result, the p-values
pM and pM,adj are correlated and it is not straightforward to derive their joint distribution. One
approach is to calculate the empirical p-value of Tpmax by considering several permuted datasets.
This option is suitable for a candidate gene study of secondary traits. However, for a GWAS, this
is computationally very intensive.
4.2.5.2 POM-PS: A propensity-score adjusted proportional odds model
It is clear from DAGs ‘E’ and ‘F’ that bias and inflated type I error arise as a result of the con-
founding effect of the primary outcome on the secondary phenotypes. If one can make D and Y
conditionally independent in the analysis model, then it might be possible to reduce the bias consid-
erably and maintain proper type I error. Rosenbaum and Rubin (1983) proposed propensity scores
in the context of observational (non randomized) studies, where the treatment assignment and the
observed covariates are independent when conditioned on the propensity score. The propensity score
was defined as the conditional probability of treatment assignment given the covariates. Since then,
propensity score methods have been used for reducing effects of confounding variables in observa-
tional studies (Zhao et al., 2009; Austin, 2011, and references therein). In our context, the secondary
phenotypes can be considered as covariates for the primary case-control study, and we can model
our propensity score PS(D;Y ) := P(D|Y ) as
logit (P(D = 1|Y )) = γ0 + γ′Y
According to Rosenbaum and Rubin (1983), Y is independent of D given PS(D;Y ). We then use
POM to regress the genetic variant on the secondary phenotypes while adjusting for the propensity
score. The proportional odds modeling does not require normality of traits and allows us the
flexibility to incorporate both binary and continuous secondary phenotypes. One can now perform
LRT for the test of association of X and Y . This approach can be easily implemented using readily
available R functions such as polr() in MASS package, or by directly using the package MultiPhen.
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4.3 Simulation Experiments
We compared the performances of different methods discussed in sections 4.2.1, 4.2.2 and 4.2.3.
For our extensive investigation, data were simulated on unrelated subjects under a variety of trait
models. In Simulation 1 (section 4.3.1), we considered null datasets withK = 2 traits having pairwise
correlation ρ ∈ (−1, 1). Bias, variance distortion and type I error of each of the methods is studied for
DAGs ‘A’-‘F’. In Simulation 2 (section 4.3.2), we studied the bias and variance distortion for K = 2
traits under the alternative hypothesis. In Simulation 3 (section 4.3.3), we considered K = 5, 10, 20
traits with genetic effects in the same direction as the positive correlation. Compound symmetry or
CS(ρ) correlation structure is considered for residual trait correlation. Apart from comparing the
power performance of existing methods, we also empirically compared the performance of the two
proposed approaches (described in section 4.2.5) against MANOVA.
In order to simulate data for DAGs ‘A’, ‘B’, ‘C’, ‘E’, we followed the model (4.6) since DAG ‘E’
contains the other DAGs. For DAGs ‘D’ and ‘F’, the model (4.7) was followed. We first simulated
X taking values 0, 1, 2 with probabilities (1− f)2, 2f(1− f), f2 respectively. f = 0.2 is the m.a.f. of
the single SNP. The two alleles at the SNP were sampled independently to ensure Hardy-Weinberg
equilibrium. Depending on the DAG, either Y or D is simulated next. Conditional on X, we
simulated Y for a fixed K using the simulation model Y = β∗01 + β
∗X + Φ∗D + , where the
vectors Y , 1, β∗, Φ∗,  are K-dimensional. We took β0 = 0, Φ∗ = φ∗1, and simulated  from
NK(0, σ
2R(ρ)), where R(ρ) is a CS correlation matrix. The genetic effect size for a given associated
trait was chosen such that h% (0 < h < 1) of the total phenotypic variance was explained by the
SNP. For a given trait, the choice of h and the m.a.f. of the SNP determine the effect size for the SNP.
The specific choices of h, β∗, φ∗, σ2 and ρ for each simulation are given in their respective sections.
The disease status is simulated using the following model: logit(P(D = 1)) = α0 + α
′Y + αxX.
Parameter α0 is chosen such that the disease prevalence in the general population is κ = 0.1. We
took α = α1. Within each DAG, N = 21, 000 individuals representing the population are simulated,
out of which N0 are controls and N1 are cases. n0 controls and n1 cases are randomly sampled from
the population to form our case-control ascertained sample. For each scenario, NR independent
datasets (replications) are simulated for our empirical analysis. The different parameter values in
each simulation scenario are summarized in Table 4.1. We are interested in testing H0 : β
∗ = 0. All
the analyses were implemented in R 3.0.1 (R Development Core Team, 2014).
4.3.1 Simulation 1: K = 2 traits under the null
First, type I error comparison was performed for the 5 existing methods, along with our proposed
approach POM-PS, by considering only K = 2 correlated traits. Since our pmax approach does
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Table 4.1: List of parameter values considered under different scenarios and trait models in our simulation experi-
ments in sections 4.3.1-4.3.3.
K Parameters ‘A’ ‘B’ ‘C’ ‘D’ ‘E’ ‘F’
2 f 0.2 0.2 0.2 0.2 0.2 0.2
β∗0 0 0 0 0 0 0
h (null trait) 0 0 0 0 0 0
h (non-null trait) 0.002 0.002 0.002 0.002 0.002 0.002
φ∗ 0 0 0 3.5 0 3.5
σ2 9.98 9.98 9.98 9.98 9.98 9.98
α0 −2.197 −2.197 −2.197 −2.197 −2.197 −2.197
α 0 0 log(3) 0 log(3) 0
αx 0 log(1.5) 0 0 log(1.5) log(1.5)
NR (null datasets) 10
4 104 104 104 104 104
NR (non-null datasets) 500 500 500 500 500 500
n0 = n1 2000 2000 2000 2000 2000 2000
5, f 0.2 0.2 0.2 0.2 0.2 0.2
10, β∗0 0 0 0 0 0 0
20 h (null trait) 0 0 0 0 0 0
h (non-null trait) 0.005 0.005 0.005 0.005 0.005 0.005
φ∗ 0 0 0 3.5 0 3.5
σ2 9.95 9.95 9.95 9.95 9.95 9.95
α0 −2.197 −2.197 −2.197 −2.197 −2.197 −2.197
α 0 0 log(3) 0 log(3) 0
αx 0 log(1.5) 0 0 log(1.5) log(1.5)
NR (null datasets) 5000 5000 5000 5000 5000 5000
NR (non-null datasets) 500 500 500 500 500 500
n0 = n1 (null) 2000 2000 2000 2000 2000 2000
n0 = n1 (non-null) 200 200 200 200 200 200
not have an asymptotic distribution yet, we could not consider it for type I error analysis. In this
setting, no trait is associated with the SNP in the population, and hence we have β∗1 = 0 = β
∗
2 .
Estimation of type I error generally requires a large number of replicates (NR) and a large sample
size (n) in order to generate a reliable estimate at a stringent level of significance α. The type I error
is estimated as the proportion of null datasets in which the p-value ≤ α. We considered significance
level α = 0.01. At α = 0.01, one expects to find one ‘non-null’ dataset out of every 100 null datasets.
Hence, for this purpose, we simulated NR = 10, 000 null datasets with n0 = 2, 000 controls and
n1 = 2, 000 cases (all individuals are unrelated). All the methods, except SMAT and POM-PS,
have been analyzed twice: once without considering any adjustment for the non-random sampling
scheme (event [S]), and once with adjustment for D as a covariate (event [S,D]). Analysis of SMAT
with adjustment for D does not make sense since SMAT is designed specifically for secondary traits.
Although SMAT and POM-PS consider adjustment for ascertainment, their type I error estimates
are placed under event [S] to indicate that these methods did not consider adjustment of D as a
covariate in their respective models. Table 4.2 shows the type I errors for each of the methods under
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the 6 possible DAGs for 4 values of ρ: −0.8,−0.2, 0.2, 0.8. As expected from Theorem 4.1, all of
the methods (irrespective of any adjustment for ascertainment) maintain proper type I error under
DAGs ‘A’, ‘B’, ‘C’ and ‘D’. For DAG ‘E’, the methods that treat the ascertained sample as if it
was a random sample from the underlying population do not exhibit inflated type I error. SMAT,
however, seems to have a slightly inflated error level. Our method POM-PS exhibits correct type I
Table 4.2: Estimated type I errors of the afore mentioned association tests for K = 2 correlated traits. Type I
error rate is calculated as the proportion of null datasets (out of 10, 000) with p-value ≤ 0.01. Event [S]
means the case-control sample is analyzed without any adjustment for ascertainment. Event [S,D] means
the analyses are based on the case-control sample and adjusted for D. Although SMAT and POM-PS
consider adjustment for ascertainment, their type I error estimates are placed under [S] to indicate that
these methods have not considered adjustment of D as covariate in their respective models. The inflated
errors are boldfaced. The very conservative errors are in italics.
ρ = −0.8 ρ = −0.2 ρ = 0.2 ρ = 0.8
dag Method [S] [S,D] [S] [S,D] [S] [S,D] [S] [S,D]
A MANOVA 0.0104 0.0105 0.0101 0.0102 0.0114 0.011 0.0105 0.0105
SSU 0.0103 0.01 0.0113 0.0113 0.0119 0.0118 0.0099 0.0101
SSU-POM 0.0104 0.0105 0.0105 0.0107 0.0124 0.0126 0.0095 0.0095
LRT-POM 0.0111 0.0109 0.0103 0.0103 0.0112 0.0112 0.0104 0.0105
SMAT 0.0115 — 0.0096 — 0.0107 — 0.0099 —
POM-PS 0.0103 — 0.0088 — 0.0114 — 0.0094 —
B MANOVA 0.0105 0.0115 0.0113 0.0104 0.0103 0.0101 0.0101 0.0101
SSU 0.0112 0.0105 0.0105 0.0096 0.0086 0.008 0.0105 0.0107
SSU-POM 0.0106 0.0107 0.0104 0.0103 0.01 0.0098 0.0108 0.011
LRT-POM 0.0098 0.0103 0.0109 0.0113 0.0101 0.0103 0.0103 0.0108
SMAT 0.0084 — 0.0113 — 0.0096 — 0.0111 —
POM-PS 0.0089 — 0.011 — 0.0099 — 0.009 —
C MANOVA 0.0101 0.0101 0.0116 0.0113 0.011 0.0102 0.0097 0.0102
SSU 0.0113 0.011 0.0113 0.0117 0.0117 0.0099 0.01 0.0089
SSU-POM 0.0102 0.0093 0.011 0.0066 0.011 0.0013 0.01 0
LRT-POM 0.0097 0.0114 0.0108 0.011 0.0101 0.0103 0.0094 0.0096
SMAT 0.0097 — 0.0114 — 0.0112 — 0.0101 —
POM-PS 0.0095 — 0.0099 — 0.0093 — 0.0092 —
D MANOVA 0.0106 0.0097 0.0094 0.0107 0.0113 0.0109 0.0077 0.0089
SSU 0.0094 0.0093 0.0088 0.0093 0.0109 0.0117 0.01 0.0098
SSU-POM 0.0096 0.007 0.01 0.0028 0.0109 0.0016 0.0104 0.0024
LRT-POM 0.0103 0.0095 0.0097 0.0105 0.0106 0.0106 0.0089 0.0099
SMAT 0.0109 — 0.0096 — 0.0113 — 0.0101 —
POM-PS 0.0108 — 0.0091 — 0.0091 — 0.0106 —
E MANOVA 0.0133 0.5961 0.0094 0.4123 0.0096 0.3111 0.009 0.2103
SSU 0.01 0.0161 0.0092 0.0686 0.0087 0.2049 0.0101 0.2898
SSU-POM 0.0106 0.0152 0.0085 0.0354 0.0085 0.0435 0.0099 0.0182
LRT-POM 0.0148 0.5697 0.0097 0.3855 0.0089 0.2968 0.0096 0.2006
SMAT 0.0198 — 0.0112 — 0.0094 — 0.0102 —
POM-PS 0.0109 — 0.0101 — 0.0098 — 0.0089 —
F MANOVA 0.9999 0.0096 0.9817 0.009 0.9344 0.0101 0.8149 0.011
SSU 0.9963 0.0093 0.9864 0.0096 0.9633 0.0103 0.888 0.0108
SSU-POM 0.9954 0.0074 0.9825 0.0025 0.9574 0.002 0.8725 0.0031
LRT-POM 0.9998 0.009 0.9775 0.0102 0.9274 0.0094 0.7964 0.0122
SMAT 0.9997 — 0.956 — 0.868 — 0.7007 —
POM-PS 0.0096 — 0.0092 — 0.0089 — 0.0101 —
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error. The methods which adjust D as a covariate in the model suffer from high error levels and the
type I errors seem to decrease with increase in the correlation ρ. Observe that the type I error of
SSU-POM (SSU test based on POM) is much closer to the true error level. SSU-POM seems to be
conservative when D is adjusted in the model. Exactly opposite behavior is observed under DAG
‘F’. As indicated by Theorem 4.2, the methods adjusted for D maintain type I error across all values
of correlation while the unadjusted methods have severe type I errors. SMAT, too, has noticeably
high type I errors even when its assumption about common genetic effects and positively correlated
traits are not violated. Our method POM-PS still maintains correct type I error.
In order to study the source(s) of such inflated type I errors in the existing methods, we cal-
culated the biases (in genetic effect estimation) and variance distortion (distortion in the variances
of estimated genetic effects) using the null datasets. The bias in estimating k-th genetic effect is
defined as E(βˆk) − β∗k , where βˆk is the MLE of βk under the models we considered in the sections
4.2.1, 4.2.2, 4.2.3. E(βˆk) is estimated by Eˆsim(βˆk), which is the average of the βˆk observed over NR
simulation replicates. Variance distortion is defined as σmodel(βˆk)/σ(βˆk), where σmodel(βˆk) is the
theoretical standard deviation (SD) under the models we considered, and σ(βˆk) is the true SE. We
estimated σmodel(βˆk) by taking the square root of the average of the reported variances from each of
the models (average based on NR datasets). σ(βˆk) is estimated by calculating the sample SD of the
βˆk from NR replicates. The mean empirical bias in genetic effect estimation and distortion in the
estimated variances under the 6 DAGs are plotted in Figures 4.2-4.7. As expected, DAGs ‘A’-‘D’ do
not reflect biases or distorted variances for any method. For DAGs ‘E’ and ‘F’, we do not observe
any distortion in the variances of the estimated genetic effects. However, the bias in estimating
genetic effects is very high in situations we observed inflated type I errors. When D is adjusted
under DAG ‘E’, the bias in estimating genetic effects is not as high as when D is not adjusted under
DAG ‘F’. In both scenarios, the reverse regression based methods seem to provide estimates that
are closer to the true value (zero) than the other approaches.
4.3.2 Simulation 2: K = 2 traits under the alternative
This simulation experiment is meant to study the biases in estimated effects when at least one of the
traits is associated. We considered 2 possible levels of association: only the first trait is associated
(β1 = 0.25, β2 = 0), or both the traits are associated (β1 = 0.25 = β2). To ensure genetic effect
size of 0.25 for the associated trait, h = 0.002 was chosen. Rest of the simulation parameters are
exactly same as in Simulation 1 (section 4.3.1). The estimated effects for the prospective model
based methods are around the true value for DAGs ‘A’-‘D’ (plots not provided). The biases for
prospective models under DAGs ‘E’ and ‘F’ are similar to what we observed for null datasets. The
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Figure 4.2: For DAG ‘A’, the following simulation order is used: [X], [Y ], [D]. Event [S] means the case-control
sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are
based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias, variance
distortion and type I error (at level 0.01) respectively. Since both traits are identical in every respect in
the population, results for only Trait 1 is shown.
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Figure 4.3: For DAG ‘B’, the following simulation order is used: [X], [Y ], [D|X]. Event [S] means the case-control
sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are
based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias, variance
distortion and type I error (at level 0.01) respectively. Since both traits are identical in every respect in
the population, results for only Trait 1 is shown.
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Figure 4.4: For DAG ‘C’, the following simulation order is used: [X], [Y ], [D|Y ]. Event [S] means the case-control
sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are
based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias, variance
distortion and type I error (at level 0.01) respectively. Since both traits are identical in every respect in
the population, results for only Trait 1 is shown.
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Figure 4.5: For DAG ‘D’, the following simulation order is used: [X], [D], [Y |D]. Event [S] means the case-control
sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are
based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias, variance
distortion and type I error (at level 0.01) respectively. Since both traits are identical in every respect in
the population, results for only Trait 1 is shown.
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Figure 4.6: For DAG ‘E’, the following simulation order is used: [X], [Y ], [D|Y , X]. Event [S] means the case-
control sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses
are based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias,
variance distortion and type I error (at level 0.01) respectively. Since both traits are identical in every
respect in the population, results for only Trait 1 is shown.
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Figure 4.7: For DAG ‘F’, the following simulation order is used: [X], [D|X], [Y |D]. Event [S] means the case-
control sample is analyzed without any adjustment for ascertainment. Event [S,D] means the analyses
are based on the case-control sample and adjusted for D. Columns 1, 2 and 3 correspond to bias,
variance distortion and type I error (at level 0.01) respectively. Since both traits are identical in every
respect in the population, results for only Trait 1 is shown.
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plots for the case with one trait associated are provided in Appendix C3.
4.3.3 Simulation 3: K = 5, 10, 20 traits
To study the power performance of the existing methods, we simulated three sets of data: one with
K = 5 traits, another with 10 traits and the last one with 20 traits. Since this experiment involves
a large number of comparisons for varying K and ρ, we reduced the sample size further to save
computation time. We considered NR = 500 simulated datasets for each scenario with n0 = 200
controls and n1 = 200 cases. The pairwise correlation ρ was varied to have values 0.2, 0.4 or 0.6.
We chose h = 0.005 so that the genetic effect size is 0.395 for an associated trait. 6 different levels
of association are considered: 0%, 20%, 40%, 60%, 80% or 100% of the traits are associated with
the SNP. Since the existing methods provide valid tests of H0 in the scenarios represented by DAGs
‘A’, ‘B’, ‘C’ and ‘D’, we have presented results for only DAGs ‘E’ and ‘F’ here. Empirical power
curves are presented for comparison because the existing methods do not maintain correct type I
error. The empirical power at 5% error level was calculated as follows. For each of MANOVA and
SSU, the 95-th quantile of the empirical distribution of the test statistic was determined based on
the NR = 500 test statistics obtained from NR null datasets. Empirical power for these methods
was calculated as the proportion of test statistics that exceeded the 95-th quantile. For each of
SSU-POM and SMAT, the 5-th quantile of the empirical distribution of the p-value was determined
using the N = 500 p-values under null. Empirical power was, then, calculated as the proportion of
p-values that could not exceed the 5-th quantile. Since LRT based on POM (i.e., MultiPhen) and
MANOVA have similar behavior (as seen in chapter 3), only the empirical power curve for MANOVA
is plotted.
Figure 4.8 shows the empirical power curves of the existing methods under DAG ‘E’. In most
of the situations MANOVA (both the unadjusted and the adjusted for D versions) dominates over
the other methods. Power of MANOVA falls drastically when almost all of the secondary traits are
associated (the behavior we explored in chapter 3). The power curves for MANOVA (unadjusted) and
D-adjusted MANOVA tend to be similar with increase in K and ρ. Also, the unadjusted MANOVA
seems to uniformly dominate the D-adjusted MANOVA power curve. Unadjusted versions of SSU
and SSU-POM have similar power curves and they dominate over SMAT. The D-adjusted versions
of SSU and SSU-POM are similar, and they behave like MANOVA when all the traits are associated.
The unadjusted SSU, SSU-POM and SMAT can have better power compared to MANOVA when
the pairwise correlations between the traits are low (ρ = 0.2).
For DAG ‘F’, the empirical power curves of all methods except MANOVA are similar (refer
Figure 4.9). With increase in K and ρ, the unadjusted and the D-adjusted versions of a given
Chapter 4. Association Analysis of Multiple Secondary Traits 76
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.2; K = 5
fraction of traits associated
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.2; K = 10
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.2; K = 20
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.4; K = 5
fraction of traits associated
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.4; K = 10
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.4; K = 20
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.6; K = 5
fraction of traits associated
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.6; K = 10
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
ρ = 0.6; K = 20
fraction of traits associated
po
w
e
r
0.2 0.4 0.6 0.8 1.0
l
l
l
l
l
l
l
l
l
l
l
l
MANOVA
MANOVA−adj
SSU
SSU−adj
SSU−POM
SSU−POM−adj
SMAT
Figure 4.8: The empirical power curves of the existing methods under DAG ‘E’. LRT based on POM (i.e., MultiPhen)
is similar to MANOVA and is not depicted in the plot to avoid clutter. MANOVA-adj means the method
MANOVA where D is adjusted as a covariate. Similarly for the other methods. K = 5, 10 or 20 traits
have been simulated at different within trait correlation values ρ = 0.2, 0.4, 0.6. For each value of K
and ρ, there were NR = 500 datasets consisting of n = 400 unrelated individuals (200 cases and 200
controls). Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for the traits
that are associated. The power is plotted along y-axis while the fraction of traits associated with the
SNP is plotted along x-axis.
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Figure 4.9: The empirical power curves of the existing methods under DAG ‘F’. LRT based on POM (i.e., MultiPhen)
is similar to MANOVA and is not depicted in the plot to avoid clutter. MANOVA-adj means the method
MANOVA where D is adjusted as a covariate. Similarly for the other methods. K = 5, 10 or 20 traits
have been simulated at different within trait correlation values ρ = 0.2, 0.4, 0.6. For each value of K
and ρ, there were NR = 500 datasets consisting of n = 400 unrelated individuals (200 cases and 200
controls). Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for the traits
that are associated. The power is plotted along y-axis while the fraction of traits associated with the
SNP is plotted along x-axis.
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Table 4.3: Estimated type I error of the proposed approach POM-PS for K = 5, 10, 20 correlated traits with pairwise
correlations ρ = 0.2, 0.4, 0.6. Type I error rate was calculated as the proportion of null datasets (out of
5, 000) with p-value ≤ 0.01.
ρ = 0.2 ρ = 0.4 ρ = 0.6
dag K = 5 K = 10 K = 20 K = 5 K = 10 K = 20 K = 5 K = 10 K = 20
E 0.009 0.0098 0.0102 0.0122 0.0096 0.0086 0.0118 0.0096 0.008
F 0.0112 0.0102 0.0106 0.0086 0.0098 0.0094 0.0078 0.0082 0.009
method become very similar. Specifically for MANOVA, the adjusted and the unadjusted versions
are very similar in terms of empirical power (irrespective of K and ρ), unlike in DAG ‘E’. This
behavior of MANOVA indicates that our pmax approach will not lose much power compared to
MANOVA under DAG ‘F’ but can be significantly less powerful than MANOVA under DAG ‘E’
when K is not large and pairwise correlations are weak.
We now explore the performances of the two proposed approaches: pmax and POM-PS. For the
type I error analysis, we considered only the POM-PS method since asymptotic distribution of pmax
is not known. For this purpose, we considered NR = 5, 000 datasets with 2, 000 cases and 2, 000
controls. The type I error was estimated at significance level α = 0.01 and reported in Table 4.3 for
K = 5, 10, 20 traits with pairwise correlations ρ = 0.2, 0.4, 0.6 under DAGs ‘E’ and ‘F’. Unlike the
existing methods, POM-PS can maintain proper type I error irrespective of the dependency among
Y , X and D, and will provide valid test of the null hypothesis of no association.
Figures 4.10 & 4.11 show the empirical power curves of pmax and POM-PS methods against
the empirical power curves of MANOVA under DAGs ‘E’ & ‘F’ respectively. The empirical perfor-
mance of pmax, POM-PS and D-adjusted MANOVA are very similar under DAG ‘E’. For a few
weakly correlated secondary traits, the powers of these methods are weak compared to unadjusted
MANOVA. For DAG ‘F’, the empirical performance of pmax and the MANOVA methods are quite
similar and dominates over POM-PS. POM-PS suffers from low power when K is small. However,
one must keep in mind that the dependency among Y , X and D will probably not be known apriori
and using any existing test may not provide valid test for H0. In this regard, POM-PS seems to
be the only approach that provides valid test, does not require computationally intensive empirical
p-value calculation, and has reasonable power to detect association. The easy and fast implemen-
tation of POM-PS using existing R packages makes it applicable to large case-control GWASs with
many secondary traits. The proportional odds framework of POM-PS allows any number of binary
and/or continuous secondary traits to be analyzed jointly.
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Figure 4.10: The empirical power curves of the two new proposed methods under DAG ‘E’. MANOVA’s power
curve is plotted as well for comparison with pmax approach and the POM method with propensity
score adjustment (POM-PS). MANOVA-adj means the method MANOVA where D is adjusted as
a covariate. K = 5, 10 or 20 traits have been simulated at different within trait correlation values
ρ = 0.2, 0.4, 0.6. For each value of K and ρ, there were NR = 500 datasets consisting of 200 cases and
200 controls. Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for the traits
that are associated. The power is plotted along y-axis while the fraction of traits associated with the
SNP is plotted along x-axis.
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Figure 4.11: The empirical power curves of the two new proposed methods under DAG ‘F’. MANOVA’s power
curve is plotted as well for comparison with pmax approach and the POM method with propensity
score adjustment (POM-PS). MANOVA-adj means the method MANOVA where D is adjusted as
a covariate. K = 5, 10 or 20 traits have been simulated at different within trait correlation values
ρ = 0.2, 0.4, 0.6. For each value of K and ρ, there were NR = 500 datasets consisting of 200 cases and
200 controls. Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for the traits
that are associated. The power is plotted along y-axis while the fraction of traits associated with the
SNP is plotted along x-axis.
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4.4 Discussion
In this chapter, we investigate the performances of several methods for testing the association of
multiple quantitative secondary phenotypes with a genetic variant in case-control studies (non-
randomized studies). Based on our literature study, there are very few research articles that focus
on the analysis of multiple secondary traits. We discuss some of the existing methods in sections
4.2.1, 4.2.2 and 4.2.3. Our simulation results show that no single method can maintain type I error
under different scenarios of dependency among the secondary phenotypes, the genetic variant and
the primary disease status (case-control design variable). We consider six possible underlying sce-
narios depicted by DAGs ‘A’-‘F’ (refer Figure 4.1) and establish theoretical conditions as to when
naive analysis approaches (that analyze entire case-control sample and do not take ascertainment
into account) will provide valid tests of the null hypothesis. For DAG ‘F’ we show that popular
multivariate approaches need to adjust for the primary disease status as a covariate to maintain
type I error. Although we have not been able to establish similar theoretical conditions for DAG ‘E’,
our empirical studies show that such adjustment can, in fact, inflate the type I error considerably.
SMAT (Schifano et al., 2013), which was specifically designed for secondary traits to take the ascer-
tainment bias into account, does not provide valid test of the null hypothesis of no association when
the secondary phenotypes are caused by the primary disease outcome (DAG ‘F’). Our empirical
power analyses show that SMAT is usually dominated by well-known multivariate approaches like
MANOVA and SSU.
Based on the theoretical and empirical studies, we propose two approaches for testing the as-
sociation of secondary phenotypes with a single SNP. Our first method, pmax, is based on the
maximum p-value of the unadjusted and the D-adjusted MANOVA methods. This approach of
selecting the maximum p-value guards against inflated type I error, which is a severe problem for
the existing methods. Choosing the less significant p-value causes the pmax method to lose some
power compared to MANOVA. In the simulation scenarios we considered, the power loss for pmax
compared to MANOVA does not seem to be severe. To implement this method, one needs to calcu-
late empirical p-value (by considering several permuted datasets) since the asymptotic distribution
of pmax is unknown. This makes it suitable only for candidate gene studies. For a GWAS, this
method of calculating p-value will be computationally burdensome. We are currently exploring ways
to approximate the p-value of pmax. One approach could be to use a correlated Gaussian copula to
model the joint distribution of (pM , pM,adj). However, a single choice of the correlation parameter
in the copula would not work for all the scenarios. For example, a very high value of this copula
correlation parameter can yield proper type I error for DAGs ‘A’-‘D’ but very conservative errors
for the other scenarios. One, thus, needs to incorporate a data-adaptive value of this parameter in
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the copula.
Our second method, POM-PS, is based on a proportional odds model for X which adjusts
the estimated propensity score as a covariate. The propensity score is modeled as the conditional
probability of being a case given the secondary phenotypes. Such propensity score adjustments
are often done in observational studies to reduce confounding effects. Our choice of adjusting this
propensity score eliminates the confounding effect of primary disease on the secondary traits. Our
simulation experiments show that POM-PS can not only maintain type I error in all the scenarios
we considered but also provides reasonable power to detect association. The reverse regression
framework does not require normality assumption for the traits, and allows us to accommodate
both binary and continuous traits. The asymptotic p-value can be computed and POM-PS can be
implemented easily using existing R packages (like MultiPhen).
Finally, the simulation scenarios used to establish the performances of the proposed methods
are not exhaustive. For example, in DAG ‘E’, we have assumed that all the secondary phenotypes
affect the primary disease status in the same direction. We have not considered scenarios where
some of these effect sizes are zero or in opposite direction. We also assumed no interactive effect of
X and Y in the population model for D, and considered only one value of the disease prevalence
(κ = 0.1). Trait outliers may significantly affect our proposed approaches. O’Reilly et al. (2012)
showed that in the presence of outliers, MANOVA is substantially inflated for low m.a.f. of the
SNP. We simulated data for an additive model only and did not consider non-additive genetic model
and/or interactions. We intend to study how power of our methods, pmax and POM-PS, would
be affected in such situations. As observed for MANOVA in chapter 3, we find POM-PS more
powerful when a few of the secondary traits are associated, and has almost no power at ‘complete
association’. We are currently exploring if USAT (method proposed in chapter 3, Ray et al. (2015))
can be extended in the context of secondary phenotypes.
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Appendix A
Supplementary Materials for Chapter 2
A1 Details of dimension moves of the RJMCMC
To implement our Bayesian Partitioning Model (BPM) approach, we constructed a Markov Chain
using reversible jump (RJMCMC) with “dimension” moves, and “allocation” & “coefficient” moves
within a fixed dimension. The “dimension” moves include ‘death’ and ‘birth’ steps to increase or
decrease the dimension by one. The dimension parameter K can take 4 values : 0, 1, 2, and 3, which
refers to the case that the model has parameter(s) α; α and β1; α and β2; and all three parameters
α, β1, β2 in our logistic regression model
log
(
P (yi = 1|Xi,A)
1− P (yi = 1|Xi,A)
∣∣∣∣α, β1, β2) = α+ β1Z1i + β2Z2i, (A.1)
where i = 1, 2, ..., n, β1 < 0 and β2 > 0 respectively defines the fixed effects of the LR and the
HR group of SNPs, A is the p× 3 allocation matrix of the p SNPs, and the predictors Z1i, Z2i are
respectively the values of scores for the LR and HR groups of a specific individual i (i = 1, 2, ..., n). It
is to be noted that a dimension move from K(t−1) = 1 to K(t) = 3 involves increasing the dimension
by 1 although the dimension parameter K is increased by 2.
The acceptance probability for the dimension moves (from step t− 1 to step t) is
min
(
1, a(K(t−1),K(t))
)
, where a
(
K(t−1),K(t)
)
is given by
a(K(t−1),K(t)) =
P [K(t)].P [β(t),A(t)|K(t)].P [y|A(t),β(t),K(t)].P [K(t−1)|K(t)]
P [K(t−1)].P [β(t−1),A(t−1)|K(t−1)].P [y|A(t−1),β(t−1),K(t−1)].P [K(t)|K(t−1)]
× Q[D
(t−1)|D(t)]
Q[D(t)|D(t−1)] × |1| (A.2)
Let us now look at the possible forms of proposal Q[D(t)|D(t−1)] depending upon the move from
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K(t−1) to K(t). Suppose K(t−1) = 0 and K(t) = 1. The difference between β(t−1) and β(t) is due
to the extra random component β1. The proposal density Q[D
(t)|D(t−1)] is then the density from
which β1 is drawn, which in this case is a truncated standard normal density N(0, 1) × I(β1 < 0).
The other proposal density Q[D(t−1)|D(t)] is just 1 since the move from β(t) = (α, β1) to β(t−1) = α
requires dropping the parameter β1. For β2, the truncated density N(0, 1)× I(β2 > 0) is used. The
possible moves along with the corresponding acceptance probabilities are listed below.
Case 1 : (K(t−1),K(t)) = (0, 1) or (2, 3) : β1 is added with increase in dimension parameter. Thus,
a(K(t−1),K(t)) equals
P [β(t)|A(t),K(t)]P [A(t)|K(t)]P [y|A(t),β(t),K(t)]
P [β(t−1)|A(t−1),K(t−1)]P [A(t−1)|K(t−1)]P [y|A(t−1),β(t−1),K(t−1)] ×
1
N(0, 1)× I(β1 < 0)
Case 2 : (K(t−1),K(t)) = (0, 2) or (1, 3) : β2 is the extra parameter, so a(K(t−1),K(t)) equals
P [β(t)|A(t),K(t)]P [A(t)|K(t)]P [y|A(t),β(t),K(t)]
P [β(t−1)|A(t−1),K(t−1)]P [A(t−1)|K(t−1)]P [y|A(t−1),β(t−1),K(t−1)] ×
1
N(0, 1)× I(β2 > 0)
Case 3 : (K(t−1),K(t)) = (1, 0) or (3, 2) : Since β1 is dropped, a(K(t−1),K(t)) equals
P [β(t)|A(t),K(t)]P [A(t)|K(t)]P [y|A(t),β(t),K(t)]
P [β(t−1)|A(t−1),K(t−1)]P [A(t−1)|K(t−1)]P [y|A(t−1),β(t−1),K(t−1)] ×
(
N(0, 1)× I(β1 < 0)
)
Case 4 : (K(t−1),K(t)) = (2, 0) or (3, 1) : Since β2 is dropped, then a(K(t−1),K(t)) equals
P [β(t)|A(t),K(t)]P [A(t)|K(t)]P [y|A(t),β(t),K(t)]
P [β(t−1)|A(t−1),K(t−1)]P [A(t−1)|K(t−1)]P [y|A(t−1),β(t−1),K(t−1)] ×
(
N(0, 1)× I(β2 > 0)
)
A2 Comparison of M-score and P-score of BPM
To illustrate the advantage of the proposed pair-wise-score modeling (P-score) over the main effect
modeling (M-score) in presence of interaction, we did a three-loci simulation study. We simulated
data on 3 loci with epistatic interactions in 1000 cases and 1000 controls using the following logistic
regression model:
logit(p) = −5 +X1 + 0.5X3 + 3X1X2X3,
where Xj is the number of minor alleles for j-th SNP, j = 1, 2, 3. The simulation was repeated 200
times, with 10,000 MCMC iterations in each simulation. For each MCMC iteration of a simulated
data, we sampled a risk-allocation A and β and implemented our pair-wise scoring (P-score) algo-
rithm and M-score. We then used our MCMC scheme to move between the different risk-allocations
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and calculated the average posterior probability of each SNP belonging to LR, HR or NA category
from 5,000 sampled risk-allocations (first 5,000 iterations were discarded as burn-in). So, for ex-
ample, for a given score and a given dataset, the posterior probability of SNP1 to belong to LR
category is the proportion of times SNP1 is allocated to the LR group in the 5,000 non-discarded
MCMC iterations.
Figure A1: Figure shows the proportion of times each of the 10 categories ‘iH-jL-kN’ (where i SNPs in HR, j in
LR and k in NA groups, i+ j + k = 3) are observed in each of the 200 simulated datasets. For M-score,
although all iterations of 154 datasets allocate the SNPs to 3H-0L-0N category, 38 out of 200 datasets
did not have a single 3H-0L-0N allocation among 5000 iterations. On the other hand, for P-score, all
iterations of all datasets had 3H-0L-0N allocation.
The estimated posterior probabilities of different risk-allocations of 3 SNPs for each simulated
dataset were summarized in Figure A1. For Figure A1, we ignored the distinctiveness of the 3 SNPs
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Table A1: Estimated marginal posterior probabilities of categorizing each of the 3 SNPs by the 2 scoring algorithms
of BPM. Here all 3 SNPs are HR; SNP1 and SNP3 contribute through main effect while SNP2 enters the
model through a 3-way interaction with the other 2 SNPs. M-score captures the true risk of SNP2 only
79% of the times while P-score captures it all the time.
M-score P-score
Locus LR NA HR LR NA HR
SNP1 0 0 1 0 0 1
SNP2 0.00447 0.20353 0.792 0 0 1
SNP3 0 0 1 0 0 1
and only considered 10 possible categories ‘iH-jL-kN’, where i SNPs are categorized as HR (high-risk
or bad), j as LR (low-risk or good) and k as NA (nost-associated or null), i+ j+ k = 3. For a given
score, the corresponding plot in Figure A1 has 200 points (corresponding to 200 datasets) at each of
the 10 categories. For example, in case of M-score, all 200 points at 0 for category 0H-0L-3N means
in each of the 200 datasets, none of the non-discarded iterations had an allocation where all 3 SNPs
were categorized as NA. On the other hand, for category 2H-0L-1N, the 200 points were distributed
between 0 and 1; each point corresponds to the proportion of times 2 SNPs were allocated in HR and
1 SNP in NA group for that particular dataset. In our simulated data, two loci (SNP1 and SNP3)
had main effects, and the third one (SNP2) only entered the model through a three-way interaction
with the other two SNPs. According to Figure A1, SNP2 was mis-categorized as LR or NA SNP by
M-score in many datasets, whereas P-score categorized all 3 SNPs as HR with probability 1.
Table A1 compares the marginal posterior probabilities of each SNP being categorized as LR,
NA or HR by the two scoring algorithms. The estimated proportions in Table A1 are based on
the allocations of the three SNPs in 5000 × 200 iterations (5000 MCMC iterations of each of 200
datasets). When the BPM M-score approach (equivalent to main effect logistic regression) was used,
the estimated posterior probability of correctly allocating all three loci into the ‘high-risk’ group was
at most 0.792, where SNP1 and SNP3 were correctly allocated to HR group with probability 1. When
the pair-wise scoring algorithm was used, the estimated posterior probability of correctly allocating
all three loci into the high-risk group was 1. This simulation study demonstrates the increase in
power to detect a three-way interaction using the P-score as compared to the M-score for our BPM
approach.
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A3 Convergence checks for Simulation study
A3.1 Convergence of β parameter
For our BPM approach, convergence of the RJMCMC was checked using only the common parameter
α since the parameters change as the RJMCMC moves from one dimension to another (Sisson, 2005).
(a) Posterior Distribution of α for 6 independent chains for a randomly chosen dataset
(b) Boxplots for posterior β1 (LR group) for 15 independent datasets
(c) Boxplots for posterior β2 (HR group) for 15 independent datasets
Figure A2: (a) The posterior distribution of the common parameter α for 6 independent chains under Model 1 with
independent-SNP data using BPM M-score approach. For this purpose, a dataset was chosen randomly
from the 200 simulated datasets. For all the 6 chains, the starting β and A parameters were different.
Each chain had 10, 000 MCMC iterations, where the first 5, 000 were discarded; (b) and (c) Boxplots of
posterior β1 and β2 values using BPM M-score for 15 randomly chosen datasets (out of 200) of Model
1. The broken red horizontal lines denote the true effect sizes for the respective risk group (−1 for LR
and 0.2 for HR group of SNPs).
A3.2 Convergence of A parameter
The parameter A is a p× 3 risk allocation matrix, where j-th row A′j corresponds to the allocation
of j-th SNP, j = 1, 2, ..., p. The possible allocations of a SNP are (1, 0, 0), (0, 1, 0) or (0, 0, 1) which
respectively indicates that the SNP is in LR, NA or HR category. A lies on a high-dimensional
discrete space {(1, 0, 0), (0, 1, 0), (0, 0, 1)}p. For checking the convergence of A, we chose SNPs 2
(∈ HR), 3 (∈ LR) and 5 (∈ NA) from a randomly chosen dataset under Model 1 and checked the
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Figure A3: The trace plots of the common parameter α for 6 independent chains under Model 1 with independent-
SNP data using BPM M-score approach. For this purpose, a dataset was chosen randomly from the 200
simulated datasets. For all the 6 chains, the starting β and A parameters were different. Each chain
had 10, 000 MCMC iterations, where the first 5, 000 were considered as burn-in. The regions left of the
broken red vertical lines denote the burn-in periods for each chain.
estimated marginal posteriors of A2, A3 and A5 across 6 chains. Each chain had different starting
parameters β and A. Figure A4 shows consistent estimate of marginal probabilities of each of the
SNPs to belong to the 3 categories across all 6 chains. This shows convergence of the A parameter.
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(a) Marginal Posterior Distribution of SNP 2 (HR group) for 6 chains
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(b) Marginal Posterior Distribution of SNP 3 (LR group) for 6 chains
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(c) Marginal Posterior Distribution of SNP 5 (NA group) for 6 chains
Figure A4: (a), (b) and (c) The estimated marginal posterior distributions of 3 randomly chosen SNPs from the 3
categories are plotted for 6 independent chains under Model 1. Simulated data assumed 20 independent
SNPs with the first 4 SNPs causal. BPM M-score approach was used for all the 6 chains. For this
purpose, a dataset was chosen randomly from the 200 simulated datasets. For all the 6 chains, the
starting β and A parameters were different. Each chain had 10, 000 MCMC iterations, where the first
5, 000 were discarded.
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A4 Convergence checks for Real data analysis: gene MMRN1
We first analyzed gene MMRN1 from Chromosome 4 consisting of 57 SNPs after screening. For
BPM, the M-score chain for α passed HW stationarity test and half-width mean test at 5% level
without any burn-in while a burn-in of 100, 000 was needed for P-score. Figure A5 shows the
posterior distributions and the trace plots of α for both the chains. We observe symmetric, unimodal
distributions for α. Also, the trace plots are suggesting good mixing for α for both scores of BPM.
Figure A5: The first two plots give the posterior distribution of α for M- and P-scores respectively, while the last
two plots give the trace plot of α over the 500, 000 RJMCMC iterations using MMRN1 gene dataset
(with 57 SNPs after screening).
A5 Prior specification of the SNPs
For the construction of our RJMCMC, we made three simplifying assumptions. One of the assump-
tions include equal prior probabilities for a SNP to be in each of the 3 categories LR (low-risk), NA
(null) and HR (high-risk). This choice of prior gave a simplified form (equation (2.4) of Chapter 2) of
the acceptance probability in equation (2.3) Chapter 2. For real data analysis, we applied our BPM
method to the top two genes identified by another gene-based association analysis (which provided
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Table A2: BPM performance for different priors: Power of the BPM approach in detecting the four associated
SNPs for Bonferroni corrected error level 0.0025 (= 0.05/20) based on 200 datasets with 200 cases and
200 controls. 3 different prior specifications have been used to study BPM’s performance. Default prior
is the equal probability prior used throughout in the paper. pi is the probability of a SNP to be non-null.
For more stringent prior (such as pi = 0.001), the chains were run longer to ensure convergence. N is the
length of the chain. The first N/2 iterations were discarded as burn-in.
Model 1 Model 3
Prior N (main effects only) (interaction effect only)
M-score P-score M-score P-score
Prior 1 (default) 10, 000 0.433 0.439 0.211 0.479
Prior 2 (pi = 0.05) 10, 000 0.461 0.424 0.188 0.514
Prior 3 (pi = 0.01) 10, 000 0.443 0.456 0.184 0.460
only gene-based p-values). So, our decision to assign such high prior probability for each SNP to
be in non-null category is reasonable. However, if applied to a genome-wide data, a more informa-
tive prior would be to assign much higher probability for each SNP to be in the NA (null) group.
For example, BEAM has default prior probabilities of 0.01 for each SNP to belong to marginal or
interaction groups. We performed a small simulation experiment to study how change in the prior
specification affects the performance of BPM.
Let pi be the prior probability of a SNP to be non-null. The prior probabilities of the SNP to be
in LR, NA and HR categories are pi/2, 1− pi and pi/2 respectively. For this simulation experiment,
we considered 3 different prior settings.
Prior 1 : pi = 2/3 (this is the simplifying prior we used in our paper)
Prior 2 : pi = 0.05
Prior 3 : pi = 0.01
We simulated data for Models 1 and 3 as described in Section 2.3.1 of Chapter 2.
Model 1: logit(p) = −4 + 15X1 + 15X2 − X3 − X4, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2
minor alleles respectively.
Model 3: logit(p) = −4 + 2X1X2X3X4, where Xj = 0, 1, 2 denote SNP j with 0, 1, 2 minor alleles
respectively.
For our simulation scenario with 4 non-null SNPs among 20, a prior more stringent than Prior 3
does not make sense. For each model and each prior, we applied both M- and P-scores of BPM. For
comparison of BPM performance across different priors, we calculated the true positive rate (tpr)
and the false positive rate (fpr) of BPM. Details of calculation of fpr and tpr can be found in Section
2.3.1 of Chapter 2. Table A2 shows the performance of BPM for different models for different choices
of prior. We see that choice of prior does not strongly affect power of BPM in detecting association
from different models. Our choice of prior not only simplifies the acceptance probability in our
RJMCMC but also requires a smaller number of MCMC iterations for convergence. More stringent
priors would require longer chains and more computation time.
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A6 Adjustment of additional covariate effects
The BPM model (A.1) provides the flexibility of adjusting other covariate effects. Suppose, in addi-
tion to response vector Y n×1 and genotype matrix Xn×p, all individuals have data on q covariates
(such as age, gender, race etc.). Let C = (C1, ...,Cq) be the n × q matrix of covariates. Given a
specific risk allocation A, we use the logistic regression
log
(
P (yi = 1|Xi,A,Ci)
1− P (yi = 1|Xi,A,Ci)
∣∣∣∣β,γ) = β′Zi + γ′Ci (A.3)
where β = (α, β1, β2)
′ is the vector of fixed effects for the 3 groups of SNPs, Zi = (1, Z1i, Z2i)′ is the
vector of scores for the SNP groups of an individual i (i = 1, 2, ..., n), and γ = (γ1, . . . , γq)
′ is the
vector of q fixed effects corresponding to the q covariates. In the absence of additional covariates (as
in equation (A.1)), we assumed priors for our paramaters β and A (details can be found in Chapter
2):
β ∼ N3(µ,V )× I(β1 < 0)× I(β2 > 0)
P [A] =
p∏
j=1
P [Aj ] = constant
Currently, due to other covariates, we need to assume a suitable prior for the additional parameter γ.
Assume γ ∼ Nq(0,V γ) for some suitable choice of covariance matrix V γ . Our interest is still in the
joint posterior distribution of A and β. We use our RJMCMC scheme to study this joint posterior.
The acceptance probability for dimension moves (from step t− 1 to step t) is min (1, a(K(t−1),K(t))),
with
a(K(t−1),K(t)) =
P [y|β(t),γ(t),A(t),K(t)]
P [y|β(t−1),γ(t−1),A(t−1),K(t−1)] (A.4)
Here K is the dimension parameter. At t-th iteration of the RJMCMC, K(t) indicates whether there
is only NA SNPs, or NA & LR SNPs, or NA & HR SNPs, or all 3 groups of SNPs in the model. One
can deduce K(t) from the corresponding risk allocation A(t). We obtain P [y|β(t),γ(t),A(t),K(t)]
and P [y|β(t−1),γ(t−1),A(t−1),K(t−1)] using the model in (A.3).
As before, within a fixed dimension, we first update A from its full conditionals and then update
(β,γ) simultaneously using Metropolis Hastings algorithm. The full conditional of Aj at step t has
the multinomial distribution
[
A(t)j
∣∣∣∣β(t−1),γ(t−1),A(t−1)(−j) ] ∼Multinomial(m = 1; p(t)j1 , p(t)j2 , p(t)j3)
where p
(t)
j1 , p
(t)
j2 , p
(t)
j3 are the posterior probabilities of SNP j to be in the LR, NA and HR group
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respectively. These posterior probabilities are given by
p
(t)
js =
P [y|β(t−1),γ(t−1),A(t−1)(−j) ,A(t)j = as]P [A(t)j = as]∑3
k=1 P [y|β(t−1),γ(t−1),A(t−1)(−j) ,A(t)j = ak]P [A(t)j = ak]
where s = 1, 2, 3, as ∈ {(1, 0, 0)′, (0, 1, 0)′, (0, 0, 1)′}. After updating A from its full conditionals
and getting A(t), we sample β∗ from the proposal density N3
(
β(t−1),V
)
I(β1 < 0)I(β2 > 0), and
sample γ∗ from Nq
(
γ(t−1),V γ
)
. For each draw of (β∗,γ∗) from the proposals, we accept (β∗,γ∗)
as (β(t),γ(t)) with probability min
1, a′
β(t−1)
γ(t−1)
 ,
β∗
γ∗
, where
a′
β(t−1)
γ(t−1)
 ,
β∗
γ∗
 = P [y|β∗,γ∗,A(t)].P [β∗|A(t)].P [γ∗]
P [y|β(t−1),γ(t−1),A(t)].P [β(t−1)|A(t)].P [γ(t−1)] ×
P [β(t−1)|β∗]
P [β∗|β(t−1)]
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Supplementary Materials for Chapter 3
B1 Mathematical Proofs
B1.1 Proof of Theorem 3.1
Without loss of generality, we assume that Y andX are centered. For testing H0 : β = 0, the Wilk’s
Lambda test statistic is detE/det(H + E) = det( 1nE)/det(
1
nH +
1
nE) , where H = βˆ(X
′X)βˆ
′
,
E = Y ′Y −βˆ(X ′X)βˆ′, n is the number of unrelated individuals, and βˆ = Y ′X(X ′X)−1 is the least
squares estimate of the vector of genetic effects β. Note that X ′X =
∑n
i=1X
2
i is a random variable
(not a matrix), where E(X2i ) = 2f(1−f) = Var(Xi)∀ i. Using our distributional assumptions about
centered X and E, it can be shown that 1nH
P→ 2f(1 − f)ββ′ and 1nE
P→ Σ as n → ∞. Here, P→
denotes convergence in probability as n→∞.
For the CS residual covariance matrix Σ, we know that the eigen vector corresponding to the
largest eigenvalue λ1 = σ
2{1 + (K − 1)ρ} is v1 ∝ 1, while the eigen vectors corresponding to
λ2 = ... = λK = σ
2(1 − ρ) are respectively v2, ...,vK such that 1′vk = 0 ∀ k = 2, ...,K. For the
eigen vectors to be orthonormal, we must have v1 = cK1 where c
2
K = 1/K. Thus, we can write,
Σ = λ1c
2
K11
′ +
∑K
i=2 λiviv
′
i and Σ
−1 = 1λ1 c
2
K11
′ +
∑K
i=2
1
λi
viv
′
i.
Consider the testing of H0 : β = 0 against two possible alternatives: Ha,u : β1 = ... = βu 6=
0, βK−u = ... = βK = 0 (partial association) and Ha,K : β1 = ... = βK 6= 0 (complete association).
Under the alternative Ha,K (complete association), |I +HE−1| is given by∣∣∣∣∣I + HKn
(
E
n
)−1∣∣∣∣∣ P→n→∞
∣∣∣∣∣IK + (2f(1− f)β2111′)
(
1
λ1
c2K11
′ +
K∑
i=2
1
λi
viv
′
i
)∣∣∣∣∣
= 1 +
2f(1− f)β21
λ1
K
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Under the alternative Ha,u (partial association),
|I +HE−1| Ha,u= |I + Hun
(
E
n
)−1 |
P→
n→∞
∣∣∣∣∣∣∣IK + 2f(1− f)
β211u1′u 0
0′ O
 Σ11(u×u) Σ12(u×K−u)
Σ′
12(K−u×u) Σ22(K−u×K−u)
−1
∣∣∣∣∣∣∣
=
∣∣∣∣∣∣I + 2f(1− f)
β211u1′u 0
0′ O
Σ11 Σ12
? ?
∣∣∣∣∣∣
=
∣∣∣∣∣∣I + 2f(1− f)
A B
0′ O
∣∣∣∣∣∣
= |Iu + 2f(1− f)A|
= 1 +
2f(1− f)β21
σ2(1− ρ)
1 + (K − u− 1)ρ
1 + (K − 1)ρ u
where Σ11 = σ
2(1 − ρ)Iu + σ2ρ1u1′u, Σ22 = σ2(1 − ρ)IK−u + σ2ρ1K−u1′K−u, Σ12 = σ2ρ1u1′K−u,
Σ11 = (Σ11 −Σ12Σ−122 Σ′12)−1, Σ12 = −Σ−111 Σ12(Σ22 −Σ′12Σ−111 Σ12)−1,
A = β211u1
′
u
(
Σ11 −Σ12Σ−122 Σ′12
)−1
, B = −β211u1′uΣ−111 Σ12(Σ22 −Σ′12Σ−111 Σ12)−1
So, |I+HuE−1|−|I+HKE−1| P→
n→∞
2f(1−f)β21
σ2{1+(K−1)ρ}
(
1+(K−u−1)ρ
1−ρ u−K
)
> 0 under the condition
u
K >
σ2{1−ρ}
σ2{1+(K−u−1)ρ} . It may be noted that the condition simplifies to ρ >
1
u+1 , which explains why
we observe higher power for partial association and lower for complete association for K = 2 traits
once the within trait correlation ρ exceeds 1/2. 
B1.2 Proof of Theorem 3.2
Without loss of generality, let us assume that Y and X are centered. In particular, for K = 2,
1
nH
P→ 2f(1− f)
 β21 β1β2
β1β2 β
2
2
 and 1nE P→ σ2
1 ρ
ρ 1
 as n→∞.
Let us now consider the alternatives Ha1 : β1 6= 0, β2 = 0 (only 1 trait is associated), and
Ha2 : β1 6= β2 6= 0 (both traits are associated). Under Ha1, the H/n matrix becomes 1nH1
P→
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2f(1− f)
β21 0
0 0
 for large n. Let H2 be the H matrix under Ha2. So,
det
(
H1
n
+
E
n
)
− det
(
H2
n
+
E
n
)
P→
∣∣∣∣∣∣σ
2 + 2f(1− f)β21 ρσ2
ρσ2 σ2
∣∣∣∣∣∣−
∣∣∣∣∣∣ σ
2 + 2f(1− f)β21 ρσ2 + 2f(1− f)β1β2
ρσ2 + 2f(1− f)β1β2 σ2 + 2f(1− f)β22
∣∣∣∣∣∣
= 2f(1− f)β2σ2(2ρβ1 − β2)
> 0 if {β2 < 2ρβ1 & β2 > 0} or {β2 > 2ρβ1 & β2 < 0}
This means, we expect the statistic |E|/|H1 +E| under Ha1 (when only 1 trait is associated) to be
closer to 0 than the statistic |E|/|H2 +E| under Ha2 when {0 < β2 < 2ρβ1} or {0 > β2 > 2ρβ1}.
Thus, for K = 2, MANOVA is expected to have more power when 1 trait is associated than when
both traits are associated if 0 < β2 < 2ρβ1 or 0 > β2 > 2ρβ1. 
B2 Acceptance Region for MANOVA based on Z
Consider the MMLR model
Y n×K = Xn×1β′1×K + En×K (B.1)
where β′ = (β1, ..., βK) is the vector of fixed unknown genetic effects corresponding to the K
correlated traits, and E is the matrix of random errors. For testing that the SNP is not associated
with any of the K traits, the null hypothesis of interest is H0 : β = 0.
Assume E is a normal data matrix from NK(0,Σ). The log-likelihood l(β,Σ) of the trait matrix
Y is given by
l(β,Σ) = −1
2
n log |2piΣ| − 1
2
tr
{
Σ−1(Y −Xβ′)′(Y −Xβ′)} (B.2)
where Σ is a positive definite matrix representing residual covariance among the traits. The MLE
of β and Σ are βˆ = Y ′X(X ′X)−1 and Σˆ = 1nY
′(IK −X(X ′X)−1X ′)Y respectively. Under the
null, β = 0 and the MLE of Σ is Σˆ0 =
1
nY
′Y . The likelihood ratio test (LRT) of H0 based on the
MMLR model with matrix normal errors is equivalent to MANOVA statistic Λ (Wilk’s Lambda):
−2 log Λ = 2
(
l(βˆ, Σˆ)− l(0, Σˆ0)
)
= n log
|Σˆ0|
|Σˆ| = −n log
|E|
|H +E| (B.3)
where H and E are the hypothesis and the error sum of squares and cross product (SSCP) matrices
respectively.
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Let us now consider the following notations: l˙(β) = ∂∂β l(β,Σ); l¨(β) =
∂2
∂β2
l(β,Σ). The Fisher
Information matrix under H0 is I(0) = −Eβ=0(¨l(β)). Using Taylor’s Expansion upto order 2, we
can write the LRT statistic as
−2 log Λ = 2
{
0 +
1
2
√
n(βˆ − 0)′
(
− 1
n
l¨(β∗)
)
(βˆ − 0)
}
, where |β∗ − 0| ≤ |βˆ − 0|
Observe that
√
n(βˆ − 0)′ D→ Z ∼ NK(0, I−1(0)). If a particular component of the true β is large
(small), we expect the corresponding component of βˆ and hence of Z to be large (small). Thus for Z
to be larger than 0, we need to have the true β larger than 0. We can then write the asymptotically
equivalent form of MANOVA Wilk’s Lambda statistic in terms of a statistic involving Z:
−2 log Λ D→ Z ′I(0)Z a∼ χ2K
Instead of drawing the acceptance region of Wilks Lambda statistic, one can draw the acceptance
region of the test statistic Z ′I(0)Z. The ellipse representing acceptance region for MANOVA is
asymptotically equivalent to
Ec(z;S, z¯) ≡
{
z : (z − z¯)′S−1(z − z¯) ≤ c2}
where S = (n − 1)−1∑ni=1(zi − z¯)(zi − z¯)′ and c2 is the 95-th percentile of the distribution of Z.
The boundary of the ellipse Ec is computed as a transformation of the unit circle, U = (sin θ, cos θ)
for θ ∈ (0, 2pi). Let A = S1/2 be the Choleski square root of S in the sense that S = AA′. Then,
Ec = z¯ + cAU is an ellipse centered at the mean z¯ = (z¯1, z¯2). The size of the ellipse reflects the
standard deviations of z1 and z2 while the shape reflects their correlation. Z has a NK(0, I(0)
−1)
distribution due to which we expect z¯ ≈ 0 and S ≈ 1n
∑
zz′ P→ I(0)−1 = 12p(1+p)Σ where p is the
m.a.f. of the genetic variant. Thus, for drawing the theoretical acceptance region of MANOVA,
we use the facts that Z¯
P→ 0 and S P→ 12p(1+p)Σ. For Figure 3.1 in Chapter 3, we assumed
Σ = σ2{(1− ρ)IK + ρ11′} with K = 2. The theoretical acceptance region for MANOVA will then
be asymptotically equivalent to Ec
(
z; Σ2p(1+p) ,0
)
≡
{
z : z′
(
Σ
2p(1+p)
)−1
z ≤ c2
}
.
B3 Mathematical Details: Approximate p-value calculation
for USAT
Let TM = −2 log Λ a∼ χ2K be the MANOVA test statistic based on Wilk’s lambda and TS
approx∼
aχ2d + b be the SSU test statistic based on score vector from marginal normal models. For USAT,
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we first consider the weighted statistic Tω = ωTM + (1− ω)TS , where ω ∈ [0, 1] is the weight. Both
MANOVA and SSU are special cases of the class of statistics Tω. Under H0, for a given weight ω,
Tω is approximately a linear combination of chi-squared distributions. The computation of p-value
pω of the test statistic Tω does not require independence of the statistics TM and TS . A detailed
explanation of the determination of pω is provided below.
Observe that one can write TM = U
′I(0)−1U , where U is the score vector under H0 : β = 0 from
the MMLR model (3.1) and I(0) = −Eβ=0
(
∂
∂β l(β,Σ)
)
= Cov(U)|β=0 is the Fisher Information
matrix under H0. On the other hand, TS = U
′
MUM , where UM is the marginal score vector
under H0 from the marginal models in equation (3.2) of Chapter 3. As derived in Chapter 3,
UM = Y
′X/σˆ20 , where Y is the n×K phenotype matrix, X is the n× 1 genotype matrix and σˆ20 is
the MLE of σ2 under H0. Similarly, one can show that U = Σˆ
−1
0 Y
′X, where Σˆ0 = Y ′Y /n is the
MLE of Σ in MMLR model (3.1) under H0. The estimated variance of the score vector U under
H0 is given by Cov(U)|β=0 = I(0) = (X ′X)Σˆ−10 . For a given weight ω, one can thus write
Tω = ωTM + (1− ω)TS
= ω
(
Σˆ
−1
0 σˆ
2
0UM
)′
I(0)−1
(
Σˆ
−1
0 σˆ
2
0UM
)
+ (1− ω)U ′MUM
= U ′M
(
ωσˆ40(X
′X)−1Σˆ
−1
0 + (1− ω)IK
)
UM
where IK is the identity matrix of order K. Denote A = ωσˆ
4
0(X
′X)−1Σˆ
−1
0 + (1 − ω)IK , which
is a K × K symmetric, non-negative definite matrix. Note that marginal score vector UM has
mean 0, estimated variance Cov(UM ) = X
′XY ′Y /(nσˆ40), and has an asymptotic K-variate normal
distribution. Let P be aK×K orthonormal matrix that convertsB = Cov(UM )1/2ACov(UM )1/2 =
ωIK + (1 − ω)Cov(UM ) to the diagonal form Γ = diag(λ1, ...λK), where λ1 ≥ 0, ..., λK ≥ 0. The
weighted statistic Tω can, then, be expressed as a non-negative quadratic form:
Tω = U
′
MAUM = V
′
MΓV M =
K∑
j=1
λjχ
2
hj (δj) (B.4)
where V M = PCov(UM )
−1/2UM
a∼ N(0, IK), and hj = 1, δj = 0 for all j = 1, 2, ...,K. For a given
ω ∈ [0, 1], the p-value pω of the statistic Tω can, thus, be calculated by Liu et al. (2009) algorithm
as:
pω = P (Tω > tω) ≈ P
(
χ2l (δ) > t
∗
ωσχ + µχ
)
(B.5)
where tω is the observed value of Tω statistic, t
∗
ω = (tω−E(Tω))/
√
Var(Tω), µχ = E
(
χ2l (δ)
)
= l+ δ,
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σχ =
√
Var (χ2l (δ)) =
√
2(l + 2δ). The parameters δ and l are chosen such that the skewness of Tω
and χ2l (δ) are same and the difference between the kurtoses of Tω and χ
2
l (δ) is minimized.
Apriori the optimal weight ω is not known. We propose our unified test USAT as
TUSAT = min
0≤ω≤1
pω
Thus, the USAT test statistic is not exactly the best weighted combination of MANOVA and SSU. It
is the minimum of the p-values of the different weighted combinations. For practical implementations
of USAT, a grid of 11 ω values were considered: {ω1 = 0, ω2 = 0.1, ..., ω10 = 0.9, ω11 = 1}.
To find the p-value of our USAT test statistic, we need the null distribution of USAT. We
propose an approximate p-value calculation using a one-dimensional numerical integration, which
makes USAT suitable for application on a GWAS scale. Observe that the p-value of statistic TUSAT
is
pUSAT = P (TUSAT ≤ tUSAT ) = 1− P (TUSAT ≥ tUSAT )
= 1− P
(
min
ω
pω ≥ tUSAT
)
= 1− P
(
1−min
ω
pω < 1− tUSAT
)
= 1− P
(
max
ω
(1− pω) < 1− tUSAT
)
= 1− P ({1− pω1 < 1− tUSAT }, . . . , {1− pω11 < 1− tUSAT })
= 1− P
(
{(1− pω1)th quantile < (1− tUSAT )th quantile}, . . . ,
{(1− pω11)th quantile < (1− tUSAT )th quantile}
)
= 1− P (Tω1 < qmin(ω1), ..., Tω11 < qmin(ω11))
= 1− P
(
TS < min
ω
qmin(ω)− ωTM
1− ω
)
= 1−
∫
FTS |TM
(
δω(x)|x
)
fTM (x)dx
where tUSAT is the observed value of USAT test statistic for a given dataset, qmin(ωb) is the (1 −
tUSAT )-th percentile of the distribution of Tωb for a given ω = ωb, FTS |TM (.|x) is the conditional cdf
of SSU statistic TS given MANOVA statistic TM , fTM (.) is the pdf of MANOVA test statistic TM ,
and δω(x) = minω∈{ω1,...,ω11}
qmin(ω)−ωx
1−ω .
Recall that TS and TM are two quadratic forms (QF), which are not independently distributed.
The exact joint distribution of TS and TM is too complicated to compute (Khatri et al., 1977; Khatri,
1980). Our literature search did not yield any computationally feasible method for approximating
the distribution FTS |TM (.|TM = x) required to calculate pUSAT . In such a scenario, a simple and
straightforward approximation seems to be the assumption of independence and thereby we get the
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approximate p-value
pUSAT ≈ 1−
∫ ∞
0
FTS
(
δω(x)|x
)
fTM (x)dx
where FTS (.) is the cdf of SSU test statistic TS . This approximation of distribution [TS |TM ] by
[TS ] can yield conservative p-values at heavier tails of the null distribution of USAT test statistic.
However, for extreme tails (regions in which we are interested when applying USAT at GWAS level),
this conservativeness is not an issue (as demonstrated by USAT type I error analysis in Chapter
3). Detailed study on the accuracy of this approximation is provided in the next section. In this
context, it is worth noting that we have not assumed TS and TM to be independent throughout.
For example, the information on their dependence has been incorporated in the calculation of pω
(p-value of weighted statistic Tω). The independence assumption has been made only in the last
step of USAT p-value calculation.
Implementation of the approximate p-value method
For the integral
∫∞
0
FTS
(
δω(x)
)
fTM (x)dx, we first need to evaluate
FTS
(
δω(x)
)
= P (TS ≤ δω(x)) ≈ P
(
aχ2d + b ≤ δω(x)
)
= P
(
χ2d ≤
δω(x)− b
a
)
This can be easily evaluated using function pchisq() in R (R Development Core Team, 2014). The in-
tegrand as a function of x can then be coded as pchisq((delta.x-b)/a, df=d, ncp=0)*dchisq(x,
df=K). The integration has been performed numerically using R function integrate(). When the
optimal choice of ω lies near the boundary (i.e., close to 0 or 1) and the corresponding statistic (TS
or TM depending upon whether optimal ω is close to 0 or 1) is highly significant (i.e., corresponding
p-value is of the order of 10−8), the function integrate can have low accuracy and can give rise
to an integral value exceeding 1. In such a scenario, R function quadinf() from package pracma
(Borchers, 2012) can give very accurate results. The cost of accuracy is longer computation time:
quadinf takes almost twice as much time compared to integrate. For our simulated datasets as
well as real dataset, we found the two functions giving very similar results in most situations except
in the afore-mentioned scenario where integrate gave negative p-values for USAT. In such rare
situations, we implemented the numerical integration using quadinf.
Details on the accuracy of the approximation involving independence assumption
Since the exact distribution of [TS |TM ] is not known, we studied the accuracy of our approximation
(independence assumption in the last step of pUSAT calculation) using Monte Carlo samples. For
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this purpose, we first simulated two independent sets of N = 10, 000 marginal score vectors UM
from multivariate NK(0,C), where C is the score covariance matrix that directly depends on the
trait covariance structure Σ. Both CS(ρ) and AR1(ρ) correlation structures were considered for
ρ = 0.2, 0.5, 0.8. We took three different choices of K as in our simulation studies: K = 5, 10, 20.
For each set, we calculated the statistics TS and TM (i.e., we have samples of SSU and MANOVA
statistics from their null distributions). Let us denote T
(j)
S and T
(j)
M to be the SSU and the MANOVA
statistics from the j-th set of Monte Carlo samples, j = 1, 2. Note that the statistics T
(j)
S and T
(j′)
M
are correlated for j = j′ and uncorrelated for j = j′. Thus, for a given value of tUSAT , the Monte
Carlo estimate (MCE) of the true probability pUSAT = P(TS > δω(tUSAT , TM )) is
ptrueUSAT =
1
N
N∑
i=1
I
(
T
(1),i
S > δω
(
tUSAT , T
(1),i
M
))
where I(.) is the indicator function, T
(1),i
S is the SSU statistic based on i-th sample in the 1st set,
T
(1),i
M is similarly defined, and δω(.) is as defined earlier. The MCE of the approximate pUSAT (where
independence of TS and TM was assumed) can be obtained as
papproxUSAT =
1
N
N∑
i=1
I
(
T
(1),i
S > δω
(
tUSAT , T
(2),i
M
))
Note that one can also obtain this approximate pUSAT using our p-value calculation method directly.
Next we plotted these three different estimates of pUSAT against a range of values of tUSAT . In the
following Figures B1−B4, the black solid curve corresponds to ptrueSUAT (MCE of true p-value), blue
solid curve corresponds to papproxUSAT (MCE of approximate p-value) and the red solid curve corresponds
to pUSAT computed directly from our approximate p-value calculation approach. Figures B1 and B2
show the plots of these different estimates of pUSAT against tUSAT in [0, 1] range using weights ω =
0, 0.1, 0.2, ..., 0.9, 1 for CS and AR1 correlation structures respectively. As expected, the approximate
p-values from Monte Carlo samples and the approximate p-values from our method are similar (the
blue and the red curves are overlapping). We also observe that our approximation causes the
USAT p-values to be conservative, more so at the heavier tails of the null distribution of USAT.
With increase in strength of correlation parameter ρ or increase in the number of traits K, this
conservativeness decreases. For very small values of tUSAT (the region we are interested in when
applying USAT on a genome-wide scale), our approach does not seem to be very conservative. In
fact, Table 3.2 in Chapter 3 shows that USAT can maintain proper Type I error at low error levels
like 10−4.
To verify that the conservativeness of our approximation is very small at the extreme tail (near
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0), we considered tUSAT values in the range of [0, 10
−3]. Precisely, the tUSAT values considered were
0, 10−5, 2× 10−5, ..., 10−3. In order to consider tUSAT values of the order of 10−5, we simulated two
independent sets of N = 107 Monte Carlo samples of TS and TM . Using these samples, we calculated
ptrueUSAT and p
approx
USAT as before. To reduce computation time, we considered only two weights: ω = 0
and 1. Figures B3 and B4 show the plots of true and approximate pUSAT against tUSAT for CS
and AR1 correlation structures respectively. The approximate p-value curve (blue) always stays
above the true p-value curve (black), indicating that the approximation of distribution [TS |TM ] by
marginal distribution [TS ] is conservative in nature. The conservativeness decreases with increase
in K and increase in ρ. For extreme values of USAT statistic (i.e., for stringent error levels), this
conservativeness seems to be negligible.
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Plot of pUSAT= Pr(TS > δω(tUSAT,TM)) vs tUSAT
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Figure B1: Comparison of approximate and true p-value of USAT based on Monte Carlo samples for CS(ρ) corre-
lation structure. The different parameter values are: N = 10, 000 samples, weight ω ∈ {0, 0.1, ..., 0.9, 1},
tUSAT ∈ {0, 0.01, 0.02, ..., 0.99, 1}, K ∈ {5, 10, 20} traits and ρ ∈ {0.2, 0.5, 0.8}. The black solid curve
corresponds to ptrueSUAT (MCE of true p-value), blue solid curve corresponds to p
approx
USAT (MCE of approx-
imate p-value) and the red solid curve corresponds to pUSAT computed directly from our approximate
p-value calculation approach. The approximate curves lie above the true curve indicating conservative-
ness of the approximation.
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Plot of pUSAT= Pr(TS > δω(tUSAT,TM)) vs tUSAT
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Figure B2: Comparison of approximate and true p-value of USAT based on Monte Carlo samples for AR1(ρ) corre-
lation structure. The different parameter values are: N = 10, 000 samples, weight ω ∈ {0, 0.1, ..., 0.9, 1},
tUSAT ∈ {0, 0.01, 0.02, ..., 0.99, 1}, K ∈ {5, 10, 20} traits and ρ ∈ {0.2, 0.5, 0.8}. The black solid curve
corresponds to ptrueSUAT (MCE of true p-value), blue solid curve corresponds to p
approx
USAT (MCE of approx-
imate p-value) and the red solid curve corresponds to pUSAT computed directly from our approximate
p-value calculation approach. The approximate curves lie above the true curve indicating conservative-
ness of the approximation.
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Plot of pUSAT= Pr(TS > δω(tUSAT,TM)) vs tUSAT
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Figure B3: Comparison of approximate and true p-value of USAT based on Monte Carlo samples for CS(ρ)
correlation structure. The different parameter values are: N = 107 samples, weight ω ∈ {0, 1},
tUSAT ∈ {0, 10−5, 2×10−5, ..., 10−3}, K ∈ {5, 10, 20} traits and ρ ∈ {0.2, 0.5, 0.8}. The black solid curve
corresponds to ptrueSUAT (MCE of true p-value) and the blue solid curve corresponds to p
approx
USAT (MCE of
approximate p-value). Curve corresponding to pUSAT computed directly from our approximate p-value
calculation approach is not plotted to avoid clutter. The approximate curve lies above the true curve
indicating conservativeness of the approximation.
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Plot of pUSAT= Pr(TS > δω(tUSAT,TM)) vs tUSAT
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Figure B4: Comparison of approximate and true p-value of USAT based on Monte Carlo samples for AR1(ρ)
correlation structure. The different parameter values are: N = 107 samples, weight ω ∈ {0, 1},
tUSAT ∈ {0, 10−5, 2×10−5, ..., 10−3}, K ∈ {5, 10, 20} traits and ρ ∈ {0.2, 0.5, 0.8}. The black solid curve
corresponds to ptrueSUAT (MCE of true p-value) and the blue solid curve corresponds to p
approx
USAT (MCE of
approximate p-value). Curve corresponding to pUSAT computed directly from our approximate p-value
calculation approach is not plotted to avoid clutter. The approximate curve lies above the true curve
indicating conservativeness of the approximation.
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B4 Simulation 4: Other correlation structures
Apart from the compound symmetry (CS) structure, we also considered AR1(ρ) and other structures
for correlation in our simulation studies. Details on how the datasets were simulated can be found
in Section 3.3 of Chapter 3.
B4.1 Correlation Structure I: uncorrelated traits
We assumed that none of the traits was correlated with another. From Figure B5, we see that
performances of all methods are similar except minP/TATES. All the methods, including MANOVA,
have steadily rising power curves with increase in proportion of associated traits. This confirms
that MANOVA’s lack of power in detecting pleiotropy in certain situations is primarily due to the
correlatedness of all the traits.
B4.2 Correlation Structure II
Here we assumed that first 80% of the K traits were correlated (with a compound symmetry struc-
ture) and the rest 20% were uncorrelated. For our simulation study, we considered K = 5, 10, 20
traits and positive correlation parameter ρ = 0.2, 0.4, 0.6. In such a situation we noticed that as
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Figure B5: Correlation structure I (uncorrelated): Empirical power curves of the different association tests
for K = 5, 10, 20 traits and within trait correlation ρ = 0 based on N = 500 datasets. The correlation
structure assumes all traits to be uncorrelated. Same direction and same size effects (effect size of 0.395;
proportion of variance explained is 0.5%) are used when 2 or more traits are associated. The power
is plotted along y-axis while the fraction of traits associated with the genetic variant is plotted along
x-axis.
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Figure B6: Correlation structure II: Empirical power curves of the different association tests for K = 5, 10, 20
traits and different within trait correlation values ρ = 0.2, 0.4, 0.6 based on N = 500 datasets. This
correlation structure assumes that the first 80% of the traits are correlated (Compound Symmetry
structure with correlation ρ) and the last 20% of the traits are independent of the others. Same direction
and same size effects (effect size of 0.395; proportion of variance explained is 0.5%) are used when 2 or
more traits are associated. The power is plotted along y-axis while the fraction of traits associated with
the genetic variant is plotted along x-axis. Upto the point 0.8 on the x-axis, all the traits are correlated.
correlation increased among the associated traits, the power of MANOVA dropped. Figure B6 shows
that the lowest point in the MANOVA power curve occurs at 0.8 on the axis, which means MANOVA
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has the least power in detecting association when all the correlated traits are associated. At point
1.0 on the x-axis, when all the traits are associated but not all are correlated, the performance of
MANOVA improves but not as good as the methods that do not explicitly consider the covariance
matrix in the test statistic.
An important observation from Figure B6 is that MANOVA is not expected to suffer from power
loss at ‘complete association’ (when all traits are associated) if all associated traits are not correlated
(refer B5 for theoretical result).
B4.3 Correlation Structure III: AR1(ρ)
For given K traits, we assumed the covariance structure
Σ = σ2R(ρ) = σ2

1 ρ ρ2 . . . ρK−1
ρ 1 ρ . . . ρK−2
...
. . .
...
ρK−1 ρK−2 ρK−3 . . . 1

Figure B7 shows that for a given ρ, MANOVA performs better with increase in K and with increase
in the fraction of associated traits. This is so because at a higher fraction (on the x-axis), the AR1
correlation among traits becomes negligible and the latter traits are effectively uncorrelated (the
behavior we saw in Figures B5 & B6). Observe that for a given ρ, the power at or near ‘complete
association’ (where all traits are associated) increases with increase in K since for the latter traits,
the correlation rapidly goes towards 0. With increase in the parameter ρ and for small K, we start
observing MANOVA’s lack of power as the latter pairwise correlations are not effectively zero.
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Figure B7: Correlation structure III (AR1): Empirical power curves of the different association tests based
on N = 500 datasets for K = 5, 10, 20 traits and AR1(ρ) correlation structure with ρ = 0.2, 0.4, 0.6.
Same direction and same size effects (effect size of 0.395; proportion of variance explained is 0.5%) are
used when 2 or more traits are associated. The power is plotted along y-axis while the fraction of traits
associated with the genetic variant is plotted along x-axis.
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B5 Another theoretical insight (Theorem 3.3)
Figure B6 shows that if all the traits are not correlated, MANOVA does not experience power loss
for testing H0 even when all the traits are associated. This behavior is theoretically explained by the
following theorem for the special case of CS residual correlation structure for the correlated traits.
Theorem 3.3. Without loss of generality, let Y and X be the centered phenotype matrix and the
centered genotype vector respectively. Consider the MMLR model
Y n×K = Xn×1β′1×K + En×K , vec(E) ∼ NnK(0, In ⊗Σ)
where ΣK×K =
Σ11(m×m) Σ12
Σ21 Σ22
, Σ11 = σ2 ((1− ρ)Im + ρ11′), σ2 > 0, ρ (> 0) is the within
trait correlation such that Σ11 is a positive definite covariance matrix, Σ12 = Σ
′
21 = Om×(K−m),
Σ22 = σ
2IK−m and β′ = (β1, ..., βK) is the vector of genetic effects. Assume that the genetic effects
of the associated traits are equal in size and positive. Consider two scenarios of association: ‘partial
association’ (when the SNP is associated with u (< K) traits), and ‘complete association’ (when all
K traits are associated).
For testing H0 : β = 0, MANOVA is not expected to suffer from power loss at ‘complete associ-
ation’ compared to ‘partial association’ with u (> m) associated traits.
Proof. For the m × m CS residual covariance sub-matrix Σ11, we know that the eigen vector
corresponding to the largest eigenvalue λ(m)1 = σ
2{1 + (m − 1)ρ} is v1 ∝ 1, while the eigen
vectors corresponding to λ(m)2 = ... = λ(m)m = σ
2(1 − ρ) are respectively v2, ...,vm such that
1′vk = 0 ∀ k = 2, ...,m. For the eigen vectors to be orthonormal, we must have v1 = cm1 such that√
c2m + ...+ c
2
m = 1 ⇐⇒ c2m = 1/m. Thus, we can write,
Σ11(m×m) = λ(m)1c2m11
′ +
m∑
i=2
λ(m)iviv
′
i and Σ
−1
11 =
1
λ(m)1
c2m11
′ +
m∑
i=2
1
λ(m)i
viv
′
i
Consider the 2 alternatives Ha,u : β1 = ... = βu 6= 0, βK−u = ... = βK = 0 (partial association)
and Ha,K : β1 = ... = βK 6= 0 (complete association) against the null hypothesis H0 : β1 = ... =
βK = 0. Here, for the partial association case, u (> m) is the number of traits associated and m is
the number of correlated traits. In the following, the notation
P→ denotes convergence in probability
as n→∞.
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Under the alternative Ha,K (complete association), it can be shown that
∣∣∣∣∣I + HKn
(
E
n
)−1∣∣∣∣∣ P→
∣∣∣∣∣∣IK + (2pqβ21)
 1m1′m 1m1′K−m
1K−m1′m 1K−m1
′
K−m
Σ−111 O
O 1σ2 IK−m
∣∣∣∣∣∣
=
∣∣(Im + a1m1′m)− (b1m1′K−m)(IK−m + b1K−m1′K−m)−1(a1K−m1′m)∣∣
×|IK−m + b11′|
= |(Im + a1m1′m)− ac(K −m)1m1′m| × |IK−m + b11′|
= 1 + b(K −m) + am
where a =
2pqβ21
σ2{1+(m−1)ρ} , b =
2pqβ21
σ2 , (IK−m + b1K−m1
′
K−m)
−1 = I − c11′, c = b1+(K−m)b .
For u(> m) associated traits, let us now partition the residual covariance matrix as
ΣK×K =
S11(u×u) S12
S′12 S22
 where S11 =
Σ11(m×m) O
O σ2Iu−m
 ,S12 = Ou×(K−u),S22 = σ2IK−u
Under the alternative Ha,u (partial association) where 0 < m < u < K, one can show that
∣∣∣∣∣I + Hun
(
E
n
)−1∣∣∣∣∣ P→
∣∣∣∣∣∣IK + 2pq
β211u1′u O
O O
S−111 O
O 1σ2 IK−u
∣∣∣∣∣∣
=
∣∣∣∣∣∣Iu + 2pqβ211u1′u
Σ−111 O
O 1σ2 Iu−m
∣∣∣∣∣∣
= 1 + b(u−m) + am, where a = 2pqβ
2
1
σ2{1 + (m− 1)ρ} , b =
2pqβ21
σ2
∴
∣∣IK +HKE−1∣∣− ∣∣IK +HuE−1∣∣ P→ b(K − u) > 0

B6 Covariate Adjustment for USAT
The ARIC data analysis using USAT required covariate adjustment (predictors other than SNP).
This version of USAT requires covariate adjustment for both SSU test and MANOVA. Once the
adjusted MANOVA and SSU test statistics are available, one can easily compute approximate p-
value for USAT (refer section 3.2.5 of Chapter 3 for the p-value calculation method). Let Zn×q be
the matrix of q covariates (other than SNP) for n unrelated individuals. Without loss of generality,
the phenotype matrix Y , the genotype vector X and the covariate matrix Z are centered (but not
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scaled). The following paragraphs outline the details of such covariate adjustment.
MANOVA with covariate adjustment
The MMLR model for the association test of K traits and the SNP (after adjusting for other
covariates):
Y n×K = Xn×1β′1×K + 1
′ ⊗ZΦ + En×K
where β′ = (β1, ..., βK) is the vector of fixed unknown genetic effects corresponding to the K corre-
lated traits, and E is the matrix of random errors. For testing that the SNP is not associated with
any of the K traits, the null hypothesis of interest is H0 : β = 0. For testing H0, the LRT is equiv-
alent to the MANOVA test statistic, which is the ratio of generalized variances Λ = |E|/|H +E|.
Here, H + E is the covariance matrix of the K residual vectors where the k-th residual vector is
obtained by fitting the model for k-th trait under H0. E is the covariance matrix of the K residual
vectors where the k-th residual vector is obtained by fitting the full model for k-th trait. Under H0,
Wilk’s Lambda −2 log Λ has an approximate asymptotic χ2K distribution under H0.
SSU Test with covariate adjustment
For k-th trait vector, we assume the marginal normal model :
Y k = βkX +ZΦ + k, k ∼ Nn(0, σ2In)
βk is the parameter associated with the SNP effect on the k-th trait. Φ is the q × 1 vector of
parameters associated with the q covariates. The null hypothesis associated with k-th marginal
model is H0k : βk = 0. We need to obtain the MLE Φˆ under the global null H0 : ∩Kk=1H0,k. Under
H0,k, the k-th marginal model is
Y k = ZΦ + k, k ∼ Nn(0, σ2In)
The MLE of Φ from k-th model is Φˆ(k) = (Z
′Z)−1Z ′Y k. Thus, MLE of Φ under H0 is
Φˆ =
1
K
K∑
k=1
(Z ′Z)−1Z ′Y k
The MLE of σ2 under H0 is given by
σˆ20 =
1
nK
K∑
k=1
(Y k −ZΦˆ)′(Y k −ZΦˆ)
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The log-likelihood for the k-th genetic effect from the k-th marginal model is given by
l(βk) ∝ − 1
2σ2
(Y k − βkX −ZΦ)′(Y k − βkX −ZΦ)
Marginal score for parameter βk under H0k:
Uk = l˙(βk)
∣∣∣∣
H0
=
1
σ2
(Y k − βkX −ZΦ)′X
∣∣∣∣
H0
=
1
σˆ20
(Y k −ZΦˆ)′X
Under the null, the variances and covariances of the marginal scores are:
Var(Uk) =
1
σ4
X ′Var(Y k)X
∣∣∣∣
H0
=
1
σ2
X ′X
∣∣∣∣
H0
Cov(Uk, Uj) =
1
σ4
E(Y ′kX × Y ′jX)
∣∣∣∣
H0
=
1
σ4
X ′ E(Y kY ′j)X
∣∣∣∣
H0
=
ρ
σ2
X ′X
∣∣∣∣
H0
∀ j 6= k
Thus, under H0, the score vector from the marginal normal model for Y is
UM =
(
Y − 1′ ⊗ZΦˆ
)′
X/σˆ20
with covariance
Cov(UM ) =
1
σ4
(X ′X)Σ
∣∣∣∣
H0
=
1
σˆ40
(X ′X)Σˆ0 =
1
σˆ40
(X ′X)
(
Y − 1′ ⊗ZΦˆ
)′ (
Y − 1′ ⊗ZΦˆ
)
n
The SSU test based on the marginal normal score vector UM is
TS = U
′
MUM
approx∼ aχ2d + b
where parameters a, b, d are estimated as
a =
∑
δ3i∑
δ2i
, b =
∑
δi − (
∑
δ2i )
2∑
δ3i
, d =
(
∑
δ2i )
3
(
∑
δ3i )
2
, {δi}Ki=1 are the ordered eigenvalues of Cov(UM )
B7 ARIC Study: Significant SNPs from GWAS
Appendix B 124
Table B1: List of all SNPs that exceed the genome-wide significance threshold 5×10−8 for the multivariate methods
USAT and MANOVA. SNPs with m.a.f. < 5% were screened out. It is to be noted that most of these
SNPs are in high linkage disequilibrium (LD). p values for the univariate analysis of the individual traits
are also provided. SNPs in bold are the ones detected solely by MANOVA but not by USAT. The
abbreviations used are FG (Fasting Glucose), 2-hr GL (2-hour glucose from an oral glucose tolerance
test), FI (Fasting Insulin)
MANOVA USAT Univariate Analysis p
chr SNP position p p FG 2-hr GL FI
2 rs1260326 27584444 3.77× 10−15 4.44× 10−15 1.24× 10−4 6.26× 10−6 1.24× 10−5
2 rs780094 27594741 9.99× 10−16 1.67× 10−15 7.34× 10−5 7.10× 10−6 4.65× 10−6
2 rs780093 27596107 9.99× 10−16 1.67× 10−15 7.34× 10−5 7.10× 10−6 4.65× 10−6
2 rs1260333 27602128 4.72× 10−11 8.14× 10−11 4.99× 10−4 3.84× 10−4 7.59× 10−5
2 rs2911711 27604050 4.72× 10−11 8.14× 10−11 4.99× 10−4 3.84× 10−4 7.59× 10−5
2 rs4665987 27609329 9.67× 10−10 2.31× 10−9 1.56× 10−2 4.49× 10−6 1.46× 10−2
2 rs4665991 27619788 1.23× 10−9 2.57× 10−9 1.75× 10−2 4.83× 10−6 1.44× 10−2
2 rs4665382 27637305 1.20× 10−9 2.54× 10−9 1.52× 10−2 5.13× 10−6 1.60× 10−2
2 rs10208529 27639692 1.20× 10−9 2.54× 10−9 1.52× 10−2 5.13× 10−6 1.60× 10−2
2 rs4665383 27645059 1.20× 10−9 2.54× 10−9 1.52× 10−2 5.13× 10−6 1.60× 10−2
2 rs1919127 27654997 1.20× 10−9 2.54× 10−9 1.52× 10−2 5.13× 10−6 1.60× 10−2
2 rs1919128 27655263 1.20× 10−9 2.54× 10−9 1.52× 10−2 5.13× 10−6 1.60× 10−2
2 rs12478841 27665226 1.06× 10−9 2.40× 10−9 1.63× 10−2 4.96× 10−6 1.31× 10−2
2 rs6760250 27665756 9.94× 10−10 2.34× 10−9 1.49× 10−2 6.01× 10−6 1.07× 10−2
2 rs13022873 27669014 9.94× 10−10 2.34× 10−9 1.49× 10−2 6.01× 10−6 1.07× 10−2
2 rs12467476 27679219 9.86× 10−10 2.33× 10−9 1.53× 10−2 6.00× 10−6 1.02× 10−2
2 rs2384656 27685559 9.86× 10−10 2.33× 10−9 1.53× 10−2 6.00× 10−6 1.02× 10−2
2 rs4666002 27694144 8.64× 10−10 1.43× 10−9 1.61× 10−2 5.56× 10−6 9.02× 10−3
2 rs3749147 27705422 6.52× 10−9 1.31× 10−8 3.65× 10−2 6.56× 10−6 1.86× 10−2
2 rs13002853 27706749 6.52× 10−9 1.31× 10−8 3.65× 10−2 6.56× 10−6 1.86× 10−2
2 rs13431652 169461661 1.85× 10−13 5.48× 10−13 2.24× 10−12 9.57× 10−1 2.85× 10−1
2 rs12475700 169461922 4.52× 10−8 8.76× 10−8 1.07× 10−8 3.62× 10−1 6.73× 10−1
2 rs1402837 169465600 4.91× 10−9 1.15× 10−8 2.78× 10−10 5.18× 10−2 8.07× 10−1
2 rs573225 169465787 4.55× 10−14 5.81× 10−14 9.75× 10−13 9.83× 10−1 2.33× 10−1
2 rs560887 169471394 5.55× 10−16 1.33× 10−15 1.24× 10−14 8.87× 10−1 2.93× 10−1
2 rs563694 169482317 1.54× 10−14 2.91× 10−14 4.12× 10−14 3.50× 10−1 3.54× 10−1
2 rs537183 169482892 1.54× 10−14 2.91× 10−14 4.12× 10−14 3.50× 10−1 3.54× 10−1
2 rs502570 169483205 1.54× 10−14 2.91× 10−14 4.12× 10−14 3.50× 10−1 3.54× 10−1
2 rs475612 169484992 3.54× 10−13 7.12× 10−13 3.74× 10−13 3.63× 10−1 5.12× 10−1
2 rs557462 169485841 1.54× 10−14 2.91× 10−14 4.12× 10−14 3.50× 10−1 3.54× 10−1
2 rs478333 169487402 8.61× 10−10 1.42× 10−9 3.33× 10−10 4.16× 10−1 6.41× 10−1
2 rs496550 169487958 8.61× 10−10 1.42× 10−9 3.33× 10−10 4.16× 10−1 6.41× 10−1
2 rs473351 169488142 2.58× 10−11 6.05× 10−11 1.38× 10−11 2.75× 10−1 5.29× 10−1
2 rs575671 169489064 2.58× 10−11 6.05× 10−11 1.38× 10−11 2.75× 10−1 5.29× 10−1
2 rs519887 169489131 8.50× 10−10 1.41× 10−9 3.45× 10−10 4.40× 10−1 6.41× 10−1
2 rs486981 169490395 2.72× 10−14 4.05× 10−14 1.15× 10−13 6.17× 10−1 3.89× 10−1
2 rs484066 169490727 2.01× 10−12 2.32× 10−12 6.10× 10−12 8.54× 10−1 4.87× 10−1
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. . . continued
MANOVA USAT Univariate Analysis p
chr SNP position p p FG 2-hr GL FI
2 rs569805 169491126 2.72× 10−14 4.05× 10−14 1.15× 10−13 6.17× 10−1 3.89× 10−1
2 rs579060 169491285 2.45× 10−14 3.77× 10−14 9.95× 10−14 6.04× 10−1 3.93× 10−1
2 rs17540154 169492739 3.46× 10−9 6.48× 10−9 3.41× 10−10 2.33× 10−1 9.19× 10−1
2 rs508506 169493201 3.55× 10−14 4.86× 10−14 8.64× 10−14 5.74× 10−1 4.97× 10−1
2 rs503931 169493695 8.50× 10−10 1.41× 10−9 3.45× 10−10 4.40× 10−1 6.41× 10−1
2 rs551754 169495932 8.50× 10−10 1.41× 10−9 3.45× 10−10 4.40× 10−1 6.41× 10−1
2 rs497692 169497262 8.41× 10−10 1.41× 10−9 3.27× 10−10 4.24× 10−1 6.46× 10−1
2 rs494874 169497552 1.42× 10−13 5.06× 10−13 1.70× 10−13 5.38× 10−1 6.48× 10−1
2 rs552976 169499684 1.55× 10−13 5.19× 10−13 1.87× 10−13 5.31× 10−1 6.37× 10−1
2 rs472614 169500667 1.26× 10−8 2.65× 10−8 3.55× 10−9 5.72× 10−1 8.17× 10−1
2 rs565412 169502529 9.14× 10−9 1.57× 10−8 4.16× 10−9 7.18× 10−1 7.34× 10−1
2 rs567074 169502677 3.45× 10−10 5.76× 10−10 1.51× 10−10 6.13× 10−1 8.04× 10−1
2 rs479682 169502933 7.13× 10−9 1.37× 10−8 3.33× 10−9 6.89× 10−1 7.06× 10−1
2 rs480562 169503017 7.46× 10−9 1.40× 10−8 3.43× 10−9 6.84× 10−1 7.07× 10−1
2 rs2685803 169504531 7.46× 10−9 1.40× 10−8 3.43× 10−9 6.84× 10−1 7.07× 10−1
2 rs2544367 169504534 4.54× 10−9 7.54× 10−9 2.46× 10−9 7.19× 10−1 6.85× 10−1
2 rs2685805 169505306 4.54× 10−9 7.54× 10−9 2.46× 10−9 7.19× 10−1 6.85× 10−1
2 rs1581397 169505898 4.05× 10−9 7.05× 10−9 2.40× 10−9 7.37× 10−1 6.66× 10−1
2 rs2685814 169506865 3.62× 10−9 6.63× 10−9 2.19× 10−9 7.48× 10−1 6.71× 10−1
2 rs6709087 169507256 3.87× 10−8 8.13× 10−8 2.55× 10−9 2.67× 10−1 6.74× 10−1
2 rs853789 169509734 2.00× 10−15 2.66× 10−15 8.50× 10−15 6.36× 10−1 4.84× 10−1
2 rs860510 169509874 3.62× 10−9 6.63× 10−9 2.19× 10−9 7.48× 10−1 6.71× 10−1
2 rs853788 169510151 3.62× 10−9 6.63× 10−9 2.19× 10−9 7.48× 10−1 6.71× 10−1
2 rs853787 169510498 2.00× 10−15 2.66× 10−15 8.50× 10−15 6.36× 10−1 4.84× 10−1
2 rs853786 169510556 3.62× 10−9 6.63× 10−9 2.19× 10−9 7.48× 10−1 6.71× 10−1
2 rs862662 169510575 1.52× 10−10 2.42× 10−10 1.01× 10−10 6.80× 10−1 7.17× 10−1
2 rs853785 169510840 3.62× 10−9 6.63× 10−9 2.19× 10−9 7.48× 10−1 6.71× 10−1
2 rs853784 169511920 5.48× 10−9 1.21× 10−8 3.37× 10−9 8.18× 10−1 7.11× 10−1
2 rs853783 169513757 5.48× 10−9 1.21× 10−8 3.37× 10−9 8.18× 10−1 7.11× 10−1
2 rs853781 169514567 3.43× 10−10 5.74× 10−10 2.19× 10−10 7.37× 10−1 7.53× 10−1
2 rs853780 169515728 7.62× 10−9 1.42× 10−8 4.68× 10−9 7.98× 10−1 6.76× 10−1
2 rs1101533 169516768 7.62× 10−9 1.42× 10−8 4.68× 10−9 7.98× 10−1 6.76× 10−1
2 rs853779 169517918 4.39× 10−9 7.39× 10−9 2.88× 10−9 7.91× 10−1 6.67× 10−1
2 rs853778 169519470 1.28× 10−9 2.62× 10−9 1.52× 10−9 9.11× 10−1 5.79× 10−1
2 rs853773 169522593 1.63× 10−9 2.96× 10−9 2.44× 10−9 8.12× 10−1 7.64× 10−1
15 rs17271144 59920213 4.47× 10−8 8.71× 10−8 6.21× 10−2 4.17× 10−6 1.06× 10−1
15 rs3743297 59937076 4.59× 10−8 8.84× 10−8 1.09× 10−2 2.87× 10−5 2.49× 10−1
15 rs1981916 59958771 3.14× 10−8 7.42× 10−8 8.50× 10−3 2.89× 10−5 2.56× 10−1
15 rs2414755 59959721 3.14× 10−8 7.42× 10−8 8.50× 10−3 2.89× 10−5 2.56× 10−1
15 rs2042608 60019672 3.02× 10−8 7.29× 10−8 1.71× 10−3 1.16× 10−4 0.59
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. . . continued
MANOVA USAT Univariate Analysis p
chr SNP position p p FG 2-hr GL FI
15 rs7170293 60023665 1.98× 10−8 6.28× 10−8 5.77× 10−3 3.20× 10−5 2.68× 10−1
15 rs1425270 60025002 2.25× 10−8 6.54× 10−8 1.25× 10−2 1.28× 10−5 2.68× 10−1
15 rs7166891 60026596 1.98× 10−8 6.28× 10−8 5.77× 10−3 3.20× 10−5 2.68× 10−1
15 rs7172145 60026989 1.98× 10−8 6.28× 10−8 5.77× 10−3 3.20× 10−5 2.68× 10−1
15 rs4587915 60029254 1.44× 10−8 2.82× 10−8 9.60× 10−3 1.12× 10−5 3.28× 10−1
15 rs8027751 60035012 3.81× 10−8 8.07× 10−8 8.78× 10−3 2.73× 10−5 3.33× 10−1
15 rs3784634 60046929 2.52× 10−8 6.81× 10−8 1.54× 10−2 9.17× 10−6 3.40× 10−1
15 rs8034335 60074748 1.19× 10−8 2.59× 10−8 1.43× 10−2 5.58× 10−6 3.35× 10−1
15 rs8034216 60074820 1.19× 10−8 2.59× 10−8 1.43× 10−2 5.58× 10−6 3.35× 10−1
15 rs17271305 60120272 6.87× 10−9 1.35× 10−8 6.29× 10−3 1.17× 10−5 2.86× 10−1
15 rs17271340 60135177 8.99× 10−9 1.55× 10−8 1.68× 10−2 3.71× 10−6 3.08× 10−1
15 rs8039105 60146377 8.71× 10−9 1.53× 10−8 1.65× 10−2 3.75× 10−6 3.05× 10−1
15 rs4502156 60170447 3.38× 10−8 7.65× 10−8 1.31× 10−4 1.62× 10−3 0.20
15 rs7163757 60178900 1.68× 10−8 5.98× 10−8 7.98× 10−4 3.52× 10−4 4.88× 10−2
15 rs7173964 60184234 2.06× 10−8 6.36× 10−8 1.15× 10−3 3.04× 10−4 4.47× 10−2
15 rs8037894 60181556 8.20× 10−9 1.48× 10−8 4.09× 10−4 4.89× 10−4 3.12× 10−2
15 rs6494307 60181982 1.68× 10−8 5.98× 10−8 7.98× 10−4 3.52× 10−4 4.88× 10−2
15 rs7167878 60183481 1.68× 10−8 5.98× 10−8 7.98× 10−4 3.52× 10−4 4.88× 10−2
15 rs7172432 60183681 1.68× 10−8 5.98× 10−8 7.98× 10−4 3.52× 10−4 4.88× 10−2
B8 ARIC Study: Interesting SNPs by USAT
Table B2: List of interesting SNPs that barely missed the genome-wide threshold (5× 10−8) for USAT. SNPs with
m.a.f. < 5% were screened out. The MANOVA and the univariate analyses p-values are also provided.
The SNPs listed here are the ones left after LD screening. In a group of highly correlated SNPs (i.e.,
SNPs with estimated absolute pairwise correlation coefficient > 0.8 with another SNP), one SNP was
kept as a representative. The abbreviations used are FG (Fasting Glucose), 2-hr GL (2-hour glucose from
an oral glucose tolerance test), FI (Fasting Insulin).
For convenience, the optimal ω has been reported. It represents the adaptive weight given to MANOVA
statistic by the USAT approach. One must note that when SSU and MANOVA p-values are close, the
optimal weight ω in USAT is not really identifiable. One can expect SSU and MANOVA to behave
similarly at ‘partial association’ when number of traits is few and they are weakly correlated (refer Figure
3.5).
MANOVA USAT Univariate Analysis p
chr SNP m.a.f. p p ω FG 2-hr GL FI
1 rs12095642 0.282 6.10× 10−4 4.71× 10−5 0.00 6.30× 10−1 8.08× 10−2 9.07× 10−5
1 rs10920639 0.166 1.36× 10−3 4.63× 10−5 0.00 1.15× 10−1 4.66× 10−1 9.77× 10−5
2 rs12622958 0.249 9.61× 10−4 9.61× 10−5 0.00 3.61× 10−1 4.37× 10−2 1.69× 10−4
3 rs9836499 0.367 1.26× 10−3 9.76× 10−5 0.00 4.26× 10−1 8.81× 10−1 3.51× 10−4
3 rs2336664 0.366 1.21× 10−3 9.50× 10−5 0.00 4.24× 10−1 8.94× 10−1 3.36× 10−4
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. . . continued
MANOVA USAT Univariate Analysis p
chr SNP m.a.f. p p ω FG 2-hr GL FI
3 rs6790846 0.095 5.68× 10−3 9.32× 10−5 0.00 9.06× 10−1 3.29× 10−1 6.69× 10−4
5 rs3798012 0.062 1.27× 10−4 7.84× 10−6 0.55 2.92× 10−1 7.81× 10−1 6.37× 10−6
5 rs7718567 0.132 4.49× 10−4 9.02× 10−5 0.70 5.85× 10−1 2.93× 10−1 1.23× 10−4
5 rs10213852 0.059 5.00× 10−4 9.05× 10−5 0.50 8.00× 10−1 5.32× 10−1 6.33× 10−5
5 rs10515261 0.097 3.00× 10−3 4.89× 10−5 0.00 2.31× 10−2 3.93× 10−1 6.29× 10−4
5 rs11135532 0.199 6.84× 10−4 4.90× 10−5 0.00 3.83× 10−2 1.30× 10−1 8.48× 10−5
5 rs1438733 0.255 1.72× 10−3 5.02× 10−5 0.00 8.32× 10−1 9.95× 10−1 1.47× 10−4
6 rs7753319 0.421 7.68× 10−4 3.13× 10−6 0.00 7.00× 10−1 2.20× 10−1 3.42× 10−4
6 rs6906163 0.139 2.21× 10−3 9.41× 10−5 0.00 3.66× 10−1 7.61× 10−1 2.24× 10−4
7 rs7793197 0.175 3.07× 10−3 4.56× 10−6 0.00 6.43× 10−1 1.06× 10−1 4.77× 10−4
10 rs2671692 0.367 6.96× 10−4 5.05× 10−6 0.00 5.83× 10−1 7.66× 10−1 6.15× 10−5
10 rs4376833 0.219 9.40× 10−4 8.93× 10−5 0.00 5.54× 10−1 4.47× 10−1 5.73× 10−5
12 rs7962136 0.186 1.38× 10−3 5.00× 10−5 0.00 4.53× 10−1 1.31× 10−1 1.36× 10−4
12 rs11829673 0.051 2.39× 10−4 8.91× 10−5 0.65 3.78× 10−1 6.08× 10−1 9.11× 10−5
13 rs7998882 0.122 1.60× 10−4 9.71× 10−5 0.85 8.86× 10−1 1.45× 10−1 9.18× 10−5
15 rs16957165 0.094 1.98× 10−4 9.43× 10−5 0.80 2.29× 10−2 5.81× 10−3 1.45× 10−4
15 rs931892 0.102 2.03× 10−4 8.59× 10−5 0.75 1.65× 10−2 2.21× 10−2 6.78× 10−5
16 rs11149640 0.374 1.50× 10−3 3.39× 10−5 0.00 5.93× 10−1 9.09× 10−1 1.21× 10−4
18 rs1443598 0.092 1.81× 10−4 2.80× 10−6 0.65 6.91× 10−1 9.61× 10−1 2.62× 10−5
18 rs11660607 0.287 3.16× 10−3 9.59× 10−5 0.00 4.26× 10−1 5.07× 10−1 2.03× 10−4
18 rs12604897 0.139 1.05× 10−3 4.61× 10−5 0.00 2.19× 10−1 3.27× 10−1 6.23× 10−5
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B9 Performance of USAT: Alternative scenarios
B9.1 Traits with AR1 correlation
Figure B8: Empirical power curves of the SSU and MANOVA tests along with our novel approach USAT for AR1(ρ)
within-trait correlation structure. K = 5, 10, 20 traits have been simulated at different within trait
correlation values ρ = 0.2, 0.4, 0.6. For each value of K and ρ, there were N = 500 datasets of n = 400
unrelated individuals. Same effect size of 0.395 (proportion of variance explained is 0.5%) was used for
the traits that are associated. The power is plotted along y-axis while the fraction of traits associated
with the genetic variant is plotted along x-axis.
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B9.2 Multivariate t distributed traits
The normality of traits is not a key assumption behind USAT when we have common variants.
Ensuring that the phenotypes are continuous seems to be sufficient when m.a.f. of the SNP is not
low. O’Reilly et al. (2012) found that CCA or MANOVA can be sensitive to non-normality of traits
when SNP has low m.a.f., and hence USAT will be sensitive in such scenarios. For this purpose,
we simulated phenotypes from the multivariate t-distribution. The m.a.f. of SNP was fixed at
0.2. As before, we first simulated X taking values 0, 1, 2. The two alleles at the SNP were sampled
independently to ensure Hardy-Weinberg equilibrium. Conditional on X, we simulated Y for a fixed
K using the simulation model Y = β01 +βX + , where the vectors Y , 1, β,  are K-dimensional.
We took β0 = 1 and simulated  from tν(0, σ
2R(ρ)), where R(ρ) is a CS correlation matrix. σ2 = 10
was fixed, and values of K, ρ and ν were varied. We considered K = 5, 10, 20; ρ = 0.2, 0.4, 0.6; and
ν = 3, 10, 50. The genetic effect size of 0.395 (proportion of variance explained is 0.5%) is used for
all the associated traits.
For small values of the degrees of freedom ν (e.g., ν = 3) of multivariate t, both MANOVA
and SSU lacked some power. For moderate to high values of ν (e.g., ν = 10, 50), power curves for
both methods were comparable to those from normally distributed phenotypes. Figure B9 shows
the relative performance of MANOVA, SSU and USAT for ν = 10.
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Figure B9: Empirical power curves of the SSU and MANOVA tests along with our novel approach USAT for mul-
tivariate t distributed traits with degrees of freedom ν = 10. A CS(ρ) correlation structure is assumed.
K = 5, 10, 20 traits have been simulated at different within trait correlation values ρ = 0.2, 0.4, 0.6. For
each value of K and ρ, there were N = 500 datasets of n = 400 unrelated individuals. Same effect size of
0.395 (proportion of variance explained is 0.5%) was used for the traits that are associated. The power
is plotted along y-axis while the fraction of traits associated with the genetic variant is plotted along
x-axis.
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B9.3 SNP with m.a.f. 5%
Figure B10: Empirical power curves of the SSU and MANOVA tests along with our novel approach USAT for
CS(ρ) within-trait correlation structure. K = 5, 10, 20 traits have been simulated at different within
trait correlation values ρ = 0.2, 0.4, 0.6. For each value of K and ρ, there were N = 500 datasets of
n = 400 unrelated individuals. A single SNP with minor allele frequency (m.a.f.) 0.05 was simulated.
Same effect size of 0.725 (proportion of variance explained is 0.5%) was used for the traits that are
associated. The power is plotted along y-axis while the fraction of traits associated is plotted along
x-axis. This figure shows that the relative behavior of MANOVA and the SSU test does not vary much
with change in m.a.f. Since our proposed test USAT is derived from an optimal weighted combination
of MANOVA and the SSU test, the performance of USAT compared to MANOVA or SSU also does
not vary much with change in m.a.f.
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Supplementary Materials for Chapter 4
C1 Mathematical Proofs
C1.1 Proof of Theorem 4.1
For ease of notation, let us denote distribution of a random variable/vector by the square braces [.].
For a binary/categorical variable like D, [D] would mean P(D = d) (the probability mass function
of D). For a continuous variable like Yk, [Yk] would mean fYk(yk) (the probability density function
of Yk), k = 1, 2, ...,K.
• DAG ‘A’: Under H0, the order of dependence of the variables is [X], [Y ], [D], [S|D]
For the analysis treating the ascertained sample as if it were cross-sectional,
[Y , X|S = 1] =
∑1
d=0[Y , X, S = 1, D = d]
[S = 1]
=
∑1
d=0[S = 1|D = d,Y , X] [D = d|Y , X] [Y |X] [X]
[S = 1]
=
∑1
d=0[S = 1|D = d] [D = d] [Y ] [X]∑1
d=0[S = 1|D = d] [D = d]
=
(∑1
d=0[S = 1|D = d] [D = d]∑1
d=0[S = 1|D = d] [D = d]
[Y ]
)
×
(∑1
d=0[S = 1|D = d] [D = d]∑1
d=0[S = 1|D = d] [D = d]
[X]
)
=
(∑
d[S = 1|D = d,Y ] [D|Y ] [Y ]
[S]
)
×
(∑
d[S = 1|D = d,X] [D|X] [X]
[S]
)
=
(∑
d
[Y , D = d|S = 1]
)
×
(∑
d
[X,D = d|S = 1]
)
= [Y |S = 1] [X|S = 1] 
For the analysis conditioning on the case-control design variable,
[Y , X|D = d, S = 1] = [Y , X,D = d, S = 1]
[D = d, S = 1]
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=
[S = 1|D = d] [D = d] [Y ] [X]
[S = 1|D = d] [D = d]
=
(
[S = 1|D = d] [D = d] [Y ]
[S = 1|D = d] [D = d]
)
×
(
[S = 1|D = d] [D = d] [X]
[S = 1|D = d] [D = d]
)
= [Y |D = d, S = 1] [X|D = d, S = 1] 
• DAG ‘B’: Under H0, the order of dependence of the variables is [X], [Y ], [D|X], [S|D]
For the analysis treating the ascertained sample as if it were cross-sectional,
[Y , X|S = 1] =
∑1
d=0[Y , X, S = 1, D = d]
[S = 1]
=
∑1
d=0[S = 1|D = d] [D = d|X]∑1
d=0
∑2
x=0[S = 1|D = d] [D = d|X] [X]
[Y ] [X]
=
(
[Y ]
∑1
d=0
∑2
x=0[S = 1|D = d] [D = d|X] [X]∑1
d=0
∑2
x=0[S = 1|D = d] [D = d|X] [X]
)
×(
[X]
∑1
d=0[S = 1|D = d] [D = d|X]∑1
d=0
∑2
x=0[S = 1|D = d] [D = d|X] [X]
∫
y
[Y ]
)
= [Y |S = 1] [X|S = 1] 
For the analysis conditioning on the case-control design variable,
[Y , X|D = d, S = 1] = [Y , X,D = d, S = 1]
[D = d, S = 1]
=
[S = 1|D = d] [D = d|X] [Y ] [X]
[S = 1|D = d] [D = d|X]
=
(
[S = 1|D = d] [D = d|X] [Y ]
[S = 1|D = d] [D = d|X]
)
×
(
[S = 1|D = d] [D = d|X] [X]
[S = 1|D = d] [D = d|X]
)
= [Y |D = d, S = 1] [X|D = d, S = 1] 
• DAG ‘C’: Under H0, the order of dependence of the variables is [X], [Y ], [D|Y ], [S|D]
For the analysis treating the ascertained sample as if it were cross-sectional,
[Y , X|S = 1] =
∑1
d=0[Y , X, S = 1, D = d]
[S = 1]
=
∑1
d=0[S = 1|D = d] [D = d|Y ]∑1
d=0
∫
y
[S = 1|D = d] [D = d|Y ] [Y ] [Y ] [X]
=
(
[X]
∑1
d=0
∫
y
[S = 1|D = d] [D = d|Y ] [Y ]∑1
d=0
∫
y
[S = 1|D = d] [D = d|Y ] [Y ]
)
×(
[Y ]
∑1
d=0[S = 1|D = d] [D = d|X]∑1
d=0
∫
y
[S = 1|D = d] [D = d|X] [X]
2∑
x=0
[X]
)
= [Y |S = 1] [X|S = 1] 
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For the analysis conditioning on the case-control design variable,
[Y , X|D = d, S = 1] = [S = 1|D = d] [D = d|Y ] [Y ] [X]
[S = 1|D = d] [D = d|Y ]
=
(
[S = 1|D = d] [D = d|Y ] [Y ]
[S = 1|D = d] [D = d|Y ]
)
×
(
[S = 1|D = d] [D = d|Y ] [X]
[S = 1|D = d] [D = d|Y ]
)
= [Y |D = d, S = 1] [X|D = d, S = 1] 
• DAG ‘D’: Under H0, the order of dependence of the variables is [X], [D], [Y |D], [S|D]
For the analysis treating the ascertained sample as if it were cross-sectional,
[Y , X|S = 1] =
∑1
d=0[Y , X, S = 1, D = d]
[S = 1]
=
∑1
d=0[S = 1|D = d] [Y |D = d] [D]
[S = 1]
[X]
=
(∑1
d=0[S = 1|D = d] [Y |D = d] [D]
[S = 1]
)
×
(
[S = 1]
[S = 1]
[X]
)
=
(∑1
d=0[S = 1|D = d] [Y |D = d] [D]
[S = 1]
2∑
x=0
[X]
)
×(∑1
d=0
∫
y
[S = 1|D = d] [Y |D = d] [D]
[S = 1]
[X]
)
=
(∑
d
∑
x[S = 1, D = d,Y , X]
[S = 1]
)
×
(∑
d
∫
y
[S = 1, D = d,Y , X]
[S = 1]
)
= [Y |S = 1] [X|S = 1] 
For the analysis conditioning on the case-control design variable,
[Y , X|D = d, S = 1] = [S = 1|D = d] [Y |D = d] [D]
[D = d, S = 1]
[X]
=
(
[S = 1|D = d] [Y |D = d] [D]
[D = d, S = 1]
2∑
x=0
[X]
)
×(∫
y
[S = 1|D = d] [Y |D = d] [D]
[D = d, S = 1]
[X]
)
=
(∑
x[S = 1, D = d,Y , X]
[D = d, S = 1]
)
×
(∫
y
[S = 1, D = d,Y , X]
[D = d, S = 1]
)
= [Y |D = d, S = 1] [X|D = d, S = 1] 
C1.2 Proof of Theorem 4.2
DAG ‘F’: Under H0, the order of dependence of the variables is [X], [D|X], [Y |D], [S|D]
Appendix C 135
For the analysis treating the ascertained sample as if it were cross-sectional,
[Y , X|S = 1] =
∑1
d=0[Y |D = d] [S = 1|D = d] [D = d|X] [X]
[S = 1]
while [Y |S = 1] [X|S = 1] =
∑1
d=0[Y |D = d] [S = 1|D = d] [D = d]
[S = 1]
×∑1
d=0[S = 1|D = d] [D = d|X] [X]
[S = 1]
If the two sides were equal, then∑
d[Y |D] [S|D] [D|X]
[S]
× [X] =
∑
d[Y |D] [S|D] [D]
[S]
×
∑
d[S|D] [D|X]
[S]
× [X](∑
d
[Y |D] [S|D] [D|X]
)
=
(∑
d
[Y |D] [S|D] [D]
)(∑
d
[S|D] [D|X]
)/(∑
d
[S|D] [D]
)
Expansion of the terms gives(
[S|D = 1][D = 1] + [S|D = 0][D = 0]
)
×
(
[Y |D = 1][S|D = 1][D = 1|X] + [Y |D = 0][S|D = 0][D = 0|X]
)
=
(
[Y |D = 1][S|D = 1][D = 1] + [Y |D = 0][S|D = 0][D = 0]
)
×
(
[S|D = 1][D = 1|X] + [S|D = 0][D = 0|X]
)
After term by term multiplication, we get
[Y |D = 1][S|D = 1][S|D = 0]
(
[D = 0][D = 1|X]− [D = 0|X][D = 1]
)
=
[Y |D = 0][S|D = 0][S|D = 1]
(
[D = 0][D = 1|X]− [D = 0|X][D = 1]
)
Note that [D = 0][D = 1|X] − [D = 0|X][D = 1] 6= 0, so that we get [Y |D = 1] = [Y |D = 0] (which is a
contradiction). Thus, the claim that [Y , X|S = 1] = [Y |S = 1] [X|S = 1] is wrong. 
For the analysis conditioning on the case-control design variable,
[Y , X|D = d, S = 1] = [Y |D = d, S = 1] [S = 1|D = d] [D = d|X] [X]
[D = d, S = 1]
= [Y |D = d, S = 1]× [X,D = d, S = 1]
[D = d, S = 1]
= [Y |D = d, S = 1] [X|D = d, S = 1] 
C1.3 Proof of Theorem 4.3
DAG ‘E’: The order of dependence of the variables is [X], [Y |X], [D|Y , X], [S|D]
Given genotype X, the distribution of secondary phenotypes Y conditioned on the ascertainment S
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is given by
[Y |X,S = 1] =
∑1
d=0[Y , D = d,X, S = 1]∑1
d=0[S = 1, D = d,X]
=
∑
d[S = 1|D = d] [D = d|Y , X] [Y |X] [X]∑
d[S = 1|D = d] [D = d|X] [X]
= [Y |X]
∑
d[S = 1|D = d] [D = d|Y , X]∑
d[S = 1|D = d] [D = d|X]
Clearly, if α = 0, we have [Y |X,S = 1] = [Y |X] 
Corollary C1.1. In particular, when α = 0, the population model (4.6) for X, Y and D in DAG
‘E’ boils down to:
[X] : P(Xi = x) =

(1− f)2, if x = 0
2f(1− f), if x = 1
f2, if x = 2[
Y |X] : Y i = β∗01 +Xiβ∗ + i, i i.i.d.∼ NK (0,Σ)[
D|X] : logit(P(Di = 1)) = α0 + αxXi, ∀ i = 1, 2, ..., n
which represents a scenario similar to DAG ‘B’. 
DAG ‘E’: Under H0, the order of dependence of the variables is [X], [Y ], [D|Y , X], [S|D]. For the
analysis conditioning on the case-control design variable,
[Y |X,D, S = 1] = [S = 1|D] [D|Y , X] [Y |X] [X]
[S = 1|D] [D|X] [X] =
[S = 1|D] [D|Y , X] [Y ]
[S = 1|D] [D|X]
and, [Y |D,S = 1] = [S = 1|D] [Y ]
∑2
x=0[D|Y , X = x] [X = x]
[S = 1|D] [D]
If, under H0, Y and X are independent conditioned on S and D, then the above should be equal,
i.e., we must have
[D|Y , X]
[D|X] =
∑2
x=0[D|Y , X] [X]
[D]
=
[D|Y ]
[D]
From the population model (4.6) for DAG ‘E’, the above can not hold unless αx = 0 (contradiction)
and hence X and Y are not independent conditional on S and D under the null. 
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C2 DAG ‘F’: Expected bias of SSU for K = 2 traits
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Figure C1: Plot of SSU’s expected bias and empirical bias for Trait 1 under the null for DAG ‘F’. The following
simulation order is used: [X], [D|X], [Y |D] (null simulations with true genetic effects zero). 95% confi-
dence intervals are placed for the empirical bias estimates. Conditioning event [S] means the analysis is
based on the entire case-control sample only. Conditioning event [S,D] means the analysis is based on
the entire case-control sample, and the analysis model is adjusted for D. In each case, the true β∗k = 0
for k = 1, 2
The bias in estimating genetic effects (equation (4.8)) has been quantified for the unadjusted SSU
approach under DAG ‘F’. We calculated this bias based on 500 null datasets under DAG ‘F’ (similar
to the null simulations described in section 4.3.1). For the calculation of bias, we used information
from D and X only. The secondary phenotype Y information was not used in any way. Figure C1
shows that irrespective of the correlation among the 2 traits, the bias in estimating the genetic effect
of given trait is well away from its true value (zero) when D is not adjusted in the model. When D
is adjusted, there will be no bias in genetic effect estimation.
C3 Simulation 2: Plots
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Figure C2: For DAG ‘A’, the following simulation order is used: [X], [Y |X], [D]. True genetic effect for Trait 1
is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
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Figure C3: For DAG ‘B’, the following simulation order is used: [X], [Y |X], [D|X]. True genetic effect for Trait
1 is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
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Figure C4: For DAG ‘C’, the following simulation order is used: [X], [Y |X], [D|Y ]. True genetic effect for Trait
1 is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
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Figure C5: For DAG ‘D’, the following simulation order is used: [X], [Y |X], [Y |D]. True genetic effect for Trait
1 is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
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Figure C6: For DAG ‘E’, the following simulation order is used: [X], [Y |X], [D|Y , X]. True genetic effect for Trait
1 is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
l l l l
−
0.
2
0.
2
0.
6
Mean: Trait = 1; DAG F; [S]
correlation ρ
−0.8 −0.2 0.2 0.8
l l l l
−
0.
2
0.
2
0.
6
Mean: Trait = 1; DAG F; [S,D]
correlation ρ
bi
as
−0.8 −0.2 0.2 0.8
l l l l
−
0.
2
0.
2
0.
6
Mean: Trait = 2; DAG F; [S]
correlation ρ
bi
as
−0.8 −0.2 0.2 0.8
l l l l
−
0.
2
0.
2
0.
6
Mean: Trait = 2; DAG F; [S,D]
correlation ρ
bi
as
−0.8 −0.2 0.2 0.8
l lMANOVA SSU SSU−POM LRT−POM SMAT
Figure C7: For DAG ‘F’, the following simulation order is used: [X], [D|X], [Y |D,X]. True genetic effect for Trait
1 is 0.25 and for Trait 2 is 0 (only first trait is associated). Event [S] means the case-control sample is
analyzed without any adjustment for ascertainment. Event [S,D] means the analyses are based on the
case-control sample and adjusted for D. Columns 1 & 3 correspond to mean estimated genetic effect
under [S], and columns 2 & 4 correspond to those under [S,D].
